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Abstract 
Tissue engineering has been defined as an interdisciplinary field which aims at 
developing implants to induce or support the regeneration of tissues and organs in 
compromised defect environments. Despite significant scientific advances no large 
scale clinical translation of current concepts has taken place yet. As numerous scientific 
questions remain unanswered concerning for example mechanisms of action, the 
current focus of the field is predominantly aimed at the development and validation of 
novel concepts with potential future clinical applications. Although essential for 
product development, clinical translation and implementation of these concepts will 
only be feasible if the production of the resulting products can be accomplished using 
standardized, automated, controlled, reproducible and safe processes. The translation 
of lab scale processes to a clinical and industrial relevant environment can, however, 
have significant implications on the process and resulting product. An integrated 
approach combining product and process development, thereby taking into account 
future translational aspects from the conceptual development onwards, can facilitate 
significant advances towards clinical applications. Within this context the use of 
various bioreactor systems for cell based product development has already been 
explored as these systems can provide the required controlled, automated and closed 
process environment. The integration of essential up- and down-stream process steps 
such as cell expansion as well as the development of tools for process monitoring and 
quality control towards integrated bioprocess development is, however, lacking. 
Consequently, numerous technological challenges essential for successful clinical 
implementation remain to be addressed. The influence of the in vitro micro-
environment created to facilitate these up- and down-stream processes on cell viability, 
identity, purity and potency will, however, determine the final applicability of these 
bioreactor systems. 
In order to assess the potential use of a three dimensional perfusion bioreactor system 
for the expansion of a progenitor cell population the primary objective of this 
dissertation was to elucidate the influence of this culture system on the proliferation, 
differentiation, matrix deposition and post-harvest functionality of the expanded cell 
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population. To facilitate these observations two additional objectives were defined to 
enable (i) quantitative monitoring of cell proliferation within the bioreactor system and 
(ii) to visualize and quantify neo-tissue formation within the three dimensional culture 
environment.  
In the first part of this project a method for monitoring a proliferative cell population 
in a three dimensional perfusion bioreactor system was developed. A quantitative 
correlation between cell number and the conversion of a metabolic activity assay was 
established and the influence of different culture and measurement setups on this 
correlation was determined indicating mass transport associated limitations. A 
predictive model was developed establishing a correlation between assay signal, cell 
number and the different measurement parameters. This enabled not only to determine 
cell number for a given measurement but also to define an optimal operating window 
for the measurements. 
In the second part of this work, contrast enhanced nanofocus computed X-ray 
tomography was developed as a technique to visualize and quantify the neo-tissue 
formation (i.e. cells and extracellular matrix deposition) within the constructs. A first 
proof of principle study was performed showing the potential for the use of two 
different contrast agents being Hexabrix® and phosphotungstic acid for the neo-tissue 
visualization. Using a Design of Experiment approach, the influence of different 
staining parameters (staining time, concentration and neo-tissue quantity) on the 
quantitative analysis of the datasets was subsequently determined indicating that an 
increase in concentration of the staining agents had a positive effect on dataset quality. 
High concentrations of the phosphotungstic acid, however, resulted in a significant 
negative influence on the neo-tissue integrity. Hexabrix® on
 
the contrary enabled 
automated, quantitative analysis of the full neo-tissue developed during the perfusion 
bioreactor expansion. 
Using these novel methodologies, in combination with a number of established 
techniques, the influence of the in vitro micro-environment within which the cells 
reside during the perfusion bioreactor facilitated expansion process on cellular 
characteristics was determined. Additionally, to assess cell functionality subsequent to 
expansion, a method for cell recovery from a three dimensional culture environment 
was developed using a Design of Experiment approach. Although minor differences 
were noted no significant induction of an osteogenic or chondrogenic phenotype was 
observed and post expansion functionality of the cells was maintained based on both in 
vitro and in vivo functionality assays. 
In conclusion, this dissertation showed that the in vitro micro-environment created in a 
three dimensional perfusion bioreactor can facilitate the expansion of a progenitor cell 
population without significantly influencing its functional characteristics. In addition, 
novel methods for on-line monitoring and characterization of the constructs were 
developed enabling to gain new insights in the bioreactor facilitated processes. 
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Samenvatting 
Weefsel-engineering kan omschreven worden als een interdisciplinair onderzoeksveld 
gericht op de ontwikkeling van implantaten ten einde de regeneratie van weefsels en 
organen in gecompromitteerde omgevingen te induceren of ondersteunen. Ondanks de 
aanzienlijke wetenschappelijke vooruitgang in dit veld blijft de grootschalige klinische 
translatie van deze concepten momenteel afwezig. Omwille van de complexiteit van de 
processen in de ontwikkelingsbiologie en weefsel regeneratie blijven veel vragen 
omtrent onder meer werkingsmechanismen onbeantwoord. De huidige focus van het 
onderzoeksveld is dan ook gericht op het ontwikkelen van nieuwe concepten die 
mogelijks kunnen leiden naar toekomstige klinische toepassingen. De nieuwe inzichten 
die hierdoor zullen verschaft worden zijn essentieel voor de ontwikkeling van nieuwe 
producten maar hun klinische implementatie zal enkel bereikt kunnen worden mits ze 
geproduceerd worden in een gecontroleerde, geautomatiseerde en gestandaardiseerde 
omgeving. De translatie van processen ontwikkeld op labo schaal naar een klinisch en 
industrieel relevante omgeving kan echter significante invloed hebben op het 
resulterende proces en product. Er is daarom nood aan een geïntegreerde benadering 
die vanaf de conceptuele ontwikkeling van een nieuw product toekomstige 
translationele aspecten in rekening brengt. Het gebruik van geautomatiseerde en 
gecontroleerde bioreactor systemen wordt in deze context beschouwd als een 
toegevoegde waarde en verschillende mogelijkheden voor de productie van stamcel 
gebaseerde inplanten werden reeds geëvalueerd. De integratie van essentiële 
geassocieerde processen zoals de voorgaande celgroei alsook de ontwikkeling van 
methodes voor het opvolgen van de processen in de bioreactoren en kwaliteitscontrole 
van de resulterende producten is echter grotendeels afwezig. Verschillende technische 
knelpunten verhinderen op dit moment de doorgedreven implementatie van de 
verschillende ondersteunende proces stappen in een geïntegreerde, gecontroleerde en 
geautomatiseerde omgeving. Bijkomend zal de invloed die deze artificiële omgeving 
heeft op het cel gedrag gedurende deze processen beslissend zijn voor hun finale 
toepasbaarheid. 
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In deze context was het primaire doel van deze thesis het evalueren van het gebruik van 
een drie-dimensioneel perfusie bioreactor systeem voor het opgroeien van een 
voorloper cel populatie in een geautomatiseerde, gecontroleerde en gesloten omgeving. 
De invloed van deze artificiële omgeving op het cel gedrag werd geanalyseerd op basis 
van cel proliferatie en differentiatie, matrix depositie en functionaliteit. Ter 
ondersteuning van deze waarnemingen werden ook twee additionele doelstellingen 
gedefinieerd zijnde (i) het kwantitatief opvolgen van celgroei in de bioreactor en (ii) 
het visualiseren en kwantificeren van biologisch weefsel gevormd in de drie 
dimensionele cel cultuur omgeving. 
In het eerste deel van dit project werd een methode voor het opvolgen van celgroei in 
een drie-dimensionele perfusie bioreactor ontwikkeld. Een kwantitatieve correlatie 
tussen cel aantal en de conversie van een metabool assay voor het bepalen van cel 
activiteit werd bepaald alsook de invloed van verschillende cel cultuur methodes en 
verschillende opstellingen voor het uitvoeren van de metingen. Vervolgens werd een 
voorspellend model ontwikkeld dat het verband tussen het signaal verkregen met de 
assay correleert met het cel aantal en de verschillende parameters geassocieerd met de 
meting. Naast het bepalen van cel aantal op basis van de metabole meting stond dit ook 
toe om de parameters voor de meting zo te selecteren dat een optimaal operationeel 
venster kon gedefinieerd worden.  
Het tweede deel van dit werk was gefocust op de ontwikkeling van contrast-verbeterde 
nanofocus X-stralen computer tomografie voor de visualisatie en kwantificatie van 
biologische weefselvorming in de constructen. Een initiële validatie van het concept 
gebaseerd op het gebruik van twee verschillende contrast verhogende reagens 
(Hexabrix® en fosforwolfraamzuur) bevestigde de mogelijkheid van deze nieuwe 
methodologie voor de visualisatie van het biologisch weefsel. Met behulp van 
experimenteel ontwerp werd vervolgens de invloed van verschillende methodologische 
parameters (incubatie tijd, concentratie en volume van het biologisch weefsel) op de 
kwantitatieve interpretatie van de bekomen beelden bepaald. Het gebruik van een 
hogere concentratie van beide contrast verhogende reagens resulteerde in een 
beduidend hogere beeldkwaliteit en contrast. Voor fosforwolfraamzuur resulteerde 
deze hogere concentraties echter ook degradatie van het biologisch weefsel wat de 
kwantitatieve interpretatie van de data irrelevant maakte. Het gebruik van Hexabrix® 
daarentegen stond de geautomatiseerde, kwantitatieve analyse van het biologisch 
weefsel in de constructen ontwikkeld in de perfusie bioreactor toe.  
In combinatie met gevestigde methodes werd deze nieuwe technologie gebruikt om de 
invloed van de artificiële omgeving in de drie-dimensionele perfusie bioreactor tijdens 
de celgroei te bepalen op de eigenschappen van de resulterende cel populatie. Om ook 
de functionaliteit van deze cel populatie te kunnen evalueren werd er een methode 
ontwikkeld voor de recuperatie van de cellen na het groeiproces op basis van 
experimenteel ontwerp. Ondanks het vaststellen van enkele verschillen in onder meer 
gen expressie, geïnduceerd door de perfusie bioreactor cultuur, werd er geen 
beduidende osteogene of chondrogene differentiatie vastgesteld. Bovendien toonde 
functionele testen, zowel in vitro als in vivo, aan dat na het opgroeien en recuperatie de 
functionele eigenschappen van de cellen bewaard bleef. 
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In conclusie toonde het werk voorgesteld in dit proefschrift aan dat de artificiële 
omgeving in de drie-dimensionele perfusie bioreactor de expansie van een voorloper 
cel populatie ondersteunde zonder een beduidende invloed te hebben op de functionele 
eigenschappen hiervan. Bijkomend werden vernieuwende methodes ontwikkeld voor 
het opvolgen van celgroei en voor karakterisatie van de constructen gevormd tijdens 
het expansie proces ten einde nieuwe inzichten in de bioreactor processen te verkrijgen.  
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General introduction 
 
 
 
 
Tissue engineering (TE) has been defined as an interdisciplinary field which aims at 
developing implants to induce or support the regeneration of tissues and organs in 
compromised in vivo environments. Despite significant scientific advances and the 
availability of various proof of concept studies no large scale clinical implementation 
of these TE concepts has taken place yet. As numerous scientific questions remain 
unanswered concerning for example mechanisms of action, the current focus of the 
field concentrates predominantly on the development and validation of novel concepts 
with potential clinical applications. Although indeed essential for future product 
development, clinical translation and implementation of these concepts will only be 
possible if the production of the resulting products can be accomplished using 
standardized, automated, controlled, reproducible and safe processes. The translation 
of lab scale processes to such a clinical and industrial relevant environment can, 
however, have significant implications for the process environment and therefore on 
the resulting product. An integrated approach combining product and process 
development, thereby taking into account future translational aspects from the 
conceptual development onwards, can facilitate significant advances in the field 
towards clinical applications. Within this context the use of various bioreactor systems 
for cell based product development has recently gained interest. The implementation of 
essential up- and down-stream steps correlated with this product development such as 
cell expansion as well as the development of tools for process monitoring and quality 
control towards fully integrated bioprocess development is, however, lacking. 
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The aim of this thesis was therefore to explore the potential of a three dimensional (3D) 
perfusion bioreactor system for stem cell expansion within the context of the host lab 
which focusses on skeletal TE applications. In addition, different tools required for 
monitoring and characterizing the cell behavior in the bioreactor environment were 
developed. This introductory chapter presents a brief overview of the functions and 
structure of the skeletal system and the processes involved during skeletal development. 
The relevance of these pathways in fracture repair and the potential of their application 
in TE is discussed. Subsequently, an introduction to integrated bioprocess development 
situates the current state of the art in this field with respect to TE. Finally, a short 
overview of several aspects essential for the development of a controlled and monitored 
process such as non-destructive imaging and on-line monitoring is presented. 
1.1. Skeletal tissue 
1.1.1. Bone structure and composition 
The adult human skeleton consists of a total of 206 bones. Although the primary 
function of this organ is to provide structural support and protection for other fragile 
organs, it also serves as an important reservoir for minerals and plays an essential role 
in blood synthesis by hosting the bone marrow. As a living organ, the skeletal system 
is sensitive to changes in environmental factors such as mechanical loading and is 
subject to a constant remodeling process. Moreover, it possesses a unique healing 
capacity enabling it to repair most defects without inducing scar formation. 
Depending on shape and function the bones of the skeletal system can be divided into 
five different categories. The flat bones are present in the skull, ribs and sternum serving 
mainly to provide extensive protection to the underlying organs as well as providing 
extensive attachment sites for surrounding muscles, for example in case of the scapula 
(shoulder blade). The long bones such as the tibia are subjected to the highest loads 
throughout the body and are essential for mobility. The three other groups of bones 
(short, irregular and sesamoid bones) consist mainly of smaller bones with a variety of 
functions ranging from support and stability to protection of vital organs.  
Despite this variety of anatomical shapes and functions, most bones have a similar 
macroscopic structure. The outer layers consist of compact cortical bone which 
provides the required strength and stiffness. The porous cancellous bone is mainly 
present in the center of the bones and hosts the bone marrow as well as nerves and blood 
vessels. Within the bone matrix three different cell types reside: osteoblasts, osteocytes 
and osteoclasts. The osteoblasts which originate from mesenchymal stem cells (MSCs) 
are cuboidal mononucleated cells lining the edges of the bone. They deposit a collagen 
type I (Col1) rich matrix, the osteoid, which subsequently gets mineralized resulting in 
the entrapment of the cells in the bone matrix. Subsequent differentiation of a fraction 
of the entrapped osteoblasts will give rise to the star-shaped osteocytes which form an 
interconnected network through cytoplasmic extensions. Through their 
mechanosensitivity they can regulate the bone remodeling process by transduction of 
specific biochemical signals resulting in the recruitment of osteoblasts and osteoclasts. 
The latter of the two are multinucleated cells originating from the hematopoetic cell 
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compartment. Through solubilization of the underlying mineralized extracellular 
matrix (ECM) these cells are responsible for resorption of the bone. 
The ECM of the bone provides its functional characteristics and is comprised out of an 
organic and inorganic fraction. The main constituent of the organic fraction is Col1 
which provides the required flexibility and tensile strength to the tissue. Approximately 
5% of the organic fraction comprises non-collagenous proteins such as osteocalcin and 
osteopontin which are associated with the mineral phase of the matrix and correlated 
with regulation of bone structure and its mechanical characteristics. The inorganic 
phase of the bone matrix consists mainly of hydroxyapatite crystals providing the 
required stiffness and strength to the tissue.  
1.1.2. Bone development 
The fetal development of bone occurs through two different pathways namely 
intramembranous ossification (direct bone formation) and endochondral ossification 
(indirect bone formation) (Kronenberg 2003). 
In the case of intramembranous ossification condensation of the MSCs present in the 
connective tissue results in direct differentiation of these cells to osteoblasts. These 
subsequently initiate the osteoid deposition and matrix maturation towards a functional, 
mineralized bone matrix. This direct process of bone formation in vivo is, however, 
exceptional and predominantly occurs in the flat bones of the skull (Lenas et al. 2011). 
In long bone development MSC condensation is followed by the differentiation of these 
condensations towards chondrocytes resulting in a cartilaginous template. This 
template will further expand through the proliferation of the chondrocytes and the 
associated deposition of a collagen type II and aggrecan-rich cartilage matrix 
(Kronenberg 2003). The cells in the center of the template will subsequently stop 
proliferating, become hypertrophic and start producing a collagen type X-rich matrix. 
Through the secretion of multiple biochemical signaling molecules these hypertrophic 
chondrocytes will attract blood vessels, initialize matrix mineralization, cartilage 
remodeling and resorption resulting in the formation of the primary ossification center 
(Lenas et al. 2011). Continued proliferation of the surrounding chondrocytes further 
enlarges the bone template as secondary ossification centers are formed at the 
epiphyseal ends. Chondrocytes in the cartilaginous zone between primary and 
secondary ossification centers are spatially organized in a growth plate from resting 
chondrocytes near to the epiphyseal ends to proliferating, pre-hypertrophic and 
hypertrophic chondrocytes towards the primary ossification center thereby mediating 
longitudinal bone growth. For humans, the growth plate will eventually close at the end 
of adolescence (Mackie et al. 2008). 
The process of endochondral ossification is tightly regulated by a number of zonal 
expressed transcription and growth factors as shown in Figure 1.1.A. Briefly, Indian 
Hedgehog (Ihh), expressed in the pre-hypertrophic zone, inhibits terminal hypertrophic 
differentiation and cartilage mineralization and stimulates chondrocyte proliferation, 
both direct and through stimulation of Parathyroid Hormone related Protein (PTHrP) 
which in turn inhibits Ihh expression through a negative feedback loop (Figure 1.1.B). 
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Bone Morphogenetic Protein expression (BMP), know to facilitate endochondral 
ossification when injected subcutaneously, positively influence chondrocyte 
proliferation and Ihh expression (Figure 1.1.B). Transcription factors Sox9 and RunX2 
are essential for the zonal development of the growth plate where Sox9 ensures 
mesenchymal commitment towards chondrocytes and ensures expression of several 
critical cartilage matrix genes such as collagen type II and aggrecan. RunX2 on the 
other hand is essential for terminal hypertrophic differentiation and plays an important 
role in vascular invasion of the mineralizing cartilage (Kronenberg 2003, Provot et al. 
2005). 
Figure 1.1: Endochondral ossification. 
(A) Schematic representation of tibia at late stage of fetal development. Characteristic 
markers for different zones are indicated. (B) Schematic representation of the growth 
plate regulation by feedback loops and biological interactions. Indian Hedgehog (Ihh) 
induces parathyroid hormone related protein (PTHrP), required for chondrocyte 
proliferation, which in turn inhibits Ihh expression thereby influencing chondrocyte 
proliferation and differentiation. Ihh also positivly influences Bone morphogenetic 
proteins (BMP) which, together with Ihh and PTHrP influence chondrocyte 
proliferation. Fibroblast growth factor (FGF) negativly influences Ihh expression and 
proliferation and positivly affects terminal differentiation. Finally, RunX2 is a positive 
modulator of hypertrophy and also upregulates Ihh expression  (Provot et al. 2005). 
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1.1.3. Fracture repair 
Unlike most adult tissues, bone has the capacity to heal the majority of defects without 
the formation of scar tissue. The mechanisms governing bone regeneration are closely 
related to the developmental pathways and are in addition influenced by the mechanical 
environment of the fracture. 
In case of limited stabilization of the defect hematoma formation is induced as a result 
from the bleeding at the defect site. Subsequent recruitment of inflammatory cells as 
well as the initiation of cytokine and growth factor production such as transforming 
growth factor β1 (TGF-β1), platelet derived growth factor (PDGF) and FGF result in 
recruitment of skeletal progenitor cells from the periosteum, bone marrow and the 
circulation (Lieberman et al. 2002, Papadimitropoulos et al. 2014b, Bigham-Sadegh et 
al. 2015). Under the influence of different growth factors among which TGF-β1 and 
BMPs play a major role these cells will form MSC condensations leading to the 
development of a cartilaginous callus essential for the mechanical stabilization of the 
defect (Bigham-Sadegh et al. 2015). In parallel with the developmental process of 
endochondral ossification the cartilaginous callus will mature towards hypertrophy 
followed by vascular ingrowth and remodeling of the callus leading to the formation of 
woven bone. Over a period of months this is further remodeled to the more organized, 
mechanically stronger laminar and cortical bone (Papadimitropoulos et al. 2014b). For 
defects with a rigid stability the formation of a cartilaginous intermediate for 
stabilization of the defect is not required and intramembranous ossification through the 
direct differentiation of MSC condensations occurs (Tonnarelli et al. 2014).  
Critical size bone defects 
Despite the remarkable capacity of bone to heal a broad range of defects, provided there 
is correct realignment and sufficient stabilization of the fracture, between 5 and 10% of 
the fractures in long bones result in delayed or non-union which remains a significant 
clinical problem until today (Jakob et al. 2012). The preferred treatment for these non-
unions is based on the use of autologous graft material obtained from for example the 
iliac crest of the patient due to the inherent histocompatibility and lack of 
immunological response associated with the use of this material (Jakob et al. 2012, 
Costa et al. 2014). Limited availability of autologous donor material and the significant 
risk for post-surgical complications, such as donor site morbidity, pain and infection, 
as well as the extensive surgical procedure are, however, significant drawbacks 
associated with this methodology (Costa et al. 2014). These could be addressed using 
grafts of allogenic or xenogeneic origin although these are still associated with concerns 
on pathogen transmission and immunogenicity. Engineered synthetic materials on the 
other hand often lack osteoinductive and/or osteogenic properties and have shown 
reduced healing potential in addressing complex and high load bearing fractions. 
Alternative treatment options circumventing the use of grafting materials are based on 
distraction osteogenisis. The two ends of the fracture are brought into close proximity 
of each other using external fixators. Next, they are gradually being moved apart again 
as the new bone forms. Due to the limited regeneration rate of bone (between 0.5 and 
1mm/day) this, however, results in a long healing time associated with a significant risk 
on clinical complications and pain.  
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Due to the sub optimal treatment options for these severe bone fractures there is a 
significant interest and need for the development of novel, efficient methods to address 
these defects. 
1.2. Tissue engineering 
TE was defined as an interdisciplinary field that combines the principles of engineering 
and life sciences towards the development of biological substitutes to restore, maintain 
or improve tissue function (Langer et al. 1993). Through understanding of the complex 
biology of tissue development and regeneration at the defect site, and by combining 
knowledge from different scientific disciplines such as material sciences, 
developmental biology, engineering and computational sciences, 3D constructs with an 
in vivo functionality can be developed in vitro.  
The original paradigm of TE was based on 3D cell growth and differentiation towards 
the in vitro development of a functional tissue prior to implantation (Lenas et al. 2011). 
Through the combination of cells, a scaffold and different growth factors, followed 
potentially by the in vitro development of this construct, various groups aimed at 
developing a mineralized construct to facilitate functional repair of the damaged bone 
(Cartmell et al. 2003, Zhao et al. 2005, Grayson et al. 2010, Grayson et al. 2011). 
Although several of these constructs showed to possess, to a certain extent, an in vivo 
bone forming capacity using ectopic models, reports of successful osteo-integration of 
these constructs are largely absent (Braccini et al. 2005, Janssen et al. 2006b, Agata et 
al. 2007, Grayson et al. 2007). One of the causes for the shortcomings of this approach 
was hypothesized to be the lack of relevance of the developed constructs in the in vivo 
bone regeneration process (Ingber et al. 2006, Lenas et al. 2011). 
In order to increase the biological relevance of the TE constructs the paradigm of 
developmental engineering was introduced which is based on the in vitro recapitulation 
of the in vivo processes involved in bone fracture healing (Lenas et al. 2011). As 
discussed earlier the in vivo fracture healing process as well as the development of the 
long bones takes place through endochondral ossification which comprises of 
consecutive phases of mesenchymal condensation, the development of a cartilaginous 
template, its subsequent maturation towards hypertrophy and the final remodeling 
resulting in in vivo bone formation. As blood vessel invasion in the developing bones 
and fracture callus coincides with the remodeling of the hypertrophic cartilage template 
towards bone and the formation of the primary ossification center the in vitro 
engineered constructs should not be progressed beyond this point to ensure successful 
incorporation in the host tissue. Different studies already confirmed the feasibility of 
this approach by inducing in vivo bone formation through the implantation of a 
cartilaginous template (Scotti et al. 2010, Weiss et al. 2012, Scotti et al. 2013, Bourgine 
et al. 2014b, Yang et al. 2014b). 
1.2.1. Cells 
In order to recapitulate the events of the developmental cascade the use of a relevant, 
suitable cell source is essential. Bone is a complex living tissue comprised of a variety 
of cell types but, as described earlier, the in vivo bone formation is initiated by MSC 
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condensation towards the development of the cartilaginous intermediate. As the 
developmental engineering paradigm is based upon the recapitulation of the in vivo 
developmental and fracture repair cascades the use of a potent progenitor cell 
population involved in the relevant in vivo cascades stands to reason. 
MSCs were defined by the international society for cellular therapy as a plastic adherent 
cell population which express CD 105, CD 73 and CD 90 surface markers while lacking 
the expression of CD 45, CD34, CD 14 or CD 11b, CD 79α or CD 19 and HLA-DR. 
Additionally, these cells must be able to differentiate in vitro towards osteoblasts, 
adipocytes and chondrocytes (Dominici et al. 2006). Based on this definition they can 
be isolated from a variety of tissues such as the bone marrow, the periosteum and 
adipose tissue. Although adipose derived MSCs are easily accessible and available in 
significantly larger numbers than those located in various other tissues some 
contradictory data on their potency towards the osteogenic and chondrogenic lineage 
exists (Im et al. 2005, Schaffler et al. 2007, Ghaemi et al. 2013). In addition, when 
attempting to recapitulate the native process of fracture repair, the use of the in vivo 
contributing cell populations should be aspired. In close proximity to the fracture site 
two different MSC niches can be found being the bone marrow and the periosteum. 
Although bone marrow derived MSCs are the cell population of choice for a multitude 
of research groups the periosteum has been shown to be imperative for fracture repair 
(Seeman 2003, Malizos et al. 2005, Zhang et al. 2005, Zhang et al. 2008, van Gastel et 
al. 2012a). Additionally, different groups showed their use has several advantages over 
bone marrow derived MSCs such as a faster in vitro proliferative capacity (Eyckmans 
et al. 2006a, Agata et al. 2007, Ringe et al. 2008) and a higher osteogenic potential 
(Hutmacher et al. 2003, Eyckmans et al. 2006a, Becker et al. 2010) therefore making 
them an ideal candidate for bone TE strategies.  
1.2.2. In vitro cell culture micro-environment 
As mentioned, MSCs are an in vivo self-sustainable cell population capable of self-
renewal, proliferation and differentiation. Their function is tightly controlled by their 
interaction with the micro-environment within which they reside, often referred to as 
the stem cell niche (Jiang et al. 2013). The influence of this niche on the behavior of 
the cells is exerted through a variety of components such as soluble factors, the ECM, 
the biophysical environment and contact with adjacent cells (Scadden 2006, Metallo et 
al. 2007, Ghaemi et al. 2013, Tan et al. 2013). Within the in vivo system this micro-
environment is tightly regulated and changes in a variety of critical components will 
induce a response from the stem cell population residing in that niche. The in vitro 
culture of these cells, and therefore their removal from the native niche, will 
consequently have a significant influence on their behavior. An in depth understanding 
of the various interactions of the cells with their native niche is therefore required to 
enable rigorous control of the in vitro behavior of this cell population. Due to the 
biological complexity of the in vivo system its in vitro recapitulation has proven to be 
very challenging. Although recently novel approaches have made significant advances 
towards engineering an in vitro stem cell niche (Gattazzo et al. 2014, 
Papadimitropoulos et al. 2014b), most work focusses upon elucidating the influence of 
isolated parameters. Despite that the relevance of these studies towards the 
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development of an engineered, biomimetic in vitro culture environment might be 
limited, recapitulation of the most essential aspects might be sufficient to induce the 
intended cell behavior. 
Due to the relative ease of implementation, the use of soluble factors such as growth 
factors, peptides, single molecules and ions for controlling MSC maintenance and 
differentiation has already been thoroughly documented (Kolf et al. 2007, Ghaemi et 
al. 2013). Although a broad range of these compounds are used in standardized 
procedures for proliferation and differentiation of MSCs, a lack of in depth 
understanding of the underlying signaling cascades and interactions is often a limiting 
factor for their successful application and integration in different setups (Metallo et al. 
2007). The use of novel, high throughput screening methods and tools for efficient 
statistical design of experiments has recently enabled to perform more elaborate studies 
allowing not only the optimization of the intended process but also to study the 
interactions between different external parameters in an efficient way (Jakobsen et al. 
2014). These new insights will enable the future development of tailored in vitro culture 
environments.   
As MSCs are an adherent cell population the substrate on which they are cultured and 
its architecture is another essential component of the in vitro micro-environment within 
which they reside. Current standard cell culture procedures use two dimensional (2D) 
polystyrene surfaces to expand cells in monolayer. Although these methods enable the 
proliferation of the cell population while maintaining their functional characteristics, 
the relevance of this in vitro culture environment in respect to the in vivo cell niche is 
non-existent. For cell differentiation and construct development, the transition from a 
2D to a 3D cell culture environment has been shown to significantly influence signal 
transduction resulting in for example enhanced differentiation and matrix deposition 
(Banfi et al. 2000, Cukierman et al. 2002, Martin et al. 2004, Scadden 2006, Wagner 
et al. 2008, Haycock 2011, Tandon et al. 2013, Papadimitropoulos et al. 2014a). For 
cell expansion the use of a 3D culture environment has also been suggested to be 
beneficial due to for example enhanced maintenance of the progenitor phenotype but 
its use has much less been explored (dos Santos et al. 2013). 
In order to create this 3D environment the use of various 3D support structures has been 
evaluated ranging from micro-carriers and hydrogels to porous rigid scaffolds. 
However, despite significant efforts of the research community, no purpose dependent 
scaffold specifications have been defined yet although various scaffold related 
properties have been shown to significantly influence cell behavior (Rezwan et al. 
2006, O'Brien 2011, Bose et al. 2012, Park et al. 2013). 
Scaffold architecture, both on macro and micro scale, was also shown to influence cell 
behavior in the in vitro engineered niche. While the macro-architecture for example 
influences nutrient transport and the stresses exerted on the cells in the presence of fluid 
flow, surface roughness and topology, correlated with the scaffolds micro-architecture,  
have been shown to influence cell proliferation and differentiation (Melchels et al. 
2010, McCoy et al. 2012, Ghaemi et al. 2013). The effects of the scaffolds micro-
architecture are, however, often secondary to the influence of the used materials and 
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the correlated surface chemistry. A wide range of materials has already been applied 
for research purposes, each correlated with their specific set of advantages and 
disadvantages. Examining the influence of externally applied stresses or compounds 
for example requires a biocompatible but preferably inert material while tuned 
degradability of the scaffold material will be essential for in vivo remodeling of a 
construct. Surface chemistry of these materials can in addition often be altered by 
specific functionalization in order to for example enhance cell attachment or elicit 
specific cellular responses (Perez-Sanchez et al. 2010, O'Brien 2011, Jiang et al. 2013, 
Custodio et al. 2014). The influence of several of these material properties on cell 
behavior is, however, still poorly understood, often requiring system specific 
validations of culture setups rather than using a generalized design strategy. 
Within the 3D in vivo micro-environment the cells are subjected to continuous 
mechanical loading due to the movement of the body. The intensity of the cyclic 
compression of the bones has for example been associated with changes in bone mass 
density while shear stresses (SS) resulting from interstitial fluid flow can also 
significantly influence cell behavior. Consequently, mechanobiological interactions 
between cells and their environment can significantly modulate their in vitro behavior 
(Guilak et al. 2014). Fluid flow and the associated SS have for example been shown to 
be potent mediators of cellular differentiation, although commonly applied in 
combination with chemical inducers and therefore operating as an enhancer rather than 
inducer (McCoy et al. 2010, Fisher et al. 2011, Yeatts et al. 2013). In addition, next to 
the presence of growth factors other environmental parameters such as scaffold material 
and architecture as well as for example oxygen concentration have been shown to 
influence cellular responses to SS resulting in contradictory results. Other external 
stimuli such as hydrodynamic pressure, cyclic compression and tension have also been 
shown to influence MSC differentiation, each again dependent on other aspects of the 
in vitro micro-environment (Guilak et al. 2014, Hao et al. 2015). 
The relevance of engineering a tailored in vitro micro-environment for cell expansion 
and construct development is uncontested and although, as illustrated above, significant 
advances have been made in understanding the importance of various aspects thereof 
the compartmentalization of the field and a lack of in depth understanding of the in vivo 
environment still pose significant challenges (Becerra et al. 2011). 
1.3. Bioprocess development for tissue engineering 
Although cells, scaffolds and growth factors are often considered to be the basic 
components of most TE constructs different publications have discussed the importance 
of the mechanical environment in the defect as well as the biology present in the host 
environment introducing respectively the diamond and penta-concept (Giannoudis et 
al. 2007, Lammens et al. 2012). An additional aspect which is to be taken into account 
for the successful development of a TE construct is the actual process used to develop 
this implant. For the development of a patient specific, autologous construct this 
multistep process starts with isolation of the primary cells from the patient which are 
subsequently expanded prior to the development of a functional TE construct. Each of 
these steps requires dedicated process development ensuring not only efficiency and 
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efficacy of the employed methodology but also the consideration of different aspects 
for future clinical and industrial implementation such as reproducibility and automation 
(Salter et al. 2012a). Although current lab scale methodologies have shown significant 
promise concerning efficiency and efficacy, the manual character of most procedures 
is a severe limitation for their future translation towards a clinical setting (Loring et al. 
2014). The development of enabling technologies and tools addressing these, such as 
bioreactors, has therefore become one of the important focusses of the TE field. 
Translation of current established manual processes to these automated and controlled 
systems, however, requires re-validation of the entire process and is often not 
economically feasible. Therefore, industrial relevant process development should be an 
inherent part of the product development cycle rather than a final step as is currently 
often the case. 
1.3.1. Bioreactors in bioprocess development for tissue 
engineering 
Bioreactors have been defined as any device in which biological processes progress in 
an automated environment and in which one or more environmental parameters such 
as nutrient supply and temperature are closely monitored and controlled. The 
automation and user independent operation of the system result in a high degree of 
process standardization essential for future clinical translation (Jakob et al. 2012, 
Loring et al. 2014, Nerem 2014).  
Within the field of TE and regenerative medicine a variety of bioreactor systems has 
already been introduced for different applications. The following section will give a 
brief overview of the different systems used for adherent culture of MSCs, specifically 
for applications in bone TE. 
2D based systems 
The current gold standard for cell expansion is still based upon the use of plasma treated 
2D polystyrene surfaces in the form of tissue culture flasks despite the associated 
manual labor, operator dependence and other limitations. The first attempts for 
automating cell culture were based upon these principles and are in essence automated 
scale-out versions such as the Cell FactoryTM (Nunc) or CellSTACK® (Corning). Due 
to the relatively simple translation of the established and validated procedures for 
manual 2D cell culture to these automated environments performance of these systems 
is close to what is obtained in standard manual cell culture (Liu et al. 2013b). Due to 
space restraints these systems are, however, mainly suited for cell therapy applications 
with low dosage requirements and/or small patient populations (Kirouac et al. 2008). 
Novel closed process systems such as the Integrity® XpansionTM muliplate bioreactor 
system (Pall), the CompacT SelecT (Sartorius) and the Nunc Automatic Cell Factory 
Manipulator (ThermoFisher Scientific) aim at addressing the shortfalls of the current 
automated 2D expansion systems such as space efficiency, throughput and a limited 
possibilities for online system monitoring and control but data on efficacy and 
efficiency of these systems is currently lacking (Jenkins et al. 2015). 
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Despite the widespread use of 2D expansion methodologies on tissue culture plastic the 
artificial culture environment has been shown to influence cell identity and 
functionality leading to spontaneous (de)differentiation, replication senescence, etc.  
after prolonged in vitro expansion (Banfi et al. 2000, Scadden 2006, Wagner et al. 
2008). Although these cells possess a strong capacity for in vivo self-renewal their in 
vitro expansion in these 2D conditions is therefore limited and the development of a 
more optimized in vitro cell culture niche is called for (Sensebe et al. 2011)(Table 1.1). 
Hollow fiber bioreactors 
Hollow fiber bioreactor systems are based on a densely packed bundle of fibers 
surrounded by a casing. The system can be perfused through the fibers (intra-luminar), 
the casing surrounding the fibers or both in various setups. In addition, intra- and extra-
luminar space can be interconnected depending on the membranes used for the fibers 
to enable exchange of nutrients, waste products and growth factors.  
Using the Quantum cell expansion system (Terumo), a Good Manufacturing Practice 
(GMP) compliant hollow fiber bioreactor system for cell expansion, different groups 
reported successful expansion of MSC populations while maintaining original cell 
 Advantages Disadvantages 
2D planar 
bioreactors Well characterized environment 
Spontaneous (de)differentiation 
associated with tissue culture plastic 
 Optimized procedures Large surface area 
  Large volumes of media 
Micro-carrier 
bioreactors Medium to high cell densities  Harvest 
 Expansion and construct development Nutrient gradients through micro-carriers 
 Easy scale-up  
 Tuning of cell culture surface  
Hollow fiber 
bioreactors Low shear environment Scale-up 
 Medium to high cell densities  Nutrient gradients  
 Advanced feeding regimes  
3D bioreactors Homogenous nutrient distribution Harvest 
 Mechanical stimulation No GMP compliant systems available 
 3D micro-environment Scale-up 
 Spatial organization cells  
 Expansion and construct development  
 High cell densities  
 Tuning of cell culture surface  
Table 1.1: Advantages and disadvantages of different bioreactor systems used in tissue 
engineering 
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phenotype (Jones et al. 2013, Nold et al. 2013, Rojewski et al. 2013). Due to the 
versatile setup of the system (intra- versus extra-luminal localization of the cells, the 
use of different perfusion configurations and advanced feeding regimes) cell behavior 
in the bioreactor can be optimized towards specific applications (Godara et al. 2008, 
De Napoli et al. 2011, Wung et al. 2014). Different groups have additionally 
hypothesized that although the cells cultured in these systems still experience a 
predominantly 2D environment, the 3D architecture of the system enables to better 
mimic the native cellular micro-environment which could result in a significantly 
improved phenotypical stability and post-expansion potency of the cell population (Liu 
et al. 2013b, Wung et al. 2014). The major shortfall of this bioreactor system for a 
multi-step expansion process is the difficulty for up-scaling of the setup (Liu et al. 
2013b). 
Next to the use of these systems for cell expansion different reports discus the 
application of hollow fiber based perfusion systems for the development of tissue 
constructs. For these applications cells are often located in the extra-luminal space in 
which they can proliferate and develop a complex 3D structure, potentially with the 
support of an additional fibrous matrix or hydrogel, while nutrient supply is ensured by 
luminal perfusion (Wung et al. 2014).  
Micro-carrier based systems 
Micro-carrier based systems have already frequently been used for the culture of the 
adherent MSCs (Jakob et al. 2012, Jung et al. 2012b, Liu et al. 2013b). Due to the 
simplicity and scalability of these systems, together with the versatility of the setup (the 
availability of different culture vessels and a broad range of micro-carriers) as well as 
the high surface to volume ratio this technology is often considered as being one of the 
most potent for industrial scale stem cell expansion (Liu et al. 2013b, Tandon et al. 
2013, Jenkins et al. 2015). 
Although a variety of systems is available for micro-carrier culture such as stirred tank 
bioreactors, rotating wall vessels and wave bioreactors all these systems aim at 
maintaining the micro-carriers in suspension while providing a homogenous external 
culture environment. The main difference between different systems in how the micro-
carriers are maintained in suspension and therefore the applied external forces on the 
cells. Spinner flasks are for example associated with an inhomogeneous flow profile 
and local occurrence of turbulence due to the impellers (Liu et al. 2013b). These are 
suggested to be beneficial for preventing aggregation of the micro-carriers and to 
enhance mass transport to the center of porous micro-carriers but also result in sub-
optimal behavior when aiming at the application of a specific range of SS (Chen et al. 
2006). Despite this, they are the system of choice for micro-carrier facilitated cell 
expansion and several groups already showed the feasibility of transferring lab based 
processes towards a more clinically relevant environment (Rafiq et al. 2013, Dos Santos 
et al. 2014, Nienow et al. 2014). Due to the 3D geometry of the micro-carriers the 
micro-environment created for cell expansion was also suggested to develop a cell 
culture niche which is more native to the cells than the standard 2D expansion strategies 
(Park et al. 2013). However, despite the 3D architecture of the micro-carriers, cells 
expanding on solid carriers such as the CytodexTM will predominantly experience a 2D 
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environment as they grow on the surface of the carriers (Martin et al. 2011b). Using 
porous microspheres was shown to both increase the surface to volume ratio and create 
a more complex 3D microenvironment for cell expansion resulting in significant 
stronger proliferation although significant nutrient gradients were also shown to be 
present through the microspheres (Park et al. 2013). 
More recent the use of micro-carriers for construct development was also explored by 
inducing differentiation and ECM deposition subsequent to the expansion stage. The 
resulting micro-tissues could then be used as building blocks for the assembly of a TE 
construct (Chen et al. 2014, Georgi et al. 2014).  
Perfusion bioreactor systems 
A final group of bioreactor systems are perfusion bioreactors in which a fixed 3D 
support structure, or scaffold, seeded with cells is perfused during culture. The forced 
perfusion through the scaffold results in a more homogenous distribution of nutrient 
concentration profiles thereby addressing one of the shortfalls using porous 3D micro-
carriers. Additionally, it enables the controlled application of external forces such as 
fluid exerted SS and hydrodynamic compression (Gardel et al. 2014, Li et al. 2014). 
The 3D architecture of the scaffolds can also support the deposition of ECM of which 
its presence during cell culture has been associated with significant advantages such as 
enhanced proliferation and differentiation due to the more relevant in vitro cell niche 
(Chen et al. 2007, He et al. 2009, Lai et al. 2010, Li et al. 2011, Pei et al. 2011, Liu et 
al. 2013a, Tandon et al. 2013). As a result of the development of the complex 3D neo-
tissue (ECM and cells) the subsequent cell recovery from the expansion system is, 
however, significantly impaired, thereby putting severe restraints on the use of these 
systems for cell expansion (Abbasalizadeh et al. 2013, dos Santos et al. 2013, Gardel 
et al. 2014).  
With respect to the development of TE constructs these systems have already been 
extensively used although the successful implementation of the developmental 
engineering paradigm is still absent at current. Numerous groups did, however, use the 
enhanced nutrient supply provided by these systems to develop 3D mineralized 
constructs (Braccini et al. 2005, Grayson et al. 2010, Kim et al. 2012, Gardel et al. 
2014) and the influence of the in vitro cell niche created in these systems on cell 
differentiation was extensively studied (Sikavitsas et al. 2005, Zhao et al. 2009, McCoy 
et al. 2012, Sadr et al. 2012, Youssef et al. 2012). 
1.3.2. Integrated bioprocess development 
As discussed earlier the use of bioreactor systems is indispensable for the future clinical 
implementation of the multi-step TE process. Although the entire bioprocess is centered 
on the functional construct development a multitude of supporting up- and downstream 
processes are required. The main process steps which are often discussed for the TE 
process are the initial cell isolation, the expansion of this cell population towards 
clinical relevant cell numbers and the final construct development as shown in the black 
arrows in Figure 1.2. Each of these steps can, however, still be segmented into a series 
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of separate unit operations which all require dedicated process development and 
integration in the bioprocess flow (Martin et al. 2009).  
Primary cell isolation 
MSCs can be isolated from a variety of tissues ranging from bone marrow and cord 
blood to adipose tissue and the periosteum. Due to the ease of collection and their 
relative high frequency in the bone marrow this is the most common source for MSCs 
(Mosna et al. 2010). In order to obtain the mononuclear fraction of the bone marrow 
which contains the MSCs, density gradient centrifugation is used. Subsequent rinsing 
steps are applied to wash the collected cell fraction prior to plating the cells out to 
remove non-adherent cells (Seeger et al. 2007, Mosna et al. 2010). Similar methods 
enable the isolation of MSCs from the peripheral or umbilical cord blood circumventing 
the need for the invasive bone marrow aspiration (Kassis et al. 2006, Kern et al. 2006). 
Despite the significant number of clinical trials with MSCs (Fekete et al. 2012) the 
isolation and selection of the MSC fraction from these blood derived sources still 
contain a significant number of operator dependent, open steps such as the density 
Figure 1.2: Different steps of the TE process 
Biopsy 
digest
• Enzymatic digest
• Inhibition/removal enzymatic reagent
• Cell rinsing and concentration
• Cell selection
Cell 
expansion
• Cell seeding
• Expansion
• Enzymatic cell harvest
• Inhibition/removal enzymatic reagent
• Cell rinsing and concentration
Construct 
development
• Cell seeding (3D)
• Development of functional construct
• Formulation
Several repetitions 
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gradient centrifugation. In order to address this, various studies have attempted to 
define a fixed set of surface markers for MSCs which could enable their automated, 
closed circuit selection based on fluorescent or magnetic activated cell sorting. 
Although various markers associated with the MSC population have been identified no 
defining marker set is known yet (Jones et al. 2006, Buhring et al. 2007, Ghaemi et al. 
2013, Sivasubramaniyan et al. 2013, Lv et al. 2014). 
Other frequented sources of MSCs can be obtained from a range of different tissues of 
which the subcutaneous fat and the periosteum are the most clinically relevant sources. 
In order to isolate the MSC population from these tissues an enzymatic digest is 
performed after which the adherent cell fraction is selected (Kern et al. 2006, Mosna et 
al. 2010). Despite the long standing methodological expertise in enzymatic tissue 
digests these methodologies have not been implemented in an automated bioreactor 
environment yet (De Bari et al. 2001, Kern et al. 2006, Mosna et al. 2010, van Gastel 
et al. 2012b, Oseni et al. 2013, Centola et al. 2014, Lau et al. 2014). While no specific 
technical challenges are correlated with the implementation of the actual enzymatic 
digest significant efforts still need to be made concerning the required downstream 
processing steps such as cell selection, concentration, rinsing and volume reduction 
(Martin et al. 2009, Abbasalizadeh et al. 2013, dos Santos et al. 2013).  
A broad range of highly selective, automated methodologies for cell selection such as 
fluorescent or magnetic activated cell sorting and other antibody or aptamer based 
systems are available (Abbasalizadeh et al. 2013). These molecular or cellular targeting 
based methods, however, have a limited throughput and often require specific sample 
preparation making them sub-optimal for large scale integration. Various novel tag-free 
methods such as field flow fractionation and dielectrophoresis have already shown 
significant promise for enabling high throughput separation of cell suspensions 
although further development, certainly concerning scale-up and scale-out approaches 
will be required (Diogo et al. 2012, Abbasalizadeh et al. 2013, Fernandes et al. 2013). 
While these methods can also be applied for other downstream processing steps such 
as volume reduction the high specificity provided by these methodologies is not 
required. Current GMP-compliant cell expansion systems employ batch centrifugation 
for cell concentration but the scale-out potential of this methodology is limited 
(Spanholtz et al. 2011, Rojewski et al. 2013). The need for these methodological 
developments was, however, only recognized recently and significant efforts still need 
to be made towards the development of clinical and industrial relevant processes 
(Abbasalizadeh et al. 2013, dos Santos et al. 2013, Sart et al. 2014b).  
Cell expansion 
As clinical relevant cell dosages range between 108 and 1010 cells/patient and biopsies 
can yield often only provide up to 105 cells a significant phase of in vitro cell expansion 
is required (Liu et al. 2013b). Various bioreactor systems which could facilitate this 
expansion process were already discussed earlier. Although each system is associated 
with a specific set of technical and process related challenges at current the most 
limiting step for successful industrial implementation of this process is not the actual 
cell expansion but the cell recovery subsequent to this expansion (Cierpka et al. 2013, 
Jiang et al. 2013, Liu et al. 2013b). 
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The long standing use of enzymatic methods for cell recovery has led to the 
optimization of cell detachment for various established cell culture systems (Roberts et 
al. 2012, Chen et al. 2013, Goh et al. 2013, Zhou et al. 2013a). The development of 3D 
culture substrates such as micro-carriers and hollow fiber bioreactors has started to gain 
more momentum but cell expansion in these setups still predominantly takes place in 
monolayers. This enables the relatively simple transfer of current 2D, often trypsin or 
similar proteolytic enzyme based, methods to these 3D culture environments. The use 
of more complex culture environments in which cells are expanded in a 3D 
environment and potentially produce their own supportive ECM such as porous micro-
carriers or fixed bed perfusion bioreactors, however, offers a new set of currently 
unaddressed challenges for successful cell recovery (Abbasalizadeh et al. 2013, 
Cierpka et al. 2013, dos Santos et al. 2013). 
The cell expansion process will in most cases consist of a consecutive series of 
passages. Therefore not only cell recovery but also the associated downstream process 
steps such as removal of the enzymatic reagent, washing of the recovered cells, volume 
reduction and inoculating the expansion surface of the subsequent culture need to be 
carefully considered (Figure 1.2). As each of the consecutive expansion steps will 
contain a significant higher number of cells the scale-up or scale-out of each of these 
steps also needs to be taken into account to facilitate successful integrated bioprocess 
development. 
Construct production 
Bioreactor systems have already frequently been applied for the final step of the TE 
process, the functional construct development (Rauh et al. 2011, Salter et al. 2012a, 
Gardel et al. 2014). In contradiction to the preceding steps significant efforts have 
already been made towards the integration of associated up- and down-stream processes 
such as for example cell seeding onto the 3D scaffold (Wendt et al. 2003, Griffon et al. 
2011, Salter et al. 2012a). 
In order to develop a clinically relevant process the implementation of these different 
process steps into one integrated process is, however, not the only technical challenge. 
Next to the need for automation a high degree of reproducibility also needs to be 
ensured which requires the development of appropriate tools. Stringent process control 
entails the development of tools for monitoring the in vitro expansion and construct 
development and non-destructive imaging methodologies for characterizing the 
developing 3D structures. 
1.4. On-line monitoring of cell proliferation  
In order to receive regulatory approval for the clinical implementation of novel 
products, ensuring consistent safety and efficacy is indispensable. This requires the in 
depth characterization and standardization of the product and its production process. 
Although bioreactors are often considered to be a valuable tool in this regard, at current 
they are often ‘black box’ systems in which there is no feedback or control of the 
process (Wendt et al. 2009). Next to integrated bioprocess development, bioprocess 
control, providing real time information on the in vitro culture environment as well as 
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on the cell expansion and construct development, is therefore an essential part of the 
development of clinically relevant TE processes.  
The most direct way of monitoring in vitro cell proliferation is measuring the 
concentration of specific metabolites correlated with cell number. As glucose is the 
main energy source of cells in in vitro culture systems, changes in its concentration and 
correlated metabolites such as lactate and l-glutamine can be used as an indication for 
cell number. (Chong et al. 2013, Dos Santos et al. 2014). Recent advances in 
technological development have enabled the integration of various techniques such as 
near infrared spectroscopy in large scale production bioreactors for bacterial culture 
and Chinese hamster ovary cells but successful, cost efficient implementation of these 
systems in the small scale TE bioreactors has not been reported yet (Clavaud et al. 2013, 
Alves-Rausch et al. 2014). Measuring the consumption of oxygen by the cells as well 
as production of carbon dioxide is another way of monitoring cell proliferation as both 
are also involved in the metabolic pathways governing the cells energy regulation. 
Different authors showed changes in dissolved oxygen concentration could be 
correlated to cell number (Janssen et al. 2006a, Santoro et al. 2012). Limitations in 
sensor sensitivity and the perturbation sensitive setups, however, result in a limited 
resolution of the measurement, certainly when monitoring relatively low numbers of 
cells typically present in these TE related setups.  
Instead of measuring concentration of cell metabolism correlated compounds such as 
glucose or oxygen other approaches are based upon the metabolic conversion of non-
toxic dyes. The use of resazurin, a non-fluorescent component which is reduced in the 
cells to form the fluorescent resorufin, already has a long standing use as indicator for 
cell viability (Gloeckner et al. 2001, Cui et al. 2007, Mueller et al. 2013, Zhou et al. 
2013b). Recent reports also hint at the quantitative use of this methodology for 
monitoring cell proliferation but no consistent correlation between cell number and 
assay conversion has been shown yet (Ng et al. 2005, Quent et al. 2010). 
1.5. Nondestructive imaging in tissue engineering 
Characterization of the 3D constructs during expansion and final quality control is 
imperative for process and product quality assessment. Although histology is currently 
still the golden standard for analysis of biological structures it is associated with 
significant disadvantages such as the destructive nature of the technique and the limited 
3D resolution. Recent advances in the field of imaging have therefore been moving 
towards non-destructive characterization of complex 3D structures. The next section 
will give a brief overview of the frequently applied imaging techniques used for in vitro 
characterization of 3D constructs. 
1.5.1. Optical based techniques 
Optical, and in particular fluorescence, based imaging techniques have already been 
applied in the TE field for various applications. Despite its high sensitivity, spatial 
resolution and specificity it has a limited applicability for the characterization of 3D 
constructs due to material induced photon scattering, resulting in limited penetration 
depths of the methodologies (Nam et al. 2014). Recent advances such as the use of two- 
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or multiphoton systems and selective plane illumination microscopy enabled increases 
in imaging depth up to 500µm but they do not yet enable the visualization of complete 
TE constructs  (Chalal et al. 2009, Chen et al. 2010, Ntziachristos 2010, Ward et al. 
2013). The use of probes emitting in the near-infrared spectrum could further enhance 
this due to the low optical absorption in the tissue although this is also correlated with 
an increase in optical scattering and therefore a decrease in resolution (Ntziachristos 
2010). Optical coherence tomography, another novel technique in the field of optical 
imaging based upon scattering of the photon beams, can reach a penetration depth up 
to 3mm and spatial resolutions around 1µm (Mason et al. 2004). Different studies 
already showed the applicability of this technique for characterizing TE constructs but, 
as is the case for all other optical based techniques, it is still limited to constructs with 
a relative high optical translucency (Tan et al. 2004, Chen et al. 2011). 
1.5.2. Ultrasound imaging 
Ultrasound imaging is based upon the same principles as optical coherence tomography 
with the difference that sound waves are used instead of light. Depending on the 
acoustic impedance of the material greyscale images can be generated enabling 
morphological analysis of the samples. Quantitative analysis of the images enabled to 
determine overall collagen content of fibrin gels, monitor mineralization or obtain 
volume averaged data on cell density (Oe et al. 2010, Kreitz et al. 2011, Gudur et al. 
2012). Using high frequency transducers higher spatial resolutions (up to 
approximately 25µm) could be obtained which was, however, associated with a reduced 
maximal penetration depth to 2mm. 
Photoacoustic imaging is considered to be one of the more promising imaging 
techniques and is based upon the detection of the acoustic waves generated after the 
thermos-elastic expansion of a sample subsequent to a nanosecond laser pulse 
irradiation (Ntziachristos 2010, Nam et al. 2014). The use of ultrasound significantly 
increases the penetration depth of the methodology in comparison to optical based 
methods. In comparison to ultrasound this methodology enables the use of additional 
contrast agents for obtaining functional and/or molecular information although this is 
mainly applied for in vivo measurements (Luke et al. 2012).  
1.5.3. Magnetic resonance imaging 
Due to its excellent penetration depth and safety magnetic resonance imaging is a 
frequently applied clinical and preclinical imaging technique based upon the nuclear 
alignment of the atoms in the presence of a strong magnetic field. Radiofrequency 
pulses altering the magnetization of the aligned nuclei are applied and the return of the 
nuclei to the aligned position enables the registration of the transversal and longitudinal 
relaxation time resulting in greyscale images which depend on proton density of the 
sample. Although mainly applied for in vivo studies the excellent contrast was also 
applied in a number of in vitro studies (Xu et al. 2008, Appel et al. 2013, Nam et al. 
2014). In the field of bone TE various studies showed the possibility of monitoring in 
vitro mineralization using this technique (Washburn et al. 2004, Xu et al. 2006) as well 
as for evaluating in vitro cartilage development (Potter et al. 1998, Nieminen et al. 
2001). The technical complexity of this method and the maximal image resolution, 
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ranging between 50µm and 500µm, however, limit the broad application of this 
methodology for in vitro analysis of tissue engineered constructs (Xu et al. 2008, Appel 
et al. 2013).  
1.5.4. X-ray computed tomography 
X-ray computed tomography (CT) is based on the material specific attenuation of X-
rays enabling the visualization of a broad spectrum of materials at high resolution. 2D 
projection images are generated while the sample is being rotated enabling subsequent 
3D image reconstruction. Depending on the X-ray energy a broad range of materials 
can be imaged and it is often the technique of choice in bone TE due to the excellent 
X-ray penetration of the samples (Appel et al. 2013, Nam et al. 2014). One of the 
limitations, however, is the limited X-ray contrast induced by soft materials such as 
ECM. Although low X-ray energies can be employed the attenuation differences 
between different components of the soft matrix is often insufficient. Additionally, if 
the materials being imaged are hybrid constructs, containing next to the soft ECM, more 
dense materials such as a mineralized matrix or a dense scaffold matrix, the X-ray 
energies required to penetrate the dense materials often do not enable the visualization 
of the soft tissue. More advanced setups such as phase contrast systems of phase 
enhanced imaging can enable the visualization of these soft tissues within hybrid 
constructs (Mastrogiacomo et al. 2004, Voronov et al. 2012, Olubamiji et al. 2014). 
The availability of these advanced systems is, however, limited and there is a need for 
more general applicable methodologies for imaging these constructs.  
1.6. Conclusion 
In this chapter, different aspects of bone and bone development were discussed and 
their relevance for skeletal TE approaches was elucidated. The need for integrated 
bioprocess development was introduced and the relevance of bioreactor systems in this 
context was explained. The current state of the art of bioprocess development for 
skeletal TE was discussed showing that despite significant efforts several aspects of the 
skeletal TE bioprocess flow remain unaddressed. In addition, the availability of 
different tools for bioprocess monitoring and characterization of the 3D constructs were 
discussed providing a comprehensive overview of the context within which the work 
discussed in this dissertation was performed.  
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2.1. General hypothesis 
Despite significant advances in the field of TE, large scale industrial and clinical 
implementation of established concepts is currently lacking. Bioprocess development, 
enabling the integration of the entire TE process in a controlled, monitored and 
automated environment will be essential for the future translation of lab-scale processes 
to clinically relevant applications. Although this need is recognized within the research 
field its current focus is mainly on functional construct development while the need for 
integration of preceding process steps such as cell expansion is often neglected.  
The general hypothesis upon which this work is based states that the in vitro micro-
environment present in a 3D perfusion bioreactor system is supportive for cell 
proliferation while maintaining its functional characteristics, thereby enabling its use 
for the automated expansion of a progenitor cell population. The main objective of the 
research presented in this dissertation was therefore defined as the study of the 
influence of the in vitro cell niche created in a 3D perfusion bioreactor on the behavior 
of a multipotent progenitor cell population. In addition techniques required for 
monitoring and characterizing the cell proliferation and neo-tissue formation in the 
system were developed. 
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2.2. Methodology 
In order to study the formulated hypothesis a specific methodology was defined using 
a consistent set of materials throughout this dissertation. 
• Cell culture system 
o Human Periosteal Derived Cells (hPDCs): As discussed in chapter 1 
the multipotent periosteal derived cell population is an ideal 
candidate for the development of bone TE constructs.  
o Ti6Al4V scaffolds: A porous 3D printed Ti6Al4V scaffold with a 
repeating unit cell was employed as a 3D cell culture substrate. The 
regular shape of the scaffold enabled homogenous, reproducible 
control of the micro-environment created for the cell resulting in 
consistent application of external stimuli. The Ti6Al4V alloy used 
for the scaffolds is a clinically approved material with various 
applications in the orthopedic field. Due to the biocompatibility of 
this material it provides a suitable culture substrate to study the 
influence of external stimuli on cell behavior without interfering with 
the biological processes. 
o Perfusion bioreactor system: To ensure controlled, reproducible and 
homogenous nutrient supply and waste removal for the cells in the 
three dimensional scaffold a perfusion bioreactor system was 
developed.  
• Measured outputs 
o Cell number: Cell number was monitored in order to quantify 
proliferation during the expansion process. DNA measurements and 
a hemocytometer were used to measure cell number at final time 
points. On-line monitoring of cell number and proliferation was 
performed using a non-destructive assay which was quantitatively 
validated for this purpose within this dissertation.  
o Neo-tissue formation: Expansion of a cell population in standard 2D 
setups is a space constrained process regulated by the contact 
inhibition between cells once confluence is reached. As cells 
proliferate within the 3D environment a neo-tissue containing cells 
and ECM is formed in the scaffold. Contrast enhanced nano-
computed X-ray tomography (CE-nanoCT), a novel technique 
developed within the context of this dissertation, was used to 
determine volume filling of the porous scaffolds, thereby monitoring 
when confluence occurs in the 3D culture system. 
o Cell characteristics: The gene expression profile is an important 
indicator of cell identity and characteristics. Gene expression 
analysis of several key marker genes was therefore used as an 
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indication of the influence of the engineered cell niche on the 
characteristics of the expanded population.   
o Cell functionality: As the final goal of a cell expansion process is to 
obtain a cell population with an unimpaired functionality, both in 
vitro and in vivo functional assays were performed.  
2.3. Objectives 
Specific research objectives were defined to validate the formulated research 
hypotheses.  The next section summarizes the key objectives for the different chapters 
which are visually represented in Figure 2.1. The first two objectives concern the 
development of different methods required for process monitoring and characterization 
which are subsequently applied to assess the influence of the in vitro micro-
environment as described in the third objective.  
2.3.1. Development of a quantitative method for 
monitoring cell proliferation in a perfusion 
bioreactor system 
The Presto Blue® metabolic assay (PB) is fluorescent based assay to monitor cell 
viability in various setups. To enable monitoring cell proliferation in a 3D perfusion 
bioreactor system a quantitative validation of the assay was required. Therefore the 
linear operating window of the assay was first determined and the influence of different 
measurement parameters on the linearity were established using standard 2D cell 
culture methods. The potential to define quantitative correlations between cell number 
and conversion of the assay was assessed using standard 2D as well as both static and 
perfused 3D culture and measurement setups. The quantitative validation of the PB 
metabolic assay is described in Chapter 3. 
2.3.2. Development of Contrast Enhanced nano-computed 
X-ray tomography as a tool for visualization of soft 
tissue in metallic scaffolds 
CE-nanoCT was developed as a tool to enable soft tissue visualization and quantitative 
analysis in porous metallic scaffolds. A proof of concept study was first performed to 
assess the potential of using two different contrast agents to visualize the neo-tissue 
(cells and ECM) in the metallic scaffolds. The obtained results were compared with 
established techniques for visualization and quantification of the neo-tissue in an initial 
attempt to validate the developed techniques.  In order to enable quantitative, automated 
image analysis a design of experiment (DoE) study was subsequently performed to 
optimize image contrast and quality in function of different staining parameters. A 
semi-quantitative validation of the different stainings was performed using constructs 
with a different scaffold material enabling visualization of the neo-tissue without the 
use of the contrast agents. The results of the proof of concept study are described in 
chapter 4 while the optimization and validation for quantitative analysis is discussed in 
chapter 5. 
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2.3.3. Three dimensional perfusion bioreactor facilitated 
cell expansion 
In order to assess the potential use of a 3D perfusion bioreactor system as a tool for 
automated cell expansion the influence of the in vitro micro-environment on cell 
characteristics was determined. In addition to a number of established techniques the 
novel methodologies developed in chapters 3-5 were used to determine the influence 
of a range of different flowrates on cell proliferation after which a more in-depth 
assessment was performed for two selected perfusion velocities. Proliferation, matrix 
deposition and gene expression were assessed over time and compared to cells 
expanded in a static 3D culture system. To enable functional characterization of the 
expanded cell population a methodology for cell recovery subsequent to the bioreactor 
expansion was developed. Therefore different enzymatic reagents were initially 
screened and a DoE study was performed to optimize the yield of the developed 
methodology. A series of in vitro and in vivo assays was subsequently used to determine 
the potential influence of the expansion and recovery process on cell functionality. The 
results of these experiments are discussed in chapters 6 and 7.
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Figure 2.1: Schematic representation of the different aspects of the perfusion bioreactor facilitated 
expansion process addressed in this dissertation. 
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3.1. Abstract 
As the fields of tissue engineering and regenerative medicine mature towards clinical 
applications the need for on-line monitoring, both for quantitative and qualitative use, 
becomes essential. Resazurin based metabolic assays are frequently applied for 
determining cytotoxicity and have shown great potential for monitoring 3D bioreactor 
facilitated cell culture. However, no quantitative correlation between the metabolic 
conversion rate of resazurin and cell number has been defined yet. In this work we 
determined conversion rates of Presto Blue™, a resazurin based metabolic assay, for 
human periosteal cells during 2D and 3D static and 3D perfusion culture. Our results 
showed that for the evaluated culture systems there is a quantitative correlation between 
the Presto Blue™ conversion rate and the cell number during the expansion phase, with 
no influence of the perfusion related parameters i.e. flow rate and shear stress. The 
correlation between cell number and Presto Blue™ conversion subsequently enabled 
the definition of operating windows for optimal signal readouts. In conclusion, our data 
showed that the conversion of the resazurin based Presto Blue™ metabolic assay can 
be used as a quantitative read-out for on-line monitoring of cell proliferation in a 3D 
perfusion bioreactor system although a system specific validation is required. 
3.2. Introduction 
The development of cell based tissue engineering strategies for the repair or 
replacement of damaged organs and tissues is a rapidly evolving research field (Martin 
et al. 2011a, Martin et al. 2012).  As these novel cell-based therapies fall under the 
definition of the ‘Advanced Therapy Medicinal Products’ (ATMPs) of the European 
Medicine’s Agency (EMA), the application of the Process Analytical Technology 
guidelines (PAT) to develop well characterised products by designing and controlling 
the manufacturing process through timely measurements of critical quality attributes is 
essential (Chew et al. 2010, Rebulla et al. 2010, Schneider et al. 2010). The integration 
of bioreactor systems in current lab scale processes therefore holds promise for the 
translation in a clinical and ultimately commercial setting (Martin et al. 2010, Salter et 
al. 2012a). Bioreactors have been employed frequently to provide sufficient  nutrient 
and oxygen transport and removal of waste products (Grayson et al. 2004, Martin et al. 
2004, Haycock 2011, Rodrigues et al. 2011, Jakob et al. 2012, Salter et al. 2012a) while 
allowing for monitoring and control of physicochemical and biological parameters 
(Tsao et al. 2005, Das et al. 2010, Martin et al. 2010, Rauh et al. 2011, Santoro et al. 
2012, Zhou et al. 2013b) during cell proliferation, differentiation and the development 
of a cell-carrier constructs. Furthermore these parameters could be used as non-
destructive quality indicators of the cells or the developing construct. 
Since in vitro proliferation is an essential process step for the production of cell based 
products (Rodrigues et al. 2011), on-line measurements of metabolic activity 
parameters such as glucose, lactate and oxygen concentration, could allow for a non-
destructive assessment of the quality of the 3D cell culture (Tsao et al. 2005, Das et al. 
2010, Santoro et al. 2012, Frese et al. 2014). Although, for example, correlating a 
decrease in oxygen concentration to cell proliferation has been shown to be a viable 
strategy to monitor proliferation for high cell numbers (Santoro et al. 2012), these 
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techniques often fall short when lower cell numbers in the order of magnitude 104 to 
106 cells need to be monitored and quantified (Zhou et al. 2013b). Limited sensor 
sensitivity as well as low oxygen and glucose consumption rates per cell hamper the 
reliability of such measurements (Zhou et al. 2013b). Therefore alternate 
methodologies to monitor cell number, viability and proliferation as well as 
differentiation in bioreactors are essential, especially for the initial crucial expansion 
steps (post biopsy expansion) of scarce adult stem cell populations.  
Metabolic assays such as the tetrazolium based 3-[4-5-Dimethylthiazol-2-yl]-2-5-
diphenyl bromide tetrazolium bromide (MTT) and the resazurin based Alamar Blue® 
assay (AB) use the redox activity of the cells to qualitatively monitor cell populations 
based on the generation of an optical or fluorescent detectable component (Nociari et 
al. 1998, Back et al. 1999, Quent et al. 2010, Uzunoglu et al. 2010, Rampersad 2012, 
Mueller et al. 2013). MTT and other tetrazolium based assays are based on the cleavage 
and reduction of the tetrazolium ring to blue formazan crystals by the mitochondrial 
dehydrogenases (Nociari et al. 1998, Quent et al. 2010). These crystals can be 
solubilised and quantified in the cell lysate as a measure for metabolic cell activity. 
Despite the frequent use of these assays the fact that this methodology can only be used 
as an endpoint analysis is a serious disadvantage (Quent et al. 2010). The resazurin 
based AB and Presto Blue® (PB) assays on the other hand use the mitochondrial activity 
to reduce the non-fluorescent, blue resazurin to the fluorescent, pink resorufin (Nociari 
et al. 1998, O'Brien et al. 2000, Quent et al. 2010). This non-toxic, water soluble dye 
enables continuous cell culture monitoring and has been shown to be a powerful tool to 
assess cell viability and proliferation in both static and dynamic 3D setups (Gloeckner 
et al. 2001, Cui et al. 2007, Mueller et al. 2013, Zhou et al. 2013b). These reports show 
a clear correlation between the obtained fluorescent signal and the cell number. 
However, contradictory results showing discrepancies between cell number and the 
metabolic conversion of the resazurin when using static culture systems are also 
present, indicating that the performance of these assays is dependent on the cell type, 
culture and measurement setup (Ng et al. 2005, Quent et al. 2010). 
In order to determine whether the quantitative use of a resazurin based assay in a 
bioreactor setup is possible, the influence of the cell culture method and measurement 
setup on the conversion rate of the resazurin and on the metabolic activity of the cells 
has to be known. The redox activity of a cultured cell population was already shown to 
be influenced by long term proliferation and the induction of differentiation (Rice et al. 
2010, Quinn et al. 2012). The influence of different culture systems and parameters on 
the metabolic activity of the cells and the conversion rate of the metabolic assays is, 
however, not known, which hampers the quantitative use of these methods. 
In this work we used the PB metabolic assay to monitor and quantify cell proliferation 
in a perfusion bioreactor setup up to 21 days. At first, the influence of different culture 
setups was investigated by measuring the metabolic activity of cells cultured in 2D and 
in 3D static and 3D perfusion bioreactor setups, and correlating this to DNA content. 
Subsequently a dynamic monitoring method was developed to overcome diffusion 
limitations that were observed when 3D scaffolds were measured in a static setup, 
affecting the conversion rate. Finally, the influence of perfusion flow rate and shear 
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stress on the conversion of the metabolic assay was determined by using medium with 
different viscosities. Based on DNA measurements conversion rates for the PB assay 
in the different setups were found to enable the quantitative monitoring of cell 
proliferation.  
3.3. Materials and Methods 
3.3.1. Human Periosteal Derived cells (hPDCs)  
hPDCs were isolated from periosteal biopsies obtained from 4 different donors (age 11, 
13, 14 and 17, equal distribution of gender) as described previously and pooled for 
further use (Eyckmans et al. 2006a). This procedure was approved by the ethics 
committee for Human Medical Research (KU Leuven) and performed with patient 
informed consent. hPDCs were expanded in Dulbecco’s modified Eagle’s medium with 
high-glucose (Life Technologies) containing 10% foetal bovine serum (Gibco), 1% 
sodium pyruvate (Life Technologies) and 1% antibiotic–antimycotic (100 units/mL 
penicillin, 100mg/mL streptomycin, and 0.25 mg/mL amphotericin B; Life 
Technologies), further mentioned as culture medium. The cells were seeded at 5,700 
cells/cm² and passaged at 80%–90% confluency. Cell expansion and 2D experiments 
were performed in standard cell culture conditions (relative humidity: 95%, 5%CO2, 
37°C) 
3.3.2. Ti6Al4V scaffolds 
For 3D cell culture, additive manufactured Ti6Al4V scaffolds (Ø = 6 mm, h = 6 mm) 
(Van Bael et al. 2011, Pyka et al. 2012) were used as described before (Papantoniou et 
al. 2014b). The total volume of the scaffolds was 166 ± 3 mm³, the available volume 
130 ± 5 mm³ and the available surface 7.5 ± 0.6 cm² as determined with nanoCT 
(Kerckhofs et al. 2013a). Briefly, scaffolds were ultrasonically cleansed prior to use in 
acetone, ethanol and distilled water for 10 minutes each after which they received an 
alkaline treatment with 5M sodium hydroxide for 24 hours at 60°C. Subsequently, 
scaffolds were rinsed with distilled water after which they were sterilised in a steam 
autoclave. Prior to seeding, the scaffolds were pre-wetted by vacuum impregnation with 
culture medium for 2 hours in standard cell culture conditions after which they were 
dried in a non-humidified incubator overnight (Papantoniou et al. 2013).  
3.3.3. Viscosity measurements culture medium 
The viscosity of the culture medium was increased by the addition of dextran (average 
MW 150,000, Sigma). The viscosity of solutions containing 0, 2.5, 5, 7.5 and 10% 
dextran was determined using a MCR 501 rheometer (Anton Paar). A C-LTD 180/XL 
measurement chamber was used to enable shear stress measurements at a constant 
temperature of 37°C. For each measurement the solution was pre-sheared at a shear rate 
of 100/s for 30 seconds after which a rate sweep from 100/s to 0.1/s shear rate was 
performed using a log ramp. Data points corresponding with torques lower than 0.001 
mNm were discarded due to inaccuracy of the measurements. Since τ=η*γ (with τ: 
shear stress, η: viscosity and γ: shear rate) the viscosity of the solution could be 
determined by correlating the applied shear rate to the measured shear stress. 
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3.3.4. 2D AB and PB measurements 
For 2D experiments, cells were seeded at the standard density of 5,700 cells/cm² in 6 
well plates and cultured statically in 2 ml of growth medium. For 6 days the metabolic 
activity of the cells was measured daily using both PB and AB for 3 wells each (both 
metabolic assays were obtained from Life Technologies). For both reagents a 
measurement solution containing 1 unit volume of reagent for 10 unit volumes of 
culture medium was prepared resulting in a 9.09% solution (standard concentration 
measuring solution unless otherwise mentioned). The medium was removed from the 
wells and replaced with 2 ml of the PB or AB solution after which the cells were 
transferred back to the incubator at normal cell culture conditions. At the different 
incubation times (15, 30, 45, 60, 90 and 120 minutes) a 100 µl sample was taken from 
every well and transferred to a 96-well plate. The fluorescent signal was measured with 
an automated microplate fluorometer (SerColab Systems) using an excitation 
wavelength of 544 nm and an emission wavelength of 590 nm as described earlier 
(Zhou et al. 2013b). The measured fluorescent signal was expressed as arbitrary 
fluorescent units (FU). For every measurement the background signal of the 
measurement solution was determined by incubating an identical volume in the absence 
of cells in the experimental conditions. This blank signal was subsequently subtracted 
from the signal measured in the presence of cells to obtain the signal induced by the 
presence of the cells. After the measurement, the PB or AB solution was removed from 
the wells and replaced by normal culture medium. For the measurement on day 5, 3 ml 
of the measuring solution was used to allow for a higher number of sampling points. 
Additional samples were taken after 3, 4, 5 and 6 hours of incubation. 
To determine the quantitative correlation between the PB signal and the cell number in 
a 2D static setting two different approaches were used. 6-well plates were seeded with 
100,000 cells each and cells were allowed to attach over night after which the culture 
medium was removed and 2, 4 or 6 ml of the PB solution was added on triplicate wells. 
Cells were incubated for 8 hours in total and 100 µl samples were taken every hour and 
transferred to a 96-well plate for measurement. Alternatively, different amounts of cells 
were seeded in triplicate in 6-well plates (25,000, 50,000, 75,000, 100,000, 200,000, 
and 300,000). Cells were incubated overnight to allow cell attachment after which the 
culture medium was removed and 2ml of PB solution was added. Samples were taken 
every hour for 8 hours and measured as described before.  
3.3.5. 3D static cell culture and PB measurements 
For 3D culture experiments cells were drop-seeded onto the scaffolds at a density of 
200,000 cells/60 µl as described in previous studies (Papantoniou et al. 2013, Zhou et 
al. 2013b, Papantoniou et al. 2014b, Sonnaert et al. 2014a). 45 minutes after seeding 
60 µl culture medium was added and 135 minutes later the medium volume was topped 
up to 1 ml. Scaffolds were statically incubated overnight in standard culture conditions 
(37°C, 5% CO2, 95% relative humidity). Since the seeding process resulted in 
homogenous and reproducible seeding efficiencies in previous work (~60%) this was 
not assessed separately in this work (Papantoniou et al. 2013, Papantoniou et al. 2014b, 
Sonnaert et al. 2014a). 
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To determine the quantitative correlation between the PB signal and the cell content in 
a 3D static culturing system, scaffolds were transferred to 12 well plates containing 3 
ml of culture medium after seeding. Medium was refreshed every two days and PB 
measurements were performed at day 1, 6, 10, 15 and 22 by replacing the culture 
medium with 3 ml of the PB solution and incubating the scaffolds in standard cell 
culture conditions for 3 hours. The PB signal was measured in triplicate as described 
before. At each PB time point 3 scaffolds were sacrificed for DNA measurement as 
described below. 
3.3.6. 3D perfusion bioreactor culture and PB 
measurement 
For 3D perfusion bioreactor culture, 3D Ti6Al4V scaffolds were seeded in the 
bioreactor system using the same methods as described for the static system 
(Papantoniou et al. 2013, Papantoniou et al. 2014b, Sonnaert et al. 2014a). Scaffolds 
were subsequently press-fitted in an in-house developed bioreactor chamber  
(Papantoniou et al. 2013, Zhou et al. 2013b, Papantoniou et al. 2014b, Sonnaert et al. 
2014a) ensuring forced perfusion through the scaffold and cultured at a flow rate of 1 
ml/min in a non-humidified incubator (37°C, 5% CO2). The total medium volume in 
each circuit was 10 ml of which 7.2 ml was located in the medium reservoir. Medium 
was refreshed every second day by attaching a falcon tube containing fresh medium to 
the system. For PB measurements a falcon tube containing 2.2 ml of a 20.5% PB 
solution was connected to the circuit resulting in a total volume of 5 ml and a final PB 
concentration of 9.09% as used for the static measurements. The PB solution was 
perfused for one hour at 1 ml/min after which the resulting PB signal in the solution 
was measured. To remove remnants of the PB solution in the bioreactor circuits for 
continued cell culture two falcon tubes containing 5 ml of culture medium were 
subsequently connected to the circuits for a perfusion step of 5 minutes each after which 
a final medium refreshment was performed as described before. After seeding the 
scaffolds were dynamically cultured for 21 days and PB measurements were performed 
in triplicate on day 2, 7, 12, 17 and 21. After each PB measurement 3 scaffolds were 
sacrificed for DNA measurement. 
To determine the influence of both culture the measurement setup (static versus 
bioreactor), 3D cell seeded scaffolds cultured for 14 days in both systems were 
measured either in the respective culture systems or consecutively both in a static and 
perfusion bioreactor setup. All conditions were performed and measured in triplicate. 
In an additional 3 samples cultured in both setups no PB measurements were performed 
to verify that the performed handlings had no influence on cell number. All samples 
were used for DNA measurement after the experiment.   
To determine the influence of different flow rates during 3D perfusion bioreactor 
culture on the metabolic activity of cells in the 3D scaffolds, and thereby on the 
conversion rates of the PB, they were cultured at different flow rates (0.5 ml/min, 1.1 
ml/min and 2.2 ml/min) for 21 days after which the metabolic activity of the cells was 
determined using PB. The flow rates used during the PB measurement were the same 
as those used during culture for all conditions. The cell content of the scaffolds was 
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also determined based on DNA measurements. Additionally, two conditions in which 
the volumetric flow rate was 0.5ml/min but the shear stress was equal to respectively 
the 1.1 and 2.2 ml/min condition by increasing the viscosity of the medium as described 
earlier (Section 2.3) using respectively 3.37% and 6.36% dextran (average MW 
150,000, Sigma) were evaluated.     
3.3.7. DNA measurement 
The DNA content was determined using a highly quantitative and selective DNA assay 
(Quant-iTTM dsDNA HS kit, Life Technologies). The scaffolds were rinsed with PBS 
and lysed in 350 µl RLT lysis buffer supplemented with 3.5 µl β-mercaptoethanol 
(Qiagen). The lysed samples were vortexed for 60 seconds and stored at -80°C prior to 
analysis, thawed at room temperature and spun down for 1 min at 13,000 rpm. 10 µl of 
the sample was diluted in 90 µl milliQ water after which the DNA content was 
quantified with a Qubit® Fluorometer (Life Technologies) as described by Chen et al., 
2012 (Chen et al. 2012) 
3.3.8. Mathematical representation of the PB 
measurement in the perfusion bioreactor system 
using ordinary differential equations 
A schematic representation of the bioreactor system is shown Figure 3.1. The 
concentration of the resorufin in the medium reservoir could be determined based on a 
mass balance over the reservoir taking into account the flow rate dependent in and 
outward fluxes (eq. 1). The outward flux was defined based on the flow rate and the 
resorufin concentration (eq. 2). The inward flux in the medium reservoir was equal to 
the outward flux at the scaffold although a flow rate and tubing volume dependent time 
delay had to be implemented to account for the time the measurement suspension 
required to be perfused from the scaffold back to the medium reservoir (eq. 3). The flux 
at the outlet of the scaffold was determined by the ingoing flux and the cell mediated 
resazurin conversion (eq.4) while the flux at the inlet of the scaffold was defined based 
on the concentration in the medium reservoir, again implementing the flow rate and 
tubing volume dependent time delay in order to account for the time required to perfuse 
the solution from the medium reservoir to the scaffold (eq.5). 
At the initial time point the resorufin concentration in the medium reservoir was set at 
zero while the maximal value was set at 3,500 as these were determined to be the 
borders of the linear operating window.  
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Figure 3.1: Schematic representation of the perfusion bioreactor system.
(Adapted from Zhou et al., 2013) 
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3.3.9. Statistical analysis 
One-way Anova was performed to analyse significant differences between groups. A 
p-value < 0.05 was considered significant. 
3.4. Results 
Initially the PB metabolic assay was compared with the previously validated AB assay 
(Zhou et al. 2013b) by monitoring for both assays cell proliferation in a static 2D setup 
for different incubation times (Figure 3.2.A and B). Both metabolic assays showed an 
increase in metabolic activity in function of culture time in accordance with the 
expected exponential phase of cell growth. Although the same incubation times and 
concentrations were used, the PB signal was significantly higher compared to the AB 
signal for the same incubation time. This was also visible by the stronger increase in 
signal shown in Figure 3.2.C in which the linear operating window of both assays was 
determined respectively up to 3,000 FU for the AB assay and 3,500 for the PB assay. 
The relative standard deviation on the measured signal was also significantly lower for 
the PB measurement as shown in Figure 3.2.D. 
Figure 3.2: Comparison between Presto Blue and Alamar Blue 
(A, B) 2D static expansion of hPDCs monitored with Alamar blue and Presto Blue 
respectively for different incubation times (n=3) (C) Signal saturation determined for 
Presto Blue and Alamar Blue based on 2D static expansion. The lines indicate the linear 
operating zone for both assays (R² values are shown for a fit forced through 0;0) (n=3) 
(D) Boxplot of relative standard deviation for 2D static Presto Blue and Alamar Blue 
measurements (n=60) 
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Conversion rates for PB were determined in a static setup for both 2D and 3D cell 
culture systems. For all conditions a time dependent linear increase in the measured 
signal was observed (Figure 3.3). Linear regression was used to determine the slope 
coefficients which indicated the increase in FU per hour for all different conditions 
(Table 3.1). These values were corrected for incubation time, cell number and volume 
and were then averaged over the different experimental conditions. For the case of 2D 
cell culture the two different setups used to determine the conversion rate resulted in a 
similar average value of approximately 616 FU converted per hour for 100,000 cells. 
For the measurement in the 3D static culture system a linear correlation was again 
measurement as observed between the PB obtained signal and the cell number based 
on DNA shown in Figure 3.3.C. The resulting PB conversion rate was, however, 
significantly lower than the one obtained for the 2D static system (Table 3.1).  
Table 3.1: Observed increase in Presto Blue signal per hour for different static culture 
conditions based on Figure 3.3 and the representative Presto Blue conversion rates. 
Results   37 
 
 
 
As shown for both the 2D and 3D static culture and measurement setups the PB signal 
and DNA content measured for perfusion bioreactor expanded cells showed no 
significant differences after fitting the curves as shown in Figure 3.4.A in which both 
the increase in FU and the increase in cell number are represented on the Y-axis. 
Normalizing the signal to the volume and cell number resulted in conversion rates 
which were not significantly different from the earlier determined 2D conversion rates 
during the proliferative phase (Figure 3.4.B and Table 3.1). As also shown in Figure 
3.4.A the metabolic conversion rate of the cells in the scaffold does decrease once 
confluency is reached as determined with DNA measurements (Figure 3.4.B). 
In order to determine the influence of the culture and measurement setup on the PB 
signal, bioreactor and static measurements of cells expanded in both 3D bioreactor and 
static setups were performed. Figure 3.5.A shows a significant higher DNA content for 
all 3D bioreactor expanded cells in comparison to the static 3D expanded cells. No 
significant difference was observed between the cells expanded under the same 
Figure 3.3: Presto Blue and DNA measurement for different culture setups 
(A) Fluorescent signal measured for different volumes of Presto Blue solution for 
100,000 cells in a 2D static setup (n=3) (B) Fluorescent signal measured for different 
cell numbers in 2ml Presto Blue solution in a 2D static setup (n=3) (C) Presto Blue 
signal in function of incubation time for different time points during 3D static culture 
and corresponding cell number based on DNA measurements (n=3)  
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conditions indicating that the handlings performed for the measurements did not 
influence the cell content. Despite the significant differences observed in DNA content 
no differences in PB signal were observed between the 3D static and bioreactor 
expanded cells using the static measurement setup (Figure 3.5.C). However the 
measurements performed in the bioreactor system showed a significant difference 
between the bioreactor and the statically expanded cells (Figure 3.5.B). Since different 
incubation times and PB volumes were used for the bioreactor and static measurements 
the obtained signal was corrected for cell number, time and volume. Figure 3.5.D shows 
that a similar conversion rate was determined for all bioreactor measured conditions, 
independently from the culture setup. The conversion rate determined for static 
measurements were significantly lower in comparison to all bioreactor measured 
conditions. Additionally, the conversion rate determined for the bioreactor cultured, 
static measured samples was significantly lower than those for the statically cultured 
and measured.  
Figure 3.4: Presto Blue and DNA measurements and correlated conversion rates during 
bioreactor culture. 
(A) Cell number and Presto Blue signal during 21 days of 3D perfusion bioreactor 
culture for different time points (B) Presto Blue conversion rates for different time 
points during 3D perfusion bioreactor culture. * 0.05>p 
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Figure 3.5: Influence of different measurement and culture setups on Presto Blue 
conversion rates 
 (A) DNA content (ng/ml) after 3D cell expansion for  different culture and measurement 
setups, as shown on the axis (n=3) (B) Presto Blue signal after either 3D static or 
perfusion bioreactor cell expansion, measured in the perfusion bioreactor system  (n=3) 
(C) Presto Blue signal after either 3D static or perfusion bioreactor cell expansion, 
measured in the static system (n=3) (D) Conversion rates for 3D constructs cultured in a 
bioreactor or static setup determined using a bioreactor (black) or static (grey) 
measurement setup (n=3). * 0.05>p>0.01, ** 0.01>p>0.001, $ indicates significant 
differences between dynamic and static measurement for the same construct, p<0.05 
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No significant differences in cell proliferation were observed when using different flow 
rates nor did the increased viscosity and the correlated shear stress for the low 
volumetric perfusion influence the final cell number (Figure 3.6.A). Additionally, the 
conversion rates determined for the different conditions were not influenced by the 
perfusion velocity (Figure 3.6.B) indicating that, next to the proliferation, the PB 
conversion rates and therefore the metabolic activity of the cell population, was not 
influenced by flow rate within the examined range corresponding with initial shear 
stress values between 7E-3 Pa and 3.08E-2 Pa (Sonnaert et al. 2014a). 
Although flow rate does not influence the conversion rate of the PB assay it should be 
high enough to prevent local saturation of the assay at the outlet of the scaffold. To 
determine at which combinations of flow rate and cell number this could influence the 
readouts, mass balance equations were used to determine the relative saturation of the 
linear PB operating window in the medium reservoir and at the scaffold in- and outlet 
in function of flow rate, cell number, measurement volume and incubation time (eq.1-
5). The resulting resorufin concentrations at the scaffold outlet obtained from the time 
dependent mass balances were subsequently converted to relative PB saturation as 
shown in Figure 3.7.A-C. Although flow rate did not influence the conversion rate of  
Figure 3.6: Influence of shear stress and volumetric perfusion velocity on Presto Blue 
conversion rate. 
(A) Cell content for 3D constructs cultured in the perfusion bioreactor based on DNA 
measurement for different flowrates and medium viscosities (n=3) (B) Presto Blue 
conversion rate for 3D constructs cultured in the perfusion bioreactor with different 
flowrates and medium viscosities 
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Figure 3.7: Model based estimation of Presto Blue signal. 
Presto Blue saturation at the bioreactor chamber outlet determined for (A) different cell numbers (B) different flow rates (ml/min) (C) 
different measurement volumes (ml) (D) incubation time (min) after which saturation of the Presto Blue assay is reached at the bioreactor 
chamber outlet for specific combinations of cells and flow rate (ml/min) (E) Operating window for Presto Blue measurement of a bioreactor 
chamber containing a scaffold with 2,500,000 cells valid for flow rates above 0.4ml/min (F) Operating window for a Presto Blue 
measurement in a 3D perfusion bioreactor system containing 5ml of measurement solution valid for flow rates above 0.4ml/min. The black 
area shows the measurement conditions which result in a value outside the linear operating window of the assay. 
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the assay, flow rate dependent changes in PB saturation were observed (Figure 3.7.B). 
Figure 3.7.D subsequently shows for which combinations of incubation time, cell 
number and flow rate saturation at the scaffold outlet is reached, allowing to define an 
operating window for the measurement.  
3.5. Discussion 
A number of reports have shown that metabolic assays such as the AB assay can be 
used to monitor cell proliferation (Mueller et al. 2013, Zhou et al. 2013b) although no 
quantitative correlation between the conversion rate of the reagent and the cell number 
has been defined. To enable a quantitative use of this tool we investigated the influence 
of three different cell culture methods and correlated measurement set-ups, including 
bioreactor culture, on the conversion of the resazurin based PB metabolic assay.  
Initially, a validated metabolic activity assay, the AB assay (Zhou et al. 2013b) was 
compared with the PB assay for conventional 2D cell expansion. As shown in Figure 
3.2.C the maximum signal obtained in the linear operating range was approximately 
3,000 FU for the AB assay and 3,500 for the PB assay indicating that the latter has a 
significantly larger operating window.  Additionally, the time dependent increase in 
signal was significantly higher at each time point for the PB (Figure 3.2.A-C) 
demonstrating that this assay has a higher sensitivity power which was also confirmed 
by comparing the relative standard deviations obtained for both assays (Figure 3.2.D). 
Table 3.1 shows that a linear correlation between PB signal and cell content exists 
(R²=0.87). Due to the increase in cell number, and the correlated decrease in available 
surface for proliferation, a decreasing trend in PB conversion in function of cell number 
was, however, present.  Nonetheless, no significant differences were observed between 
the average conversion rates determined using different volumes and cell numbers and 
a quantitative correlation between cell number and PB signal could be established. 
Although other groups reported discrepancies between resazurin conversion of the AB 
assay and cell number (Ng et al. 2005, Quent et al. 2010) these could probably have 
been induced by the high cell density in the culture systems used. When performing a 
similar experiment for static 3D cell culture and monitoring proliferation in function of 
time a quantitative relation between cell number and PB signal was again observed 
(Figure 3.3.C) although a significantly lower conversion rate was obtained (Table 3.1). 
For the perfusion bioreactor 3D cell culture, the PB conversion rate was significantly 
higher than observed for the static 3D system and no difference was found in relation 
to the 2D setup (Figure 3.4.B, Table 3.1). Since previous studies already showed that 
cell growth in 3D scaffolds in a static culture setup is predominantly located at the outer 
edges of the scaffolds due to limitations in nutrient diffusion (Ishaug et al. 1997, 
Bancroft et al. 2002, Sikavitsas et al. 2003, Papantoniou et al. 2014b, Sonnaert et al. 
2014a) also the difference in PB conversion rate might be related to limited diffusion.  
In order to confirm that the different conversion rates observed between 3D static and 
perfused culture systems originated from enhanced mass transport in the perfusion 
bioreactor system, the conversion rate for cells expanded both in the 3D static or 
bioreactor system were determined using both static and bioreactor measurement 
setups. As shown in Figure 3.5.A the measurement methods and manipulations did not 
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influence the final cell content of the scaffolds. Despite the significant differences in 
DNA content, the PB signal measured in the static setup was not influenced by the 
culture conditions (Figure 3.5.C). Diffusion limitations possibly influenced the 
accessibility of the cells in the centre of the densely populated bioreactor cultured 
scaffolds (Ishaug et al. 1997, Bancroft et al. 2002, Sikavitsas et al. 2003). In order to 
confirm this hypothesis the maximal diffusion depth of the resazurin in the scaffolds 
was determined using a partial differential equation describing the spatiotemporal 
evolution of resazurin (cR) as discussed by (Demol et al. 2011) (eq.6). As no data was 
available on resazurin diffusion in an engineered neo-tissue the diffusion coefficient 
(D) of resazurin in aquatic systems was used as an approximation (2.04*10-6cm²/s) 
(Khazalpour et al. 2014). The resazurin conversion rate (Q) was based on the results 
discussed earlier and cells were assumed to be homogenously distributed in the neo-
tissue with a density (ccell) based on previous nano-CT volumetric results (Papantoniou 
et al. 2014b, Sonnaert et al. 2014a).  
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The steady state solution of the system enabled determining a maximal diffusion depth 
of 700µm. This results in an active volume of 40% of the total scaffold implying that 
only the cells present in this volume can contribute to the resazurin conversion. This 
corresponds to the discrepancy between the apparent conversion rate determined for 
bioreactor cultured, static measured scaffolds and bioreactor cultured and measured 
scaffolds in which the resasurin is perfused through the scaffold for which the static 
determined conversion rate was only 35% of the dynamic based value (Figure 3.5.D). 
For the bioreactor measured conditions we did observe an influence of the culture 
system on PB conversion (Figure 3.5.B). To compare conversion rates between the two 
measurement setups the PB signal was corrected for volume, time and cell number 
(Figure 3.5.D) which showed that conversion rates measured with the bioreactor setup 
were not influenced by the culture system used. As the Péclet number was larger than 
1, the convective mass transport in this measurement setup ensured a homogeneous 
distribution of the PB reagent throughout the scaffold independent from the cell 
distribution and therefore a realistic conversion rate could be determined as opposed to 
apparent conversion rates obtained in the static, diffusion based setups. Since the used 
culture systems did not influence the conversion rates, the differences observed 
between the static and bioreactor measurement setups were not caused by changes in 
cell metabolic activity but rather by a decreased conversion efficiency caused by 
diffusion limitations (Ishaug et al. 1997, Bancroft et al. 2002, Sikavitsas et al. 2003). 
Despite the lower conversion rate in the static setup a correlation between the obtained 
PB signal and the DNA content still exists as shown in Figure 3.3.C. This indicates that 
dependent on the measurement system different conversion rates should be used and 
that quantitative use of the methodology requires a system specific validation of the 
measurement. This was further validated by generating a correlation plot depicting the 
cell number based on the PB measurements in function of the cell number based on 
DNA measurements (Figure 3.8). Taking into account the respective conversion rates 
for the static cultured/measured and dynamic cultured/measured expansion systems an 
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R² value of 0.9548 was obtained confirming the potential quantitative use of the 
methodology. 
At day 21 of culture, after the proliferative phase as could be observed in Figure 3.4.A, 
both the increase in cell content, the PB signal and the conversion rate decreased 
significantly. As suggested for the 2D system (Figure 3.3.B and Table 3.1) the 
decreased conversion rate of the PB assay for high cell densities might be related to the 
decrease in cell proliferation. Alternatively, previous work showed a non-linear 
correlation between the resazurin conversion and the cell number for high density cell 
cultures which was due to diffusion limitations both in 2D and 3D (Ng et al. 2005), 
although the fluid flow in the bioreactor system should circumvent these problems. 
Additionally, the high cell density in these constructs has been suggested to result in 
the further reduction of the fluorescent resorufin in the non-fluorescent, colourless 
hydroresorufin (O'Brien et al. 2000) thereby resulting in a decreased amount of the 
fluorescent resorufin. However, since multiple groups showed a linear behaviour of the 
assay within the defined operating conditions (Quent et al. 2010, Mueller et al. 2013, 
Zhou et al. 2013b), the decrease in cell proliferation remains the most probable 
explanation for the observed decreased conversion rate of the PB.  
In order to determine the applicability of the proposed methodology for a broader range 
of operating conditions we subsequently also determined the influence of the use of 
different flow rates and shear stresses (using dextran to increase fluid viscosity) on the 
metabolic conversion rates of the assay. In a recent publication we showed that the use 
of range of flow rates (corresponding to initial shear stress values between 5.59E-4 and 
5.59E-2Pa) did not induce differentiation of the expanding hPDC cell population 
Figure 3.8: Validation of the predictive model. 
Correlation between cell number determined on DNA measurement and cell number 
based on Presto Blue measurement for all 3D static and dynamic cell expansion 
performed for Figures 2-6 using the respective conversion rates determined for the 
two culture systems. (▲ 3D dynamic expansion and measurement, ● 3D static 
expansion and measurement) 
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(Sonnaert et al. 2014a). Furthermore, a functional bone marrow derived MSC 
population was also expanded in undifferentiated state under flow conditions in a 
perfusion bioreactor (Papadimitropoulos et al. 2014a). In correspondence with these 
findings, we observed that the metabolic activity of the hPDCs is constant and 
independent from dextran concentration (affecting shear stress) and volumetric flow 
rate. Taking into account the determined conversion rates, expected number of cells 
and the culture and measurement setup these results now allow to define an operating 
window for each specific setup which will allow a rational selection of operating 
conditions (Gerontas et al. 2009, Papantoniou et al. 2013). Figure 3.7.D shows for 
which combination of cell number, flow rate and incubation time saturation of the assay 
is reached at the scaffold outlet, thus indicating the minimal flow rate and maximal 
incubation time required for monitoring an expansion system in function of the 
expected maximal cell number. It should be noted that, despite the fixed assay volume 
and therefore the fixed amount of resazurin which can be converted, the maximal 
incubation time for a certain cell number varies in function of flow rate. Next to the 
saturation of the assay due to high cell numbers and low flow rates, a significant 
resazurin concentration gradient will be present in the tubing of the system for high cell 
numbers and low flow rates. For higher flow rates this concentration gradient will be 
negligible resulting in a constant, cell dependent maximal incubation time. For these 
cases the operating window of the assay can be determined based on the total circuit 
volume, incubation time and expected cell number as shown in Figure 3.7.E and F in 
which the expected PB signal is shown in function of measurement volume and 
incubation time (Figure 3.7.E) or incubation time and cell number (Figure 3.7.F). This 
simplified representation of the system will be valid for flow rates that not significantly 
influence the maximal incubation time as shown in Figure 3.7.D. Next to using this 
mathematical representation of the system to define optimal operating conditions, the 
quantitative correlation between PB conversion and cell number can also be used to 
determine the cell number in the scaffold at any given time. Additionally, the theoretical 
boundaries of the window of operation could be determined for the dynamic 
measurement method i.e. convective perfusion through the constructs. For example, 
using a flow rate of 1ml/min as employed for measurements in this study, cell numbers 
as low as 50,000 cells could be detected using 5ml of PB solution although at least 120 
minutes incubation time would be required to obtain a quantitative signal. On the other 
hand, using the same flow rate and 50ml of PB solution, constructs containing up to 
25,000,000 cells could be monitored using short incubation times between 15 and 20 
minutes. A further increase in PB solution volume would even allow the further 
broadening of the window of operations, thereby enabling the methodology to 
effectively cover the entire range of cell densities used for tissue engineering 
applications for which final cell densities in the engineered constructs were reported 
between 107 and 108 cells/cm³  (Bancroft et al. 2002, Eyckmans et al. 2006a, Haycock 
2011, Rodrigues et al. 2011, Santoro et al. 2012).In conclusion we can state that the PB 
assay is a promising tool to for on-line monitoring of cell proliferation in a 3D perfusion 
bioreactor system. Since the conversion of the metabolic assay was shown to be 
constant in function of time during cell proliferation, and the culture parameters such 
as flow rate and shear stress did not influence the metabolic activity nor the conversion 
efficiency, a quantitative correlation between cell number and PB conversion could be 
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established. This allowed to determine the assay concentration at each location in the 
setup, thereby enabling to define optimal operating conditions as well as calculating 
cell number in the scaffold based on the PB concentration.  
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4.1. Abstract 
In order to successfully implement tissue engineered (TE) constructs as part of a clinical 
therapy, it is necessary to develop quality control tools that will ensure accurate and 
consistent TE construct release specifications. Hence advanced methods to monitor TE 
construct properties need to be further developed. In this study we showed proof of 
concept for contrast enhanced nanofocus computed tomography (CE-nanoCT) as a 
‘whole-construct’ imaging technique with non-invasive potential that enables 3D 
visualization and quantification of in vitro engineered extracellular matrix (ECM) in 
TE constructs. In particular we performed a 3D qualitative and quantitative structural 
and spatial assessment of the in vitro engineered ECM, formed during static and 
perfusion bioreactor cell culture in 3D TE scaffolds, using two contrast agents, namely 
Hexabrix® and phosphotungstic acid (PTA). To evaluate the potential of CE-nanoCT, 
a comparison was made to standardly used techniques such as Live/Dead 
viability/cytotoxicity, picrosirius red staining and to net dry weight measurements of 
the TE constructs. When using Hexabrix® as contrast agent, the ECM volume fitted 
linearly with net dry ECM weight independent from the flow rate used, hence 
suggesting that it stains most of the ECM. When using PTA as contrast agent, 
comparing to net weight measurements showed that PTA only stains a part of the ECM. 
This was attributed to the binding specificity of this contrast agent. Also, the PTA-
stained CE-nanoCT data showed pronounced distinction between flow conditions when 
compared to Hexabrix®, indicating culture-specific structural ECM differences. This 
novel type of information can contribute to optimize bioreactor culture conditions and 
potentially critical quality characteristics of TE constructs such as ECM quantity and 
homogeneity, facilitating the gradual transformation of ‘TE constructs’ in well 
characterized ‘TE products’. 
4.2. Introduction 
As the field of tissue engineering (TE) matures, the need for novel techniques to 
characterize engineered constructs (i.e. cells/tissue combined with scaffolds) in a more 
insightful and quantitative manner becomes imperative. Currently, standard techniques 
such as histological sectioning and Live/Dead viability/cytotoxicity staining show 
limited potential as quality controls for TE constructs as these techniques only allow 
assessment of tissue distribution in two dimensions, with loss of information and with 
limited depth resolution while being destructive in nature (Hedberg et al. 2005, 
Eniwumide et al. 2007, Stephens et al. 2007, Smith et al. 2010). Techniques such as 
confocal microscopy may offer a potential for three dimensional (3D) visualization, 
however, again a limited depth resolution (~300 µm) hinders their performance when 
larger TE construct need to be analyzed (Georgakoudi et al. 2008).  
Recent advances in 3D imaging techniques and image analysis strategies have 
demonstrated the potential of addressing some of the shortfalls of these currently 
applied methods for accurate TE construct analysis. In particular microCT has been 
frequently applied as a 3D quantitative imaging technique to assess scaffold structure, 
(Peyrin et al. 2007, van Lenthe et al. 2007, Jungreuthmayer et al. 2009) as well as bone 
ingrowth after in vivo implantation (Cancedda et al. 2007, Jones et al. 2007, 
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Papadimitropoulos et al. 2007, van Lenthe et al. 2007, Guldberg et al. 2008, Jones et 
al. 2009, Chai et al. 2012a). Furthermore it has been employed for time-lapsed follow-
up of mineralization inside scaffolds during in vitro static (Cartmell et al. 2004, 
Hagenmueller et al. 2007, Frohlich et al. 2010) or bioreactor cultures (Porter et al. 2007, 
Guldberg et al. 2008, Hagenmuller et al. 2010). In most of these studies polymeric, 
ceramic, collagen scaffolds or composites were used, in which mineralized extracellular 
matrix (ECM) could be separated from the scaffold for the purpose of volume 
calculations and no significant material-dependent artifacts were present. However, 
when imaging ECM or tissue growth in metallic scaffolds or around implants, 
additional caution has to be taken during image analysis as metal artifacts (De Man et 
al. 1999, Kerckhofs et al. 2008) can significantly influence the accuracy of the 
quantification of the newly formed ECM or tissue volume (Marechal et al. 2005, 
Stoppie et al. 2005). 
Several studies have shown that when using phase contrast imaging, in most cases only 
available by synchrotron radiation, non-mineralized ECM formed in vitro in 3D TE 
constructs can be visualized (Langer et al. 2010, Appel et al. 2011, Voronov et al. 
2012). However, routine access to systems allowing phase contrast imaging is limited 
and there are restrictions on the sample specifications. On the other hand, by using the 
more routinely available desktop microCT in standard absorption mode, without the 
use of a contrast agent, it has not been possible yet to visualize in vitro produced non-
mineralized ECM in 3D scaffolds (Albertini et al. 2009, Appel et al. 2011). To address 
this limitation osmium tetroxide, (Hilldore et al. 2007) a well-known X-ray opaque 
staining, has been used to visualize cells in 3D constructs. This stain is, however, toxic 
to cells, thus cannot be used for non-invasive quality control of ECM growth in the TE 
construct.  
In this study we propose contrast enhanced nanofocus CT (CE-nanoCT) as a 3D 
imaging technique that combines the high spatial and contrast resolution of nanoCT 
with the use of contrast agents, to characterize engineered ECM in TE constructs after 
in vitro culture. In particular we performed a 3D quantitative and qualitative structural 
and spatial assessment of the in vitro engineered ECM, formed during static and 
bioreactor cell culturing in titanium alloy scaffolds. By using metallic scaffolds in this 
case study we additionally proved the effectiveness of CE-nanoCT, as these scaffold 
types represent the worst case scenario with regard to material-dependent image 
artifacts. The two selected tissue-specific contrast agents that were used to stain the TE 
construct after culture were Hexabrix® and phosphotungstic acid (PTA). The latter is 
known to bind to connective tissues, and more specifically to collagen and fibrin 
(Metscher 2009a). The former contains a negatively charged ioxaglate, which will be 
locally repulsed by the negative fixed charge density of the tissue, thus all tissues which 
do not contain a negative charge will be stained (Palmer et al. 2006, Xie et al. 2009). 
Additionally, Hexabrix® has been used for in vivo animal studies (Piscaer et al. 2008) 
and in a clinical setting (Ginai 1987), and thus is a potential candidate for non-invasive 
TE construct quality assessment. To  evaluate the potential of CE-nanoCT for 3D 
visualization and quantification of in vitro engineered ECM by culture of human 
periosteum derived cells (hPDCS, i.e. a cell type that has been seen to be mulitpotent 
and to contribute in bone regeneration (De Bari et al. 2001, Orwoll 2003)) in 3D 
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titanium alloy scaffolds, a comparison was made to routine physical measurement 
techniques, such as Live/Dead viability/cytotoxicity for cell viability, picrosirius red 
staining for collagen content and ECM weight measurements.  
4.3. Materials and Methods 
4.3.1. Ti6Al4V scaffolds 
3D additive manufactured open porous Ti6Al4V scaffolds (subsequently referred to as 
Ti scaffolds: Ø = 6 mm, h = 6 mm, porosity = 73 ± 1%, strut diameter = 245 ± 2 µm 
and pore size = 755 ± 3 µm), produced on an in-house developed selective laser melting 
(SLM) machine, (Van Bael et al. 2011) were used. The design was based on a 
parametric unit cell (Figure 4.1.A), which consists entirely of identical beams with 
constant circular cross-section (0.1 mm) and a beam length of 0.9 mm. Figure 4.1.B 
visualizes a produced open porous Ti scaffold. Prior to cell seeding, all scaffolds were 
pre-wetted by vacuum impregnation in cell culture medium for 2 h in a humidified 
incubator at 37°C, and dried overnight in a non-humidified incubator. (Impens et al. 
2010b) 
Figure 4.1: Perfusion bioreactor system. 
(A) The parametric unit cell of the computer aided design of the porous Ti scaffolds, 
which consists entirely of identical beams with constant circular cross-section (0.1 
mm) and a beam length of 0.9 mm, (B) a typical image of an SLM produced Ti scaffold 
and (C) an image of the in-house developed perfusion bioreactor equipped with parallel 
perfusion circuits, (D) Schematic of the bioreactor setup used for 3D dynamic culture, 
consisting of a medium reservoir containing 10 ml of medium, a peristaltic pump 
forcing culture medium through the porous scaffold that was positioned in the 
perfusion chamber. 
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4.3.2. Standard 2D hPDC Culture 
hPDCs were isolated from periosteal biopsies of different donors as described 
previously (Eyckmans et al. 2006a). This procedure was approved by the ethics 
committee for Human Medical Research (KU Leuven) and with patient informed 
consent. hPDCs were expanded in Dulbecco’s modified Eagle’s medium with high-
glucose (Invitrogen) containing 10% fetal bovine serum (BioWhittaker) and 1% 
antibiotic–antimycotic (100 units/mL penicillin, 100mg/mL streptomycin,and 
0.25mg/mL amphotericin B; Invitrogen). The seeding density used for the two 
dimensional (2D) culture dish hPDC expansion was 6000 cells/cm2. hPDCs were 
passaged at 80% – 90% confluency. At the time of experiment, cells (with a population 
doubling number of 15) were trypsinized with Tryple Express (Invitrogen) to be seeded 
on the scaffolds.  
4.3.3. Static & bioreactor TE construct culture 
A validated static seeding protocol was used for seeding 2D cultured hPDCs (cell 
seeding density 30,000 cells/cm2) onto the preconditioned Ti scaffolds with an average 
cell seeding efficiency of 60% (Impens et al. 2010b). In vitro cell culture in the TE 
constructs lasted for 14, 21 and 28 days under static (n = 7) or dynamic (n = 7) culture 
conditions.  For static culture, TE constructs were positioned in 12-well plates (Greiner 
Bio One) containing 3ml cell culture medium, and incubated at 37°C in a humidified 
and CO2-controlled incubator (relative humidity: 95%, 5% CO2). For bioreactor 
culture, TE constructs were cultured in an in-house developed perfusion bioreactor 
equipped with 7 parallel perfusion circuits (Figure 4.1.C). Each perfusion chamber, 
holding a single scaffold, was connected to an individual medium reservoir (disposable 
50 ml Falcon tubes, BD Biosciences) containing 10 ml of cell culture medium via a 
Tygon® (Cole Parmer) tubing and via a two-stop tubing (BPT, Cole Parmer) connected 
to a peristaltic pump (IPC-24, Ismatec SA). Two different perfusion flow rates were 
used for the bioreactor culture: the low flow rate used was 0.04 ml/min while the high 
flow rate was 4 ml/min. In both static and bioreactor cultures medium was refreshed 
every two days for the entire culture duration.  
4.3.4. CE-nanoCT 
After static or dynamic culture the TE constructs were rinsed with 1ml phosphate 
buffered saline (PBS) and transferred to a 4% paraformaldehyde solution (Sigma) for 
2 hours to fixate the ECM. The TE constructs were stored in PBS prior to analysis. Two 
contrast agents were used as received, namely Hexabrix® 320 (Guerbet Nederland B.V) 
and PTA (VWR International). During preliminary experiments (data not shown), for 
both contrast agents an exposure time of 30 min to consistently stain the entire TE 
constructs was selected.  
Hexabrix® is a radio-opaque injectable solution containing ioxaglate meglumine 
(39.3 %) and ioxaglate sodium (19.6 %). Ioxalgate is a negatively charged ionic 
iodinated dimer that is locally repulsed by the negative fixed charge density of the 
ECM. As a consequence, all tissues with a net negative charge will not be stained, while 
Hexabrix®  will adsorb to the rest. All samples were, before imaging, immersed in a 
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solution of Hexabrix® 320 (20% in PBS), then wrapped in parafilm and stably 
positioned in the nanoCT system for imaging.  
PTA is a soft tissue contrast agent containing tungsten, which confers strong X-ray 
contrast when attached to biological tissue, and has a strong binding affinity to fibrin 
and collagen. Hence PTA is a very useful contrast agent to specifically visualize the 
collagen and fibrin content in ECM. Similar to Hexabrix®, all samples were, prior to 
imaging, immersed in a solution of PTA (1.25g/50ml PBS), were then wrapped in 
parafilm and were stably positioned in the nanoCT system. 
The nanoCT system employed in this study was a Phoenix NanoTom S (GE 
Measurement and Control Solutions) with a 180 kV/15 W high-performance nanofocus 
X-ray tube. It was equipped with a tungsten target and was operated, for all scans, at a 
voltage of 90 kV and a current of 170 µA. A 1 mm aluminum and 1 mm copper filter 
was used to reduce beam hardening and metal artifacts as much as possible. The 
exposure time was 500 ms and a frame averaging of 1 and image skip of 0 was applied, 
resulting in a total scanning time of 20 minutes per TE construct. The scanning time 
was kept low to avoid sample drying during scanning, to allow routine screening and 
to enable in future more non-invasive use and real-time monitoring. The reconstructed 
images had an isotropic voxel size of 3.75 µm. 
4.3.5. 3D visualization, and image processing and analysis 
For 3D visualization of the TE constructs, CTVox (Bruker micro-CT) was used. For 
image processing and quantification of the ECM volume in the TE constructs we used 
CTAn (Bruker micro-CT) according to the scheme in Figure 4.2. At first the 
reconstructed dataset of the entire TE construct was fragmented in different subsets 
with a similar amount of metallic artifacts (step 1). By using a 3-level automatic Otsu 
segmentation algorithm (Otsu 1979) on the individual 2D slices, the ECM was 
separated from both the scaffold and the background, the latter including noise and 
metal artifacts (step 2). As a result, grey-scale images with distinct grey-scale values 
for scaffold, ECM and background were generated for the different subsets. A global 
threshold was then chosen manually to select the ECM (step 3). In order to reduce the 
errors introduced by the partial volume effect and metallic artifacts for analyzing the 
ECM volume, the binarized images for the Ti structure were dilatated by 2 voxels and 
subtracted from the dataset of binarized ECM images (step 4). The noise was minimized 
by removing black speckle noise smaller than 500 voxels and white speckle noise 
smaller than 2000 voxels. In order to solidify the resulting structure, a ’closing’ 
operation (~ 2 voxels) was performed on the resulting images (step 4), providing images 
suitable for the 3D analysis of the ECM volume. Finally, the ECM volume in the TE 
constructs was analyzed by performing a 3D analysis on the binarized and processed 
images (step 5). 
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4.3.6. Physical characterization of TE constructs for 
comparison to the CE-nanoCT data 
In order to gain further understanding on the properties of the cultured TE constructs, 
subsequent experimental analyses were performed, as described in this section. They 
were also used to evaluate the potential of CE-nanoCT and assess the levels of 
complementarity between established analyses and the suggested imaging technique. 
Cell viability by Live/Dead viability/cytotoxicity staining 
The cell viability in the TE constructs was evaluated using Live-Dead 
viability/cytotoxicity staining (Invitrogen, USA). Constructs were rinsed with 1ml 
PBS, incubated in the staining solution (0.5µl Calcein AM and 2µl Ethidium 
Homodimer in 1ml PBS) for 20 min under normal cell culture conditions and finally 
imaged using a Leica M165 FC microscope (Impens et al. 2010b). 
Collagen content by picrosirius red staining 
The collagen-containing ECM production on the TE constructs was characterized by 
picrosirius red staining (1mg/mL Sirius Red in saturated Picric acid). (Tullberg-Reinert 
et al. 1999). The stained samples were thoroughly washed with distilled water to 
remove unbound dye and dried at 37oC before qualitative analysis by stereomicroscopy. 
For quantitative analysis, the picrosirius red dye was dissolved in 0.2M 
Figure 4.2: Image processing algorithm. 
Steps followed for image analysis from the 3D reconstruction of the CE-nanoCT scan to 
image processing and noise reduction to final 3D quantification and distribution 
analysis. 
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NaOH/Methanol (1:1 ratio) with mild shaking overnight, and the optical density was 
measured at 492nm using a microplate reader (TECAN) for 1 ml triplicate samples for 
each condition.  
ECM weight measurement 
The liquid in the TE constructs was carefully removed using vacuum after which they 
were dried overnight in 37oC and subsequently weighed on a high accuracy balance 
(Sartorius CPA225D). Ti scaffolds were cleansed ultrasonically, immersed for 10 min 
in acetone, 10 min in ethanol 70%, and 10 min in distilled water, subsequently an alkali 
treatment was applied for 24 h at 60°C in a 5 M sodium hydroxide (Sigma-Aldrich) 
solution, samples were rinsed with distilled water, and finally sterilized in a steam 
autoclave. The weight of the cleansed Ti scaffold was subtracted from the total weight, 
resulting in the net ECM weight. 
4.4. Results 
4.4.1. CE-nanoCT allows 3D visualization of ECM in TE 
constructs 
As a first step in this study TE constructs were scanned with nanoCT without the use 
of contrast agents. It allowed a visual inspection of 3D hPDC-driven ECM formation 
in the TE constructs after static or dynamic in vitro culture. However the reconstructed 
2D slices (Figure 4.3.A) were of low image quality (i.e. low contrast between ECM and 
background) making accurate qualitative evaluation and further 3D quantification 
impossible. When using Hexabrix® and PTA, both contrast agents respectively 
infiltrated and bonded to the ECM, resulting in an increase in 3D grey-scale intensity 
of the ECM for static (Figure 4.3.B) as well as for both (low and high flow rate) 
bioreactor culture derived TE constructs (Figure 4.3.C and D). Black arrows in the 
image indicate ECM boundaries within the TE construct. The high contrast difference 
between ECM, background and Ti scaffold allowed further processing of the raw CE-
nanoCT images. 
Live/dead viability/cytotoxicity staining was employed as a benchmark analysis of cell 
viability and distribution on the different TE constructs. The fluorescent images showed 
that cells were distributed over the entire outer TE construct surface, indicating similar 
results for all 3 culture conditions (Figure 4.4.A). However, CE-nanoCT images of the 
same TE constructs showed that for static culture, ECM was only formed at the scaffold 
periphery, resulting in only partially ECM filled TE constructs, while in the bioreactor 
cultured TE constructs ECM was also found back throughout the internal TE construct 
volume (Figure 4.4.B). 
The cross-sectional CE-nanoCT images were subsequently binarized and processed as 
described in Figure 4.2 to quantify the volume of the ECM formed. Figure 4.4.C shows 
representative binarized images for all culture conditions, visualizing the ECM in white 
and background plus Ti scaffold in black. In the case of static culture only thin strands 
of ECM were present at the periphery of the TE construct, resulting in a loss of 
representation after binarization and correction for metallic artifacts (i.e. step 4 in 
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Figure 4.2), making the 3D quantification and visualization of the ECM in statically 
cultured TE constructs inaccurate. Qualitative assessment of the spatial ECM 
distribution in 3D in these samples was nevertheless possible throughout the entire TE 
construct  
4.4.2. CE-nanoCT allows 3D quantification of ECM 
volume in TE constructs 
Image analysis of the binarized CE-nanoCT slices for the different contrast agents 
allowed to quantify the total amount of stained ECM formed within the available void 
volume (i.e. total TE construct volume excluding the volume of Ti scaffold) for the 
bioreactor perfusion culture conditions, which was not possible for statically cultured 
TE constructs as the amount of ECM formed was too small to be quantified. In order 
to comprehend the CE-nanoCT-based ECM characterization in the TE constructs, a 
comparison was made to two established methods for ECM assessment, namely 
picrosirius red staining to measure the collagen content and ECM dry weight 
measurement (Figure 4.5 and Figure 4.6). TE constructs giving increased values of 
picrosirius red values (absorption at 492nm, Figure 4.5.A) also showed increased values 
of ECM when measured via Hexabrix® and PTA stained CE-nanoCT (Figure 4.5.B). 
Overall, Hexabrix® stained CE-nanoCT values were seen to follow the picrosirius red 
Figure 4.3: Representative 2D CE-nanoCT cross-sections of different constructs 
(A) scanned without contrast agent, after bioreactor perfusion high flow rate (B) 
scanned after static culture with both Hexabrix® and PTA, (C) after bioreactor 
perfusion (low flowrate) culture with both Hexabrix® and PTA and (D) after 
bioreactor perfusion (high flowrate) culture with both Hexabrix® and PTA. Black 
arrows indicate boundaries of the ECM in the constructs. 
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absorption values more closely than the PTA stained ones with a stronger dependency 
on the flow rate used for TE construct culture. The ECM volume after Hexabrix® 
staining was seen to fit linearly with net dry weight values independent from the flow 
rate used (Figure 4.6.A). While for TE constructs cultured at high flow rate, only a 
small difference in ECM volume was observed between the Hexabrix® and PTA 
staining, for those TE constructs cultured at a low flow rate, Hexabrix® staining resulted 
in significantly higher ECM volumes than those obtained via PTA staining (Figure 
4.5.B) because of the binding specificity of PTA to proteins and collagen. Indeed, both 
Figure 4.5.B and Figure 4.6.B show that a part of the ECM was not stained by PTA, 
Figure 4.4: Live/dead and CE-nanoCT images constructs. 
(A) Live/dead viability/cytotoxicity staining of constructs cultured in different 
conditions, (B) typical 2D grey-scale CE-nanoCT cross-sections using Hexabrix® and 
(C) the corresponding binarized and processed cross-sections serving as input for the 
analysis of the ECM volume. 
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and that this part was more pronounced for the lower ECM content conditions (seen for 
the low flow rate).  
4.4.3. CE-nanoCT allows spatial visualization and 
quantification of the ECM in TE constructs 
Figure 4.7.B and C show typical 3D renderings of the CE-nanoCT images (both for 
Hexabrix® and PTA staining respectively) for a bioreactor perfusion cultured TE 
construct at high flow rate, together with the corresponding Live/Dead 
viability/cytotoxicity staining (Figure 4.7.A) and picrosirius red staining (Figure 
4.7.D). The 3D image obtained with Hexabrix® staining, visualizing all the ECM 
Figure 4.6: Validation CE-nanoCT based on ECM weight measurements. 
Relative ECM volume filling as function of the total TE construct internal void volume 
calculated based on CE-nanoCT using respectively Hexabrix® (A) and PTA (B) in 
function of net dry weight. TE constructs were cultured under: (○) Low flow rate 
condition (0.04 ml/min); (■) High flow rate condition (4ml/min). 
Figure 4.5: Comparison Picrosirius red and CE-nanoCT. 
(A) ECM content quantification via picrosirius red for both flow rates over culture. (B) 
Relative ECM volume filling as function of the total TE construct internal void volume 
calculated based on CE-nanoCT using respectively Hexabrix® and PTA. 
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present in the construct in green, showed a comparable ECM distribution as the 
Live/Dead viability/cytotoxicity staining for the outer TE construct surface (indicated 
by the white arrows). The PTA stained 3D images, showing the collagen and fibrin 
containing ECM in red, had a comparable ECM distribution as the picrosirius red 
staining for the outer TE construct surfaces. Moreover, the 3D rendered CE-nanoCT 
images of both the Hexabrix® and PTA staining allowed a full 3D visualization of the 
ECM distribution throughout the entire TE construct (supplementary videos may be 
seen in the appendix). A volumetric ECM distribution histogram over the TE construct 
height was plotted both for the Hexabrix® and PTA staining (Figure 4.8), giving an 
indicative example of the 3D qualitative (distribution) and quantitative (volume of 
ECM) information obtainable with CE-nanoCT. Although a homogeneous ECM 
distribution over the TE construct height could be expected, both stainings showed that 
a larger amount of ECM was formed at the bottom of the TE construct. 
4.5. Discussion 
In order to successfully implement TE constructs as part of a clinical therapy, it is 
necessary to develop quality control tools that will ensure accurate and consistent TE 
construct release specifications (Schneider et al. 2010). In general a substantial amount 
of routine lab techniques currently used in TE were initially developed and optimized 
for 2D analysis of cell growth, distribution and matrix secretion in culture flasks and 
Figure 4.7: Visual comparison of Live/dead and Picrosirius red staining with CE-
nanoCT 
Top and side view of the (A) live/dead staining of a perfusion bioreactor cultured 
construct at a flow rate of 4 ml/min, (B) 3D rendering of the CE-nanoCT images with 
Hexabrix® staining, (C) 3D rendering of the CE-nanoCT images with PTA staining 
and (D) Brightfield image of scaffold stained with Picro-sirius red. White dashed lines 
indicate identical geometric features of the ECM in microscopic images and 
reconstructed images 
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not for use in a 3D setting such as TE constructs (Table 4.1). For example the 
information obtained by destructive scanning electron microscopy (SEM) remains 2D 
and rather elusive even when multiple sample slices are analyzed (Peyrin et al. 2007, 
Albertini et al. 2009, Voronov et al. 2012). Thus one has to be careful when using 2D 
validated techniques to draw 3D conclusions. Proper validation under 3D conditions 
and/or complementary use of additional real 3D information requires substantial 
additional research, but it is a much safer route to obtain reliable information of 3D cell 
and tissue behavior. Hence advanced 3D methods to, preferably non-invasively, 
monitor TE construct properties need to be further developed. 
Routine 
Techniques Specificity Depth analysis Scale Ref. 
Live/dead stain cells 2D: limited depth µm-
mm 
(Du et al. 
2009) 
Picro-sirius red 
stain collagen 2D: limited depth 
µm-
mm 
(Paletta et al. 
2011) 
SEM and optical 
microscopy 
cells, collagen, 
mineral phase 2D ~ µm 
(Peyrin et al. 
2007) 
Alizarin red stain Mineral phase 2D: limited depth µm-
mm 
(Frohlich et al. 
2010) 
Table 4.1: Categorization of bench imaging techniques that have been routinely 
employed for the visualization and analysis of 3D engineered tissues (related to bone 
TE). 
Figure 4.8: CE-nanoCT based ECM distribution in TE construct. 
Representative longitudinal ECM distribution throughout the full TE construct i.e. 
volume of ECM per cross section, where the height of the section is 3.75 µm equal to 
the voxel size used for the analysis, in function of the scaffold height. Distributions 
obtained via Hexabrix® and PTA staining for a scaffold that was cultured for 21 days 
under a flow rate of 0.04 ml/min. 
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X-ray micro and nanoCT offer a potential solution because of their non-destructive 3D 
character. However, the value of X-ray CT-based information for TE will ultimately be 
a trade-off of factors such as physicochemical, morphological and dimensional TE 
construct properties, contrast enhanced agent and equipment limitations (Table 4.2). 
According to specific study objectives, a customized strategy will be required to extract 
the necessary information in a robust way, ranging from (i) accurate and detailed (100s 
of µm scale) identification and quantification of different TE construct components 
limited to small TE construct samples and using phase contrast imaging, (Voronov et 
al. 2012) to (ii) using standard desktop micro- or nanoCT as a routine 3D imaging 
technique for whole TE construct analysis (mm to cm scale) and quantification of 
mineralization after in vivo implantation (Jones et al. 2007, Guldberg et al. 2008). The 
latter approach, without the use of a contrast agent, has also been used for static or 
bioreactor in vitro cultures, (Cartmell et al. 2004, Porter et al. 2007, Hagenmuller et al. 
2010) showing distinct contrast differences between mineralized matrix and scaffold. 
Phase contrast imaging (Langer et al. 2010, Appel et al. 2011, Voronov et al. 2012) or 
microCT combined with osmium tetroxide as a contrast agent (Hilldore et al. 2007) 
have shown their potential to assess non-mineralized ECM in an in vitro engineered TE 
construct. However, the limited availability of synchrotron radiation or CT systems 
allowing phase contrast imaging, the toxicity of osmium tetroxide and the high cost 
associated with its disposal, all hamper their use as routine quality control for TE 
constructs.  
Both contrast agents used in this work (Hexabrix® and PTA) increased the grey-scale 
intensity difference between the different phases in the TE constructs as seen in Figure 
4.3. In the static culture case, ECM was only found around the periphery of the Ti 
scaffold in contrast with ECM the bioreactor cultured TE constructs (Porter et al. 2007). 
also reported peripheral deposition of mineralized matrix on statically cultured TE 
constructs in respect to a more dense and spatially homogeneous distribution of 
mineralized matrix in bioreactor cultured TE constructs based on microCT analysis. 
Additionally they also reported that mineralized matrix formation was initiated at the 
scaffold periphery and progressed towards the scaffold center over a period of 44 days. 
These dynamics may be attributed to fluid flow and convective nutrient and oxygen 
transport throughout the TE construct volume during culture (Bancroft et al. 2002, 
Grayson et al. 2011, Papantoniou et al. 2013). In this study CE-nanoCT revealed a 
dramatic increase of ECM content for bioreactor cultured TE constructs (up to 75% of 
void volume) with respect to the statically cultured ones (less than 4% of void volume). 
The low ECM quantity in the static culture case was below the CE-nanoCT threshold 
for ECM quantification, which in this study was determined to be an ECM volume 
lower than 4% of the total Ti scaffold void volume (Figure 4.4). This lower 
quantification limit was directly related to the artifacts introduced by the metallic 
scaffolds used in this work (Stradiotti et al. 2009). For other scaffold materials however, 
it is anticipated that the lower quantification threshold of CE-nanoCT will further 
decrease, since material-dependent artifacts will be reduced compared to the worst case 
scenario described here.   
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 Specifi
city 
Size Range Res
olut
ion 
Scaffold 
material 
Imaging 
modality 
CE-nanoCT ECM 
and 
mineral 
phase  
Whole 
construct 
(6 mm) 
µm Ti6Al4V Absorption - 
nanoCT 
(Voronov et al. 
2012) 
cells, 
ECM, 
mineral 
phase 
Localized 
region in 
the 
samples 
(~500 µm) 
Sub
-µm 
PLA Phase 
Contrast – 
micro-CT 
(Porter et al. 
2007) 
mineral 
phase 
Whole 
construct 
(3 - 9 mm) 
µm PCL Absorption - 
micro-CT 
(Hilldore et al. 
2007) 
ECM Localized 
region in 
the sample 
µm Hydroxy-apatite Absorption - 
micro-CT 
(Albertini et al. 
2009) 
ECM Localized 
region in 
the 
samples 
Sub
-µm 
PLLA/PGA Phase 
contrast - 
synchrotron 
(Cartmell et al. 
2004) 
Mineral 
phase 
Whole 
construct 
(6mm) 
µm PLDL & 
Demineralized 
trabecular bone 
matrix scaffolds 
Absorption - 
micro-CT 
 
(Langer et al. 
2010) 
Mineral 
phase, 
ECM 
Localized 
region in 
the 
samples 
µm bone graft 
substitute 
Phase 
contrast - 
synchrotron 
(Hagenmueller 
et al. 2007) 
Mineral 
phase 
Whole 
construct 
µm Silkworm 
fibroin 
Absorption - 
micro-CT 
Table 4.2: Categorization and evaluation of X-ray tomography techniques employed 
for the visualization of features of in vitro 3D engineered tissues (related to bone TE). 
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CE-nanoCT results were then compared to known physical ECM characterization 
methods, such as dry net weight as a global ECM related parameter and picrosirius red 
staining as a collagen specific assay, to comprehend the CE-nanoCT data and hence 
evaluate the potential of CE-nanoCT for 3D ECM quantification in TE constructs. In 
Figure 4.6.A, the relative ECM void volume filling obtained via Hexabrix® staining 
(an equilibrium contrast agent, thus it does not bind to the ECM) was correlated to the 
net dry weight, resulting in a linear correlation for both flow rates, suggesting that 
Hexabrix® stains most of the ECM in a quantitative manner. However when using the 
more tissue-specific contrast agent PTA, which is known to bind to various proteins 
and connective tissue, (Hanker et al. 1983, Blewitt 1984)  a difference with Hexabrix® 
staining was found (Figure 4.5.B), while when comparing to the net dry weight, it was 
shown that PTA only stained a fraction of the ECM (Figure 4.6.B).  
Figure 4.5 shows a qualitative relationship between experimental values obtained via 
the collagen specific picrosirius red staining and CE-nanoCT values demonstrating both 
increasing trends over time. Additionally, a clear flow rate dependence was seen 
(Figure 4.5.B) for both PTA and Hexabrix® stains. It can be observed that TE 
constructs cultured under high flow rate showed a larger fraction of the ECM stained 
by PTA, which could be explained as an ECM richer in protein components (on which 
PTA may specifically bind). Fluid flow is known to enhance matrix synthesis within 
TE constructs during perfusion culture (Bancroft et al. 2002, Du et al. 2009, 
Hagenmuller et al. 2010). Furthermore differences in fibrillar collagen organization of 
the ECM, which are flow dependent, (Pedersen et al. 2010) could also explain the ECM 
differences that were observed by PTA staining as the ECM morphology could 
influence the binding mechanism of PTA to the ECM proteins. In Figure 4.5, it may 
also be observed that the difference in collagen content, as determined by picrosirius 
red staining, for the different flow rates is less pronounced than the one observed with 
the PTA staining. However one has to keep in mind that the picrosirius red staining was 
used without any customization and validation for the specifics of the 3D environment 
under investigation, which could underestimate actual collagen content (Papantoniou 
et al. 2013). Certainly, for more dense TE constructs, like the ones obtained from high 
flow rate culture, this issue becomes more relevant due to increased inter-construct 
mass transport limitations that would affect the performance of the assay. 
CE-nanoCT-based imaging and quantification clearly show that by using this technique 
information that could not be previously generated by standard experimental techniques 
such as microscopy of TE constructs stained with Live/Dead viability/cytotoxicity or 
collagen-specific picrosirius red staining which are line-of-sight techniques lacking a 
3D internal visualization potential may now be obtained. Hence, a direct validation of 
CE-nanoCT using these techniques is irrelevant. Images obtained by standard 
experimental techniques are mainly limited to surface restricted TE construct 
characterization as they are line-of-sight techniques and only provide limited depth 
information (Du et al. 2009, Paletta et al. 2011). Not taking into account the latter 
limitation may result in the misinterpretation of statically cultured TE constructs as 
being full of ECM while in reality only an outer layer of ECM exists, as confirmed by 
CE-nanoCT (Figure 4.4). A potential validation technique could be histological 
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sectioning. However, the use of Ti scaffolds in this work does not allow the sectioning 
of the produced TE constructs, and thus will also not present full 3D data.  
To conclude, for the combination of factors used in this work, i.e. scaffold size and 
material type, type of CT device and scanning mode (Table 4.2), and its objective, CE-
nanoCT has shown potential as a cost effective TE construct quality control 
methodology, by providing volumetric and distribution measurements throughout the 
entire TE construct (Figure 4.7 and Figure 4.8). Although there are preliminary 
indications for ECM composition analysis via this method which need to be further 
investigated, the novel information that CE-nanoCT generates will assist to increase 
our insight in the ECM characteristics within in vitro manufactured TE constructs. In 
this study we showed proof of concept for CE-nanoCT as a ‘whole-construct’ imaging 
technique with non-invasive potential that enables 3D visualization and quantification 
of in vitro engineered ECM in TE constructs. The development of robust tools and 
methodologies such as CE-nanoCT to assess important and potentially critical quality 
characteristics of TE constructs such as ECM quantity and homogeneity, can facilitate 
the gradual transformation of ‘TE constructs’ to well characterized ‘TE products’. 
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5.1. Abstract 
To progress the fields of tissue engineering and regenerative medicine, development of 
quantitative methods for non-invasive three dimensional characterization of engineered 
constructs (i.e. cells/tissue combined with scaffolds) becomes essential. In this study, 
we optimized contrast-enhanced nanofocus computed tomography for three 
dimensional visualization and quantitative analysis of in vitro engineered neo-tissue 
(i.e. extracellular matrix containing cells) in perfusion bioreactor-developed constructs. 
A fractional factorial ‘design of experiments’ approach was used to elucidate the 
influence of the staining time and concentration of two contrast agents (Hexabrix® and 
phosphotungstic acid) and the neo-tissue volume on the image contrast and dataset 
quality. Additionally, the neo-tissue shrinkage that was induced by phosphotungstic 
acid staining was quantified to determine the operating window within which this 
contrast agent can be accurately applied. For Hexabrix® the staining concentration was 
the main parameter influencing image contrast and dataset quality. Using 
phosphotungstic acid the staining concentration had a significant influence on the 
image contrast while both staining concentration and neo-tissue volume had an 
influence on the dataset quality. The use of high concentrations of phosphotungstic acid 
did, however, introduce significant shrinkage of the neo-tissue indicating that, despite 
sub-optimal image contrast, low concentrations of this staining agent should be used to 
enable quantitative analysis. To conclude, using design of experiments we have 
optimized contrast-enhanced nanofocus computed tomography for routine screening of 
neo-tissue formation in constructs, transforming it into a robust three dimensional 
quality control methodology. 
5.2. Introduction 
The field of tissue engineering (TE) is evolving towards the development of complex, 
three-dimensional (3D) constructs (i.e. cells/tissue combined with scaffold) to mediate 
the repair of severe defects. In order to facilitate the successful clinical implementation 
of these constructs an in-depth understanding of how they develop as well as the 
optimization of the developed procedures and the availability of robust 3D quality 
assessment tools becomes essential.  
Currently, the standard technique for evaluating tissue formation is histological 
sectioning. It has a high discriminative power, both on tissue and cellular level. 
However, it shows limited potential for quantifying 3D tissue formation as it is 
destructive and costly in terms of time and resources. Most importantly, in standard 
settings it only allows assessment of tissue distribution in 2D, with loss of information 
due to a restricted sectioning orientation and with limited depth resolution (Hedberg et 
al. 2005, Eniwumide et al. 2007, Smith et al. 2010). Other standard techniques to assess 
the quality of a construct are Live/Dead, DNA content (providing cell number 
estimation), histology and weight measurements. Although Live/Dead staining gives 
additional important information concerning cell state, it has limitations for internal, 
3D visualization of tissue formation in a construct. Both DNA content and weight 
measurements are bulk measurement techniques not providing spatial information. 
Techniques such as confocal or multiphoton microscopy offer a potential for 3D 
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visualization of cells and tissues. However, limited depth resolution (~300µm) and 
limited options for detailed quantification hinders their performance when clinically 
relevant sized or opaque samples are to be analyzed. Ultrasound and magnetic 
resonance imaging could obtain significantly higher imaging depths, but limitations in 
the spatial resolution result in significant restrictions for quantitative 3D analysis. 
Therefore, there is a need for more advanced, quantitative 3D imaging techniques (Nam 
et al. 2014). 
Recent advances in 3D imaging techniques and image analysis have demonstrated the 
potential of the currently applied methods and their limitations for accurate analysis. In 
particular X-ray micro and nanofocus computed tomography (micro and nanoCT) have 
been frequently applied as 3D quantitative imaging techniques to assess mineralized 
skeletal tissues (Jones et al. 2007, van Lenthe et al. 2007). However, because of their 
low X-ray attenuation, soft tissue contrast is inherently poor in absorption mode 
imaging. Phase contrast imaging could be a solution (Davis et al. 1995, Wilkins et al. 
2014). Due to the electromagnetic properties of the X-rays, a phase shift of the waves 
can be induced as a result of differences in the refractive index of different materials 
while passing through an object.  Taking this phase shift into account, the contrast 
sensitivity will be increased, which is especially for low absorbing materials an 
important benefit. As this technology requires sophisticated X-ray optics and preferably 
monochromatic X-rays, it is mostly available using synchrotron radiation (Langer et al. 
2010), although recently also desktop CT devices allowing phase contrast imaging have 
become available (Appel et al. 2011, Voronov et al. 2012). 
A recent shift in micro- and nanoCT imaging focuses on the use of X-ray opaque 
contrast agents for visualizing soft tissues, such as cartilage (Xie et al. 2010, Kerckhofs 
et al. 2013b, Lakin et al. 2013, Kerckhofs et al. 2014), blood vessels (Granton et al. 
2008, Fei et al. 2010, Lusic et al. 2013) and connective tissues (Metscher 2009b, Wong 
et al. 2012). Specifically in the case of neo-tissues (cells and extracellular matrix), we 
have shown proof-of-concept of contrast-enhanced nanoCT (CE-nanoCT) for the 3D 
visualization and quantification of neo-tissue within constructs formed in bioreactor 
cultures (Papantoniou et al. 2014b). Two tissue-specific contrast agents were used to 
stain the neo-tissue, i.e. Hexabrix® and phosphotungstic acid (PTA). As opposed to the 
standard techniques mentioned earlier, it was shown that CE-nanoCT could allow 3D 
qualitative and quantitative structural and spatial assessment of the in vitro engineered 
neo-tissue, created during static and bioreactor cell culturing in titanium alloy scaffolds, 
revealing 3D neo-tissue distribution.  
Although this study indicated the potential of CE-nanoCT, the staining conditions, 
which were based on preliminary internal experiments (Kerckhofs et al. 2013b, 
Kerckhofs et al. 2014), resulted in datasets with sub-optimal image quality. This was 
due to limited contrast in combination with scaffold-induced imaging artifacts, such as 
beam hardening and streaks. Although extensive image processing enabled quantitative 
interpretation of the datasets, no automated image analysis was possible yet; this posed 
considerable limitations to the proposed methodology. A recent publication that 
assessed several contrast agents for CE-CT indicated the necessity to optimize the 
staining parameters for obtaining quantitative datasets. It was demonstrated that for the 
68                                  Multifactorial optimization of CE-nanoCT 
 
 
 
same staining conditions each contrast agent displayed agent-specific contrast 
enhancement levels and penetration depth, while the sample size further affected its 
performance (Pauwels et al. 2013).  
An additional concern for the use of contrast agents is their potential to influence the 
integrity of the stained tissue. Iodine potassium iodide (I2KI) was shown to cause 
substantial soft tissue shrinkage dependent on the concentration, staining time and 
tissue structure/composition (Vickerton et al. 2013). Also PTA was shown to introduce 
shrinkage of brain and muscle tissue, although in a lesser extent than I2KI (Buytaert et 
al. 2013). For some studies, the compositional information of the soft tissues in the 
sample, only obtainable by the staining, was most important (Metscher 2009a, Jeffery 
et al. 2011, Schulz-Mirbach et al. 2013), although structural tissue alterations due to 
dehydration or staining were noticed (Schulz-Mirbach et al. 2013). However, when 
aiming at using the CE-CT data for morphometric and volumetric analyses, the degree 
of specimen shrinkage, and potential deformation, is an important consideration. 
In the current study, we applied a ‘Design of Experiments’ (DoE) approach, a statistical 
method for planning experiments, for a multiparametric investigation of the influence 
of staining parameters (staining time and concentration) and neo-tissue volume on (i) 
image quality (i.e. image contrast), (ii) dataset quality (i.e. potential for quantitative 
interpretation of the obtained datasets) and (iii) tissue integrity (only for PTA). Based 
on the DoE outcome, optimum staining conditions for both contrast agents were 
selected. For these staining conditions, we were able to develop an automated, user-
independent and highly quantitative image processing and analysis procedure for 
morphometric analysis of neo-tissue within the constructs. As a result, CE-nanoCT was 
optimized for routine screening of the neo-tissue formation in TE constructs 
transforming it to a robust quality control methodology. 
5.3. Materials and Methods 
5.3.1. TE constructs 
Ti6Al4V based constructs 
To evaluate the influence of the staining parameters of the contrast agents (staining time 
and concentration) and neo-tissue volume on the image quality, dataset quality and 
tissue integrity, selective laser melted porous cylindrical 3D Ti6Al4V scaffolds with a 
height of 6mm and a diameter of 6mm were used. The design and production of the 
Ti6Al4V scaffolds is described in detail in Ref. (Van Bael et al. 2011). Human 
periosteal derived cells (hPDCs) (De Bari et al. 2006) were seeded as described before 
using a static drop-seeding protocol (Sonnaert et al. 2014a). 
In order to generate constructs with different amounts of neo-tissue they were 
subsequently cultured in a static setup for 3 weeks (low volumes of neo-tissue) or in an 
in-house developed perfusion bioreactor system for 1 to 3 weeks (respectively medium 
and high volumes of neo-tissue) as described earlier (Papantoniou et al. 2014b, 
Sonnaert et al. 2014a). For all conditions the constructs were cultured in growth 
medium (Dulbecco’s modified Eagle’s medium with high-glucose (Life Technologies) 
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containing 10% foetal bovine serum (FBS, Gibco), 1% sodium pyruvate (Life 
Technologies) and 1% antibiotic–antimycotic (100 units/mL penicillin, 100 mg/mL 
streptomycin, and 0.25 mg/mL amphotericin B; Life Technologies)), which was 
refreshed every two days. For the perfusion bioreactor system a flow rate of 1 ml/min 
was used.  
PCL based constructs 
To assess the effect of the different contrast agents on the tissue integrity, we used 
porous cylindrical polycaprolactone (PCL) scaffolds with a height of 3 mm and a 
diameter of 6 mm. PCL scaffolds were produced using the BioscaffolderVR device 
(Sys-Eng, Germany). The pressure was maintained at 5 bars and the temperature was 
set to 120°C. The selected overlay pattern was 0-90°, the anticipated strut diameter was 
100 µm and the anticipated pore size 200 µm. The scaffolds were designed in Inventor 
while PrimCam (Sys-Eng, Germany) was used to create the final structure (Desmet et 
al. 2010, Berneel et al. 2012a, Berneel et al. 2012b). Also the PCL scaffolds were 
seeded with hPDCs using a static drop-seeding protocol. The PCL based constructs 
were cultured using the same operating conditions in the perfusion bioreactor system 
as for the Ti6Al4V based constructs, but for a period of 2 weeks. 
5.3.2. Contrast-enhanced nanofocus CT (CE-nanoCT) 
After static or dynamic culture, the TE constructs were rinsed with 1 ml phosphate 
buffered saline (PBS) and transferred to a 4% paraformaldehyde solution (Sigma) for 
2 hours to fixate the neo-tissue. The TE constructs were stored in PBS prior to CE-
nanoCT scanning. Two contrast agents were used, namely Hexabrix® 320 (Guerbet 
Nederland B.V) and phosphotungstic acid (PTA - VWR International). Hexabrix®, 
containing the negatively charged ioxaglate, is an equilibrium contrast agent staining 
all non-negatively charged tissues. PTA on the other hand is known to specifically bind 
to various components of the connective tissue such as collagen and fibrin (Papantoniou 
et al. 2014b). The nanoCT system used was a Phoenix NanoTom S (GE Measurement 
and Control Solutions). 
Ti6Al4V constructs 
For the Ti6Al4V constructs, different concentrations and staining times of both contrast 
agents were used according to a 3-level 3-parameter fractional factorial design as shown 
in Table 5.1. TE constructs were initially stained and scanned with Hexabrix®, after 
which they were rinsed 3 times in PBS overnight to remove all Hexabrix® traces prior 
to subsequent staining. The same constructs were then stained with PTA and scanned 
again. As after removal from the liquid prior to scanning, remnants of the staining 
solution could be present at locations where there is no neo-tissue, and thus could 
influence the visualization of the neo-tissue, samples were dried for 15 minutes on a 
paper tissue at room temperature for both contrast agents (Papantoniou et al. 2014b). 
For scanning the Ti6Al4V-based TE constructs, the nanoCT was equipped with a 
tungsten target, and was operated at a voltage of 90 kV and a current of 170 µA. A 
1 mm filter of aluminum and 1 mm of copper was used to reduce beam hardening and 
metal artifacts as much as possible during scanning. The exposure time was 500 ms and  
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Figure 5.1: Design space for the DoE, showing the three levels of the three parameters. 
For the concentration, the top value is for Hexabrix® staining and the bottom value for 
PTA staining. The grey dots indicate the experimental conditions for the fractional 
factorial design (n=3). 
 
Table 5.1: The experimental conditions to be evaluated for the 3-level, 3-parameter 
fractional factorial design. 
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2400 radiographic images were acquired in fast scan mode (frame averaging of 1 and 
image skip of 0) resulting in a scanning time of 20 minutes per sample. The scanning 
time was kept low to allow routine screening and eliminate sample movement during 
scanning. The reconstructed images had an isotropic voxel size of 3.75 µm. A beam 
hardening correction of 9 and a Gaussian filter of 6 was applied during reconstruction 
[Datos|x, GE Measurement and Control Solutions, Germany]. 
PCL based constructs 
To determine the effect of the contrast agents on the neo-tissue integrity, a comparison 
between the datasets of constructs with and without staining was made. Therefore, the 
PCL based TE constructs were consecutively scanned (1) without contrast agent, (2) 
with Hexabrix®, (3) with PTA, (4) again with Hexabrix® and finally (5) without contrast 
agent.  
For scanning the PCL-based TE constructs, a 1 mm aluminum filter was used and the 
tungsten target was operated at a voltage of 60 kV and 220 µA. All other scanning as 
well as the reconstruction parameters were similar to what was used for the Ti6Al4V 
based constructs. 
5.3.3. DoE analysis 
To determine the influence of the concentration and staining time of the contrast agents 
as well as the neo-tissue volume (further referred to as DoE parameters) on the image 
quality, dataset quality and tissue integrity, a DoE approach was used. This statistical 
method for planning experiments enables to study the influence of various parameters 
with minimal required experimental input but resulting in the required objective 
conclusions (Kreutz et al. 2009). Figure 5.1 and Table 5.1 show the different 
combinations of the DoE parameters, selected in a randomized manner by the statistics 
software JMP (SAS, Cary, USA), that were evaluated according to a 3-level, 3-factor 
fractional factorial design. Based on previous experiments (Papantoniou et al. 2014b) 
and a preliminary range screening, the three levels were selected for each parameter. 
Ti6Al4V based TE constructs cultured for 3 weeks in the static system represented the 
low neo-tissue volume level, 1 week in the perfusion bioreactor system the mid-level 
and 3 weeks in the perfusion bioreactor the high level (Papantoniou et al. 2014b, 
Sonnaert et al. 2014a). For each condition, 3 samples were evaluated.  
DoE was applied to obtain statistically sound and objective conclusions on the 
magnitude and the importance of the main effects of the investigated factors (i.e. 
volume of neo-tissue, contrast agent concentration and staining time) on (i) the 
normalized contrast of the stained neo-tissue (i.e. contrast of the stained neo-tissue 
compared to the background and scaffold), (ii) the dataset quality (i.e. the amount of 
slices with a mismatch between the stained and the binarized neo-tissue fraction) and 
(iii) the tissue integrity (i.e. difference between the Hexabrix® and PTA stained neo-
tissue). The Pareto charts display the absolute values of the standardized effects and 
have a reference line for p = 0.05. Any effect that extends beyond this reference line is 
a significant effect. The more the effect extends the reference line, the more important 
the effect is. 
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Influence of the DoE parameters on the image contrast 
To quantify the contrast of the stained neo-tissue compared to the background and 
scaffold, a greyscale histogram was plotted along an arbitrary line through the 
background, neo-tissue and scaffold (Figure 5.2.A) using DataViewer (Bruker 
MicroCT, Belgium). The normalized contrast was then calculated according to eq. 1 
(Figure 5.2.B). 
 ( )
B
normalized contrast
A B
=
+
   (eq 1.) 
where A is the average greyscale difference between the stained neo-tissue and the 
scaffold, and B is the average greyscale difference between the background and the 
stained neo-tissue. A + B is thus the average greyscale difference between the 
background and the scaffold. The calculated averages did not take into account the 
transition grey-scale values between the different phases. We only considered the grey-
scale values within the range that did not deviate too much from the average value (i.e. 
plateau region). The thresholds to define the range for which the average was 
determined, were set at the grey-scale values that decreased below (or increased above) 
the lowest/highest value within the plateau region. 
Influence of the DoE parameters on the dataset quality 
The fraction of images containing a mismatch between the stained and binarized neo-
tissue fraction, being a measure for the potential for quantitative interpretation or the 
dataset quality, was determined as a second input for the DoE. To obtain the binarized 
Figure 5.2: Normalized image contrast quantification of the stained neo-tissue 
compared to the background and scaffold.  
(A) A representative transaxial cross-section of a Hexabrix® (60%) stained construct 
with a mid-level of neo-tissue volume. Scale bar is 1 mm. (B) The greyscale histogram 
through the grey arrow indicated in (A), used to quantify the contrast of the stained neo-
tissue compared to the background and scaffold. ‘A’ is the average greyscale difference 
between the stained neo-tissue and the scaffold, and ‘B’ is the average greyscale 
difference between the background and the stained neo-tissue. 
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neo-tissue fraction multi-level Otsu segmentation was applied. This algorithm, which 
is a histogram-based methodology that maximizes the variance between the different 
classes in the greyscale image (Otsu 1979), was performed on each individual 2D slice 
using CTAn (Bruker micro-CT, Belgium). Segmentation classes corresponding to the 
neo-tissue were subsequently binarized. The number of levels for the Otsu 
segmentation had a strong influence on the mismatch, because depending on the neo-
tissue volume and/or contrast, the background noise and artifacts could be assigned to 
different segmentation classes. Therefore, the optimal number of Otsu-levels was 
determined for each contrast agent based on the datasets obtained with low, mid and 
high levels for each DoE parameter. The optimized number of Otsu levels per contrast 
agent was then used on the datasets of all the DoE conditions to determine the dataset 
quality.  
Figure 5.3: Mismatch between the stained and binarized neo-tissue fraction as a 
measure for the dataset quality.  
(A, B) A raw (left), 2-level segmented (middle) and binarized image (right) cross-
section of a TE construct with a high level of neo-tissue volume after 120 min staining 
with 20% Hexabrix® located in the middle of zone V (A) and zone VI (B). Zoning 
depicted in (C) – green numbers indicates zones without mismatch and red numbers 
indicate zones with a mismatch larger than the 1% threshold. (C) Differential overlay 
(coronal view) of the raw image and the binarized neo-tissue with indication of the 
zones (green) without mismatch between the raw and the binarized images and (red) 
where the 2-level segmentation resulted in a mismatch between the raw and the 
binarized images. (D) The histogram showing the mismatched area between the raw 
and the binarized images as indicated in (C). The grey striped line indicates the 1% 
threshold above which a mismatch was considered. Scale bars are 1 mm. 
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To calculate the mismatch between the stained neo-tissue and the binarized neo-tissue 
fraction (Figure 5.3.A and B), a differential overlay of both was made (Figure 5.3.C). 
Binarized differential overlays were subsequently analyzed for the ‘mismatched neo-
tissue’ fraction and histograms that show the area of the mismatched fraction were 
generated (Figure 5.3.D). Based on these histograms, the fraction of mismatched 
images was determined. In order to omit the influence of background noise on the 
analysis, slides with a mismatch lower than 1% of the total slide surface were excluded 
from the analysis. 
Influence of the DoE parameters for PTA staining on the neo-tissue 
integrity 
To first evaluate the influence of both contrast agents on the neo-tissue integrity, a 
comparison between the datasets of constructs with and without staining was made. For 
the Ti6Al4V-based TE constructs, visualization of the neo-tissue without contrast agent 
was not possible as the scanning energies required to obtain sufficient transmission 
through the metal scaffold resulted in greyscale values for the neo-tissue that could not 
be segmented from the background noise and streaks. Therefore, PCL based TE 
constructs were used, as the lower X-ray opacity of PCL enabled the visualization of 
the neo-tissue without the presence of a contrast agent. Differential overlays of the 
datasets of TE constructs consecutively scanned (1) without contrast agent, (2) with 
Hexabrix®, (3) with PTA, (4) again with Hexabrix® and finally (5) without contrast 
agent were generated. The mismatch between the binarized neo-tissue for the different 
scans was determined to evaluate the influence of the contrast agent on the tissue 
integrity, and the potential staining-induced tissue shrinkage.  
Then, as final DoE read-out, the influence of the PTA staining on the tissue integrity 
was determined. This was quantified as the difference between the Hexabrix® (Figure 
5.4.A) and PTA (Figure 5.4.B) stained neo-tissue surface area relative to the Hexabrix® 
stained neo-tissue surface area in the corresponding CE-nanoCT slices. Hereto, the 
Hexabrix® and PTA stained datasets of the same sample were registered in 3D using 
DataViewer (Bruker MicroCT, Belgium). To avoid the evaluation of mismatched 
slices, three transaxial slices per dataset, distributed over the height of the TE construct, 
were selected. Using the optimal segmentation procedure for the different contrast 
agents as described earlier, the neo-tissue was binarized applying CTAn (Bruker 
MicroCT, Belgium). To reduce the errors introduced by the partial volume effect (PVE) 
and metallic artifacts for analyzing the neo-tissue surface area, the binarized images for 
the scaffold structure were dilated by 2 voxels and subtracted from the dataset of the 
binarized neo-tissue. The noise in the binarized neo-tissue images was minimized by 
removing black and white speckle noise smaller than 200 voxels. In order to solidify 
the resulting structure, a ’closing’ operation of 2 voxels was performed. Finally, the 
surface area of the binarized neo-tissue was quantified and the degree of tissue 
shrinkage (i.e. inverse of the tissue integrity) was determined relative to the Hexabrix® 
stained neo-tissue using eq. 2. The average neo-tissue thickness was calculated on every 
CT slice using the 2D thickness analysis algorithm from CTAn (Bruker MicroCT). 
Based on the 3D thickness analysis ona subsection without mismatch of the datasets, 
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3D color-coded rendering showing the neo-tissue thickness distribution were generated 
using CTVox (Bruker MicroCT). 
Hex PTA
Hex
SA SA degree of tissue shrinkage
SA
−
=
 (eq 2.) 
where SAHex is the Hexabrix® stained neo-tissue surface area and SAPTA is the PTA 
stained neo-tissue surface area in the corresponding CE-nanoCT slice.  
5.4. Results and discussion 
5.4.1. Contrast quantification 
As a DoE analysis read-out, the normalized contrast of the stained neo-tissue compared 
to the background and scaffold was determined for each experimental condition.  For 
both contrast agents, the concentration was the most influencing parameter (Figure 
5.5.B and C). This could also be observed from the raw data (Figure 5.5.A), which 
showed a concentration-dependent increase in relative contrast, independent of the 
staining time or neo-tissue volume.  
Staining time did not significantly influence the normalized contrast, indicating that 
both contrast agents had infiltrated the neo-tissue within 30 minutes, even for the largest 
neo-tissue volume (Figure 5.5.B and  C). Although limitations in staining homogeneity 
and intensity due to diffusion limitations of the contrast agent have been reported 
(Pauwels et al. 2013), these were not observed in our experiments. Non-mineralized 
Figure 5.4: Representative transaxial cross-sections  
(A) a Hexabrix® (60%, 240 min) stained TE construct and (B) the same TE construct 
stained with PTA (7.5%, 240 min). The insets show the binarized images of the neo-
tissue in the cross-section, based on which the surface area of neo-tissue was calculated. 
Scale bar is 1 mm. 
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neo-tissue developed in a perfusion bioreactor system, such as the neo-tissue in this 
study, was reported to have an approximate cell density of 6 * 106 cells/cm³ (Sonnaert 
et al. 2014a, Sonnaert et al. 2014b), while the density of native tissue, in which 
diffusion limitations were previously reported, can on average be between 108 and 109 
cells/cm³. Since no influence of the staining time was observed within the operating 
window of our experiments, the lower cell density of the engineered neo-tissues will 
enable both contrast agents to fully infiltrate within the minimal staining time of 30 
min.   
For Hexabrix® (Figure 5.5.B), the normalized neo-tissue contrast was negatively 
influenced by the neo-tissue volume. As shown in earlier work, the neo-tissue has a 
fibrous structure (Papantoniou et al. 2013). Due to the limited spatial image resolution 
and the dense packing of the individual fibers (i.e. inter-fiber distances below the spatial 
image resolution), they cannot be discriminated in the CE-nanoCT images. Moreover, 
since Hexabrix® is an equilibrium contrast agent, the staining solution might be 
entrapped between neo-tissue fibers during infiltration. For the high level of neo-tissue 
volume, the neo-tissue fibers might be more densely packed and we could hypothesize 
that less volume is available within the porous neo-tissue for the Hexabrix® solution to 
be entrapped. As a result, the greyscale of the bulk neo-tissue will be lower compared 
to the less packed neo-tissue for the low- and mid-level of neo-tissue volume. 
Consequently, the normalized contrast of the neo-tissue is lower, as depicted in the 
pareto chart. 
Figure 5.5: Contrast quantification and DoE analysis 
(A) Normalized contrast difference between neo-tissue and background as shown in eq. 
1 for Hexabrix® (black) and PTA (grey) for all conditions of the DoE. Pareto charts for 
(B) Hexabrix® and (C) PTA stained TE constructs, showing the ranking of the influence 
of all staining parameters on normalized contrast. The dotted line indicates a 
significance level of p = 0.05. 
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5.4.2. Dataset quality  
Optimization of the image segmentation procedure 
To quantitatively and objectively evaluate which segmentation procedure was optimal 
for each contrast agent, the fraction of images containing a mismatch between the 
stained and the binarized neo-tissue fraction was determined for datasets with low, mid 
and high levels of each DoE factor. Figure 5.6 indicates that both for the Hexabrix® and 
PTA stained ‘low-level’ constructs (low values of all 3 parameters), binarization of the 
neo-tissue could not be done correctly, hence excluding automated analysis of the neo-
tissue volume for these conditions. Both for the Hexabrix®-stained TE constructs with 
a mid- and high-level parameter set, the 2-level Otsu segmentation enabled binarization 
of the neo-tissue with a minor mismatch (Figure 5.6.A), and was therefore further used 
for the evaluation of the Hexabrix® stained TE constructs. For the PTA stained TE 
Figure 5.6: Mismatch between stained and binarized neo-tissue 
Percentage of slices of the full dataset showing a mismatch between the stained and 
binarized neo-tissue for different Otsu segmentation levels and different value sets for 
all three DoE parameters (neo-tissue volume, staining time and concentration) for (A) 
Hexabrix® and (B) PTA stained TE constructs. *p < 0.05 
Figure 5.7: Mismatched slices and DoE analysis 
(A) The percentage of slices with a mismatch between the stained and binarized neo-
tissue for Hexabrix® (black) and PTA (grey) for all conditions of the DoE. (B, C) Pareto 
charts for Hexabrix® (B) and PTA (C) stained TE constructs respectively, showing the 
influence of the different staining parameters on the mismatch. The dotted line indicates 
a significance level of p = 0.05. 
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constructs with a mid- and high-level neo-tissue volume, all segmentation levels 
resulted in a high mismatch between the stained and binarized neo-tissue fraction. No 
significant differences were observed between the 3, 4 and 5-level segmented images 
(Figure 5.6.B). However, the more levels that needed to be segmented, the larger the 
processing time that was required to generate the segmented images. Therefore a 3-
level Otsu segmentation was used for further analysis of the PTA-stained TE constructs.  
Influence of DoE parameters on the dataset quality 
To determine the influence of the DoE parameters on the dataset quality, the fraction 
of slices with a mismatch between the stained and binarized neo-tissue was evaluated 
using the optimized segmentation settings as described above. For both contrast agents, 
their concentration significantly influenced the fraction of mismatched slices (Figure 
5.7.B and C). As the normalized contrast of neo-tissue increased with increasing 
concentration, it could be more easily separated from the scaffold-dependent image 
artifacts, and thus the amount of mismatched slices decreased significantly (Figure 
5.7.A).  
Both contrast agents showed a high mismatch for low volumes of neo-tissue (Figure 
5.7.A). This confirmed the findings from our previous study, where we determined the 
CE-nanoCT threshold for neo-tissue quantification to be a neo-tissue volume lower 
than 4% of the total TE construct void volume (Papantoniou et al. 2014b). This lower 
quantification limit was directly related to the artifacts introduced by the metallic 
scaffolds.  The DoE analysis showed, however,that only in the case of PTA the neo-
tissue volume had a significant effect on the dataset quality, as an increase in neo-tissue 
volume resulted in a significant decrease in mismatched slices (Figure 5.7.C). This is 
mainly caused by the neo-tissue structure, which for the low neo-tissue volume is on 
average much thinner compared to the other levels of neo-tissue volume (Figure 5.8). 
When compared to the Hexabrix® stained neo-tissue (Figure 5.8), the PTA stained neo-
tissue showed for all experimental conditions a more fibrous structure. Moreover its 
thickness could approach the spatial resolution of the images (i.e. 7.5 µm – 11.5 µm). 
Consequently, the PVE reduces the contrast of the neo-tissue, making it no longer 
separable from the scaffold-dependent image artifacts. Additionally, when the volume 
fraction of the bulk neo-tissue became too small, as was the case for the low neo-tissue 
volume, its peak in the cross-section greyscale histogram could no longer be segmented 
from the other phases in the images. The combination of the above mentioned factors 
all contributed to the mismatch quantified in Figure 5.7.  
5.4.3. Tissue integrity 
Influence of the contrast agents on the neo-tissue integrity 
As mentioned earlier, the use of PTA as a contrast agent can cause tissue shrinkage 
(Buytaert et al. 2013). For Hexabrix®, as this is a clinically approved contrast agent that 
does not chemically bind to the tissue, no effect on the tissue integrity was expected. 
To the best of our knowledge, there are no studies in the literature that have reported 
an effect of Hexabrix® staining on the tissue integrity. Using PCL-based TE constructs 
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without and with Hexabrix® staining (Figure 5.9.A and B respectively), we could 
confirm this, as the PCL scaffolds allow us to visualize the  neo-tissue without the  use 
  
Figure 5.8: Morphology and thickness of the neo-tissue for different DoE conditions. 
(A-C) Representative cross-sectional images and 3D color-coded renderings for TE 
constructs with (from left to right) low, medium and high levels of neo-tissue volume, 
stained with 60% Hexabrix®. (D-F) Representative cross-sectional images and 3D 
color-coded renderings for TE constructs with (from left to right) low, medium and high
levels of neo-tissue volume, stained with 7.5% PTA. Scale bar is 1 mm. For each 
condition, the average neo-tissue thickness is included (n = 3).  
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of a contrast agent. When overlaying both datasets (Figure 5.9.E), the largest difference 
(indicated in black) was the scaffold itself, since this could not be segmented from the 
neo-tissue in the images without contrast agent. Some small differences (indicated in 
white) were found in the small pores, where the Hexabrix® solution might have been 
not removed during the short drying step prior to scanning (on average 4.81 ± 3.95 % 
of the total neo-tissue volume, n = 3). The viscosity of the Hexabrix® solution is higher 
than that of the PBS itself, causing a more difficult removal of the liquid from the pores 
during the drying step. We could therefore conclude that the Hexabrix® staining does 
not influence the neo-tissue structure. 
Subsequent to the Hexabrix® staining and an overnight rinsing step in PBS solution to 
remove the Hexabrix®, TE constructs were stained with PTA and imaged again. A 
strong influence on the neo-tissue integrity was appreciated (Figure 5.9.C), and a clear 
difference with the Hexabrix® stained dataset was seen (Figure 5.9.F). To confirm that 
this difference was due to the PTA staining, the TE construct was once again stained 
with Hexabrix® after overnight rinsing in PBS and scanned (Figure 5.9.D). Although 
the small pores were again filled with the Hexabrix® solution as mentioned earlier, a 
significant difference was seen compared to the first Hexabrix® stained dataset (up to 
29 ± 17.5 % of the total neo-tissue volume), indicating that the PTA staining indeed 
caused tissue shrinkage.  
Figure 5.9: Influence of the different contrast agents on the neo-tissue integrity. 
(A) A typical transaxial cross-section through a PCL-based TE construct without a 
contrast agent. The black arrow indicates the PCL scaffold; the dashed arrow indicates 
the neo-tissue; the white arrow indicates the air space. The corresponding binarized 
images for neo-tissue of the (B) Hexabrix® (60 %) stained dataset, (C) PTA (7.5 %) 
stained dataset after Hexabrix® staining and (D) Hexabrix® (60 %) stained dataset 
after the consecutive Hexabrix and PTA staining. (E) The differential overlay image 
of (A) and (B); (F) the differential overlay image of (B) and (C); and (G) differential 
overlay image of (B) and (D). The black voxels in the overlay images represent the 
voxels present in the first dataset, but not in the second; the white voxels represent the 
voxels present in the second dataset, but not in the first. Scale bars are1 mm. 
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Influence of the DoE parameters for PTA staining on the neo-tissue 
integrity 
The degree of tissue shrinkage due to PTA staining was quantified as the difference 
between the Hexabrix® and PTA stained neo-tissue surface area in the corresponding 
CE-nanoCT slices relative to the Hexabrix® stained neo-tissue surface area. In 
agreement with other studies (Buytaert et al. 2013, Vickerton et al. 2013), the DoE 
showed that the concentration of the contrast agents has the strongest effect on the tissue 
shrinkage (Figure 5.10). Although an increase in the concentration caused a significant 
increase in the normalized neo-tissue contrast (Figure 5.5.C), as well as a significant 
decrease in the amount of mismatched images (Figure 5.7.C), it did introduce a 
significant tissue shrinkage. Hence, when accurate neo-tissue morphometric analyses 
should be performed, the concentration should be kept as low as possible. Additionally, 
also an increase in neo-tissue volume was shown to result in a significant increase in 
tissue shrinkage, which could be expected as more neo-tissue is available for the PTA 
to affect.  
As the chemistry of the staining is not fully defined yet (Vickerton et al. 2013), we 
cannot give a clear explanation for the tissue shrinkage. It has, however, been shown 
that tissue shrinkage because of the contrast agents is strongly dependent on the tissue 
composition and structure, since a different degree of shrinkage was found for different 
soft and mineralized tissue types (Buytaert et al. 2013, Vickerton et al. 2013, 
Papantoniou et al. 2014b). As we currently have no quantitative data on the 
composition or fibrous structure of the neo-tissue for the different levels of neo-tissue 
volume, we cannot claim that this could influence the tissue shrinkage. We did, 
however, show that the bulk neo-tissue structure for the low-level neo-tissue volume 
was much thinner than for the mid- and high-level neo-tissue volume. As a result, the 
segmentation and binarization of the neo-tissue was less accurate (Figure 5.7). Because 
of this, and due to the influence of the PVE, the calculation of the degree of tissue 
shrinkage for the low-level of the neo-tissue volume might be inaccurate and should be 
evaluated with care. 
Figure 5.10: Influence of the DoE parameters for PTA staining on the neo-tissue 
integrity. 
Pareto chart for the PTA-stained TE constructs when evaluating the degree of tissue 
shrinkage. The dotted line indicates a significance level of p = 0.05 
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5.5. Conclusions 
Using a DoE approach, we were able to optimize a 3D imaging protocol by quantifying 
and ranking in statistical importance the factors that influence the CE-nanoCT staining 
procedure using Hexabrix® and PTA. These factors were contrast agent concentration, 
staining time and the presence of neo-tissue (volume). Their effect on image quality, 
dataset quality and tissue integrity was investigated. 
For Hexabrix® staining of the neo-tissue in Ti alloy scaffolds, in this study the optimal 
staining conditions were (i) a concentration of 60% (vol% in PBS) and (ii) a staining 
time of 30 minutes. These were sufficient to allow accurate and fully automated 
quantification of the neo-tissue formed. When the neo-tissue volume fraction was, 
however, less than 4% of the open space, in this study represented by the low-level neo-
tissue volume, quantitative analysis of the datasets was not possible. 
For PTA staining, the DoE showed that in this study a high concentration was necessary 
for sufficient image contrast and accurate, automated 2D/3D image analysis, although 
significant tissue shrinkage was introduced. Hence, based on the results from the DoE, 
for this study we concluded using only 2.5% (weight% in PBS) of PTA. As the staining 
time did not have any significant influence, this was kept as low as possible (in this 
case 30 minutes). 
As a result of this study, and by using a DoE approach to optimize the staining 
conditions, we have converted CE-nanoCT into an optimized, quantitative and 3D 
measuring tool to evaluate neo-tissue formation in TE constructs and its spatial 
distribution. 
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6.1. Abstract 
Perfusion bioreactor systems have shown to be a valuable tool for the in vitro 
development of 3D cell-carrier constructs. Their use for cell expansion is, however, 
much less explored. Since maintenance of the initial cell phenotype is essential in this 
process, it is imperative to get an insight in the bioreactor-related variables determining 
cell fate. Therefore, this study investigated the influence of fluid flow induced shear 
stress on the proliferation, differentiation and matrix deposition of human periosteal 
derived cells in the absence of additional differentiation inducing stimuli. 120 000 cells 
were seeded on additive manufactured 3D Ti6Al4V scaffolds and cultured up to 28 
days at different flow rates ranging between 0.04 and 6 ml/min. DNA measurements 
showed on average a threefold increase in cell content for all perfused conditions in 
comparison to static controls whereas the magnitude of the flow rate did not have an 
influence. Contrast-enhanced nanofocus X-ray computed tomography showed 
substantial formation of an engineered neo-tissue in all perfused conditions, resulting 
in a filling up to 70% of the total internal void volume and no flow-rate dependent 
differences were observed. The expression of key osteogenic markers such as RunX2, 
OCN, OPN and Col1 did not show any significant changes in comparison to static 
controls after 28 days of culture, with the exception of Osx at high flow rates. We 
therefore concluded that, in the absence of additional osteogenic stimuli, the 
investigated perfusion conditions increased cell proliferation but did not significantly 
enhance osteogenic differentiation thus allowing for this process to be used for cell 
expansion.  
6.2. Introduction 
The development of cell-based regenerative therapies to treat defects in the body is 
rapidly evolving (Martin et al. 2011a, Martin et al. 2012). However, the translation of 
these techniques to a clinical setting still remains a major challenge due to suboptimal 
cell culture strategies leading to low yields of progenitor cells (Rodrigues et al. 2011). 
To address this, the development of robust processes using three dimensional (3D) 
bioreactor culture systems is a promising prospective (Grayson et al. 2004, Martin et 
al. 2004, Haycock 2011, Rodrigues et al. 2011, Jakob et al. 2012, Salter et al. 2012a). 
Bioreactors play a crucial role in establishing and maintaining 3D cell culture, 
controlling and monitoring physicochemical parameters in the system as well as 
automating manual procedures (Martin et al. 2010). Next to this, these systems allow 
to exert controlled mechanical stimuli such as hydrostatic pressure and shear stress (SS) 
on the developing construct (i.e. combination of a 3D carrier and cells/extracellular 
matrix (ECM)), which can be used to guide cell behavior (McCoy et al. 2010, Salter et 
al. 2012a).  
Bioreactor facilitated stem cell expansion has already been achieved using multiple 
systems ranging from multi-layered cell factories to micro-carriers in stirred tank 
bioreactors (Jung et al. 2012b). Different groups have already shown that the stem cell 
phenotype can be maintained in these systems despite the external hydrodynamic 
stresses applied on the cells by fluid flow during culture (Hewitt et al. 2011, Chang et 
al. 2012, Jung et al. 2012b). However, despite the 3D shape of the carriers used in these 
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systems, cells predominantly grow in a monolayer which does not reproduce the native 
environment of the cells (Haycock 2011). Additionally, the use of these systems does 
not stimulate ECM formation although its presence in a 3D architecture has been shown 
to restrain spontaneous differentiation and preserve differentiation potential (Chen et 
al. 2007). The shortfalls of these 3D culture systems can be addressed using a 3D 
perfusion bioreactor system. 
Next to enhancing the mass transport in the culture system, the combination of a 3D 
carrier and volumetrically controlled mass transport through perfusion has the potential 
to guide cell fate in function of culture conditions applied. In a range between 10-4 Pa 
and 10-1 Pa the SS exerted by the fluid flow on the developing construct has already 
been shown to have an enhancing effect on both osteogenic differentiation and 
mineralized matrix deposition, when the fluid flow is used as an additional stimuli 
combined with osteogenic inductive medium (Goldstein et al. 2001, Bancroft et al. 
2002, Cartmell et al. 2003, Gomes et al. 2003, Sikavitsas et al. 2003, Hosseinkhani et 
al. 2005, Grayson et al. 2008, Grayson et al. 2010, McCoy et al. 2010, Fisher et al. 
2011, Grayson et al. 2011, Liu et al. 2012, McCoy et al. 2012, Salter et al. 2012a). 
However, when the bioreactor system is intended to be used for a cell population 
expansion rather than the development of TE constructs containing differentiated cells, 
the maintenance of the progenitor phenotype is essential. Although the use of different 
perfusion regimes such as the use of intermittent shear stress in normal growth medium 
affects the behavior of bone marrow derived Mesenchymal stem cells (MSCs) (Kim et 
al. 2012), the expansion of a Mesenchymal progenitor cell population in the presence 
of SS with maintenance of its phenotype has proven to be possible (Scherberich et al. 
2007). Also substrate specific interactions have the potential to trigger specific cell 
responses to external stimuli (Grayson et al. 2011), explaining the large variation in 
specific cell responses to SS reported in literature (McCoy et al. 2010, Fisher et al. 
2011). Therefore, it is required to determine the effect of a bioreactor culture on the 
proliferation and differentiation of a targeted cell population for specific combinations 
of SS and carrier material and structure. 
Human periosteal derived cells (hPDCs) obtained from periost biopsies contain 
osteochondro-progenitor cell populations (De Bari et al. 2006, Eyckmans et al. 2006a, 
Marolt et al. 2010). Their multi-lineage differentiation potential, phenotypical stability, 
high proliferation and accessibility make these cells a suitable cell source for bone 
tissue engineering (Hutmacher et al. 2003, De Bari et al. 2006, Eyckmans et al. 2006a, 
Agata et al. 2007, Ringe et al. 2008, Marolt et al. 2010). Several studies have already 
demonstrated the osteoinductive potential of these cells when implanted in vivo (Agata 
et al. 2007, Marechal et al. 2008, Roberts et al. 2011), and they are further being used 
for the development of tissue engineered bone products (Chai et al. 2012c, van Gastel 
et al. 2012a, van Gastel et al. 2012b). The use of hPDCs in bioreactor systems and 
concomitantly the effect of such a system on the osteogenic differentiation of this cell 
population, is still very limited (Matziolis et al. 2006, Papantoniou et al. 2013). 
In order to determine the potential of using a perfusion bioreactor system for the 
expansion of this progenitor cell population, the goal of this study was to determine the 
influence of perfusion on the in vitro proliferation, differentiation and matrix formation 
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of hPDCs in the absence of differentiation inducing medium. hPDCs were cultured on 
inert Ti6Al4V porous scaffolds at different flow rates corresponding to the range of SS 
values used in literature and proliferation was evaluated in function of the applied SS 
based on DNA content. Thereafter the influence of two levels of SS, reported to 
respectively have a proliferation enhancing or osteogenic inductive effect, on the cell 
behavior was determined and compared with static 3D culture. Real time PCR (RT-
PCR) was employed to analyze gene expression in combination with the analysis of the 
proliferation. Contrast enhanced nanofocus X-ray computed tomography (CE-nanoCT) 
was employed in combination with Live/Dead staining to visualize and quantify the 3D 
dynamics of cell growth and extracellular matrix deposition.    
6.3. Materials and methods 
6.3.1. Ti6Al4V Scaffolds 
Regular, 3D additive manufactured Ti6Al4V scaffolds (Ø = 6 mm, h = 6 mm) were 
produced in-house using selective laser melting based on a diamond shaped unit cell 
(Van Bael et al. 2011, Pyka et al. 2012) (Figure 6.1.A). The total volume of the 
scaffolds was 166 ± 3 mm³, the available volume 130 ± 5 mm³ and the available surface 
7.5 ± 0.6 cm² as determined with nanoCT (Kerckhofs et al. 2013a). Prior to use, 
scaffolds were ultrasonically cleaned for 10 min consecutively with acetone, ethanol 
and distilled water. Subsequently they received an alkali treatment with 5M sodium 
hydroxide (Sigma-Aldrich) at 60°C for 24 hours, were rinsed with distilled water, and 
finally sterilized in a steam autoclave. Prior to cell seeding, all scaffolds were pre-
wetted by vacuum impregnation in cell culture medium for 2 h in a humidified 
incubator at 37°C, and dried overnight in a non-humidified incubator (Impens et al. 
2010a, Papantoniou et al. 2013, Zhou et al. 2013b, Papantoniou et al. 2014b). 
Figure 6.1: CFD based shear stress distribution in Ti6Al4V scaffold 
(A) Bright field image of a Ti6Al4V scaffold, (B) SS distribution on a scaffold unit cell 
for a perfusion velocity of 4 ml/min, (C) relative distribution of the SS on the scaffold 
unit cell for a perfusion velocity of 4 ml/min and (D) interstitial fluid velocity and 
average SS corresponding with the applied perfusion velocities. All calculations were 
performed on an empty scaffold, thus representing the initial SS present after cell 
attachment and prior to construct culturing. 
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6.3.2. Fluid flow modelling 
In order to determine the SS correlated with the volumetric perfusion velocity and 
hence select a relevant range of flow rates, fluid flow modelling using computational 
fluid dynamics (CFD) was used as described by Truscello et al., 2012. Due to the 
symmetrical design of the scaffold the calculations were limited to one geometrical unit 
cell. A 3D geometrical model of a scaffold unit cell was created and meshed in the 
ACIS-based solid modeller Gambit 2.2 (Fluent). The mesh was refined until the 
solution was stable (mesh independent) and contained 750 000 elements which were 
sized to 30 µm³. To determine velocity fields and the related SS in the scaffold the finite 
volume code Fluent 6.3 (Fluent) was used. The culture medium was considered to be 
an incompressible and homogeneous Newtonian fluid with properties equal to water 
(viscosity: 10-3 Pa s, density: 103 kg/m3, temperature: 37 °C). Since the Reynolds 
number was lower than 1 the correlation between the flow rate and the SS was linear. 
Therefore the correlation between the flow rate and the SS was determined for one flow 
rate and thereafter extrapolated to the range of interest. A constant velocity of 2.36 
mm/s was assigned to the inlet, corresponding to a volumetric flow rate of 4 ml/min. 
No-slip conditions were applied to the walls of the scaffolds, symmetry conditions to 
the lateral surfaces and a zero gauge pressure was set at the outlet. The flow problem 
was described with steady-state Navier-Stokes equations.  
6.3.3. hPDC culture 
hPDCs were isolated from periosteal biopsies of different donors as described 
previously (Eyckmans et al. 2006a). This procedure was approved by the ethics 
committee for Human Medical Research (KU Leuven) and with patient informed 
consent. hPDCs were expanded in Dulbecco’s modified Eagle’s medium with high-
glucose (Invitrogen) containing 10% foetal bovine serum (Gibco), 1% sodium pyruvate 
(Invitrogen) and 1% antibiotic–antimycotic (100 units/mL penicillin, 100 mg/mL 
streptomycin, and 0.25mg/mL amphotericin B; Invitrogen). The cells were seeded at 5 
700 cells/cm² and passaged at 80 % – 90 % confluence. Prior to the 3D culture 
experiments cells were harvested using Triple Express (Invitrogen) and drop-seeded by 
a single drop onto the scaffolds at a density of 200 000 cells per 60µl drop as performed 
in earlier studies (Papantoniou et al. 2013, Zhou et al. 2013b, Papantoniou et al. 2014b). 
45 min after seeding 60 µl culture medium was added and 135 min later the medium 
volume was topped up to 1 ml. Scaffold-cell constructs (further mentioned as 
constructs) were incubated overnight in standard culture conditions (37°C, 5% CO2, 
95% relative humidity). Since the seeding process resulted in homogenous and 
reproducible seeding efficiencies in earlier experiments (~60%) this was not assessed 
separately in this work (Papantoniou et al. 2013, Papantoniou et al. 2014b). This 
seeding procedure resulted in an initial cell density of 17 100 cells/cm² or 7*105 
cells/cm³. 
For the initial flow rate screening 5 different values (0.04, 0.25, 1, 4 and 6 ml/min) were 
applied, corresponding with a SS range of 5.6*10-4 Pa to 8.4*10-2 Pa, thereby covering 
the range of SS reported in literature (McCoy et al. 2010). 30 scaffolds were seeded as 
described before (5 scaffolds per flow rate and 5 as static control). After the overnight 
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static incubation, the constructs were transferred to a 12 well plate containing 3ml 
culture medium/well for static culture or to an in-house developed bioreactor system. 
This system contained in total 13 ml of culture medium for perfusion culture of which 
3 ml was located in the circuit and the remaining 10 ml in the medium reservoir. 
Medium was refreshed every two days either by attaching a new medium reservoir 
containing 10 ml of fresh culture medium or by manually replacing the 3 ml of culture 
medium for the static constructs. Continuous perfusion was applied for a total duration 
of 21 days.(Papantoniou et al. 2013, Zhou et al. 2013b, Papantoniou et al. 2014b).  
For the time point experiment 54 scaffolds were seeded and afterwards divided in 3 
groups for static culture and perfusion at low and high flow rate (0.04 ml/min and 4 
ml/min) corresponding with SS values reported to have a proliferation of differentiation 
enhancing effect in different systems (McCoy et al. 2010). Samples were taken at 14, 
21 and 28 days. Time points were chosen to allow for the different stages of possible 
osteogenic differentiation and matrix deposition to occur. 
As a positive control for mineralization constructs were cultured for 21 days at the high 
flow rate using a bio-instructive medium based on normal growth medium with the 
addition of 6 mM Ca2+, 4 mM Pi and 0.05 ng/ml ascorbic acid (Chai et al. 2012d, 
Papantoniou et al. 2013). 
6.3.4. DNA measurement 
The DNA content was determined using a highly quantitative and selective DNA assay 
(Quant-iTTM dsDNA HS kit, Invitrogen). The methods used were developed and 
optimised for combined DNA measurement and RNA extraction from 3D constructs 
(Chai et al. 2012c, Chen et al. 2012, Papantoniou et al. 2013). The constructs were 
rinsed with PBS and lysed in 350 µl RLT lysis buffer (Qiagen) supplemented with 3.5 
µl β-mercaptoethanol after which the lysed samples were vortexed for 60 s and stored 
at -80°C. Prior to analysis, the samples were thawed at room temperature and spun 
down for 1 min at 13 000 rpm. 10 µl of the sample was diluted in 90 µl milliQ water 
after which the DNA content was quantified with a Qubit® Fluorometer (Invitrogen) as 
described by Chen et al., 2012. 
6.3.5. Quantitative PCR 
For the time point experiment, RNA was extracted from 4 random, representative 
constructs for each culturing condition and time point using the RNeasy mini kit 
(Qiagen) and quantified using a Nanodrop ND-1000 spectrophotometer (Thermo 
Scientific). Complementary DNA was synthesized using the RevertAid H Minus First 
Strand complementary DNA synthesis kit (Fermentas). Sybr green quantitative 
polymerase chain reaction was performed for different key osteogenic and 
chondrogenic markers (Sox9, Col1, RunX2, OCN, OPN, OSX and BSP (Chai et al. 
2012c)) and compared to HPRT (HPRT-F, 5’-TGAGGATTTGGAAAGGGTGT-3’; 
HPRT-R, 5’-GAGCACACAGAGGGCTACAA-3’). The PCR reaction was cycled in a 
Rotor-Gene sequence detector (Qiagen) as follows: 95 °C for 3 min, 40 cycles of 95 °C 
for 3 s and 60 °C for 60 s. Differences in gene expression were determined relatively 
in comparison to HPRT and shown as 2-ΔCT.  
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For the constructs cultured with or without bioinstructive mineralisation medium for 21 
days the expression of Sox9, OCN, OPN and OSX was determined. Differences in gene 
expression were shown relative to HPRT expression and to the static control (2-ΔΔCT). 
6.3.6. Contrast-enhanced nanofocus computed 
tomography (CE-nanoCT) 
CE-nanoCT was performed on two random, representative constructs for each time 
point and culture condition as described earlier (Papantoniou et al. 2014b). The 
constructs were fixed in 4% paraformaldehyde (Sigma) for two hours and stored in PBS 
prior to analysis. Hexabrix® 320 (Guerbet) was used as a contrast agent to visualize the 
neo-tissue formed in the construct (Papantoniou et al. 2014b). As the Hexabrix® is an 
equilibrium contrast agent it will equally infiltrate all non-negatively charged tissues 
and thereby enable the visualization of the radio-transparent neo-tissue in the opaque 
Ti6Al4V structure. 
A Phoenix NanoTom S (GE Measurement and Control Solutions) with a 180 kV/15 W 
high-performance nanofocus X-ray tube was used to perform the CE-nanoCT. A 
tungsten target was operated at a voltage of 90 kV and a current of 170 µA. An 
aluminum and copper filter, both 1 mm thick, were used to reduce beam hardening and 
metal artefacts. The exposure time was 500 ms, a frame averaging of 1 and image skip 
of 0 were applied, resulting in a scanning time of 20 min. The reconstructed images had 
an isotropic voxel size of 3.75 µm. 
6.3.7. 3D visualization, image processing and analysis 
CTAn (Bruker micro-CT) was used for image processing as described by Papantoniou 
et al., 2013b. Briefly, the neo-tissue was separated from the background noise and the 
scaffold using a 2-level Otsu thresholding method (Otsu 1979), resulting in a greyscale 
image containing 3 fractions, respectively background, neo-tissue and scaffold 
material. To analyze the volume of the Ti6Al4V scaffolds the resulting greyscale 
dataset was thresholded to obtain binary images representing the scaffold. In order to 
subsequently reduce the influence of the partial volume effect, edge effects and metallic 
artefacts introduced by the presence of the Ti6Al4V scaffold while analyzing the neo-
tissue volume, the binarised images for the scaffold were dilatated by two voxels and 
subtracted from the region of interest for further analysis. The neo-tissue fraction within 
the new region of interest was then binarised and the noise was removed by removing 
black speckles smaller than 500 voxels and white speckles smaller than 2 000 voxels. 
To solidify the resulting structure, a ’closing’ operation (~ 2 voxels) was performed on 
the resulting images, providing the images used for the 3D analysis of the neo-tissue 
volume. 
6.3.8. Live/Dead assay 
A Live/Dead viability/cytotoxicity kit (Invitrogen) was used to evaluate qualitatively 
cell viability and cell distribution by optical microscopy. For each culture condition two 
random, representative constructs were imaged of which one was subsequently used 
for CE-nanoCT and one for DNA measurement and RNA extraction. Constructs were 
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rinsed with 1 ml PBS after which they were incubated in the staining solution (0.5 µl 
of a 4mM Calcein AM in anhydrous DMSO solution and 2 µl of a 2mM Ethidium 
Homodimer in DMSO/H20 (1:4, v:v) in 1 ml PBS) for 20 min in normal cell culture 
conditions. The constructs were imaged using a Leica M165 FC microscope. 
6.3.9. Alizarin red staining 
Constructs cultured for 21 days with normal growth medium or bio-instructive medium 
were fixed in 4% paraformaldehyde and stored in PBS prior to staining. Staining was 
performed with a 2% Alizarin Red S (Sigma) solution in water (pH 4.2) for 1 hour at 
room temperature during continuous gentle agitation. Samples were subsequently 
rinsed with demineralized water until no additional staining was removed from the 
constructs after which they were imaged using a stereo microscope (Leica M165 FC). 
6.3.10. Statistical analysis 
Student t-test was performed to analyze significant differences between groups using 
Statistica 7 (Statsoft). A p-value < 0.05 was considered significant. 
6.4. Results 
6.4.1. Shear stress range 
 CFD was used to determine the initial SS which the fluid exerted on the constructs in 
order to compare our results with other reports (Grayson et al. 2011, Kim et al. 2012). 
Since the scaffold design consists of a repetition of a regularly shaped diamond unit 
cell (Figure 6.1.A), the calculations were performed for only one unit cell (Truscello et 
al. 2012). Figure 6.1.B-C show a 3D visualization of the SS on a scaffold unit cell and 
the corresponding histogram of the relative SS distribution within the unit cell. Figure 
6.1.D shows the initial average CFD-calculated SS based on the experimentally used 
flow rates. The obtained distribution could be extrapolated for the other flow rates used 
since fluid flow remained laminar in the used range. 
6.4.2. Proliferation 
The use of different flow rates did not significantly influence the DNA content of the 
constructs after 21 days of dynamic culture in growth medium (Figure 6.2.A). However, 
analysis of all perfused constructs cultured for 21 days at different flow rates showed 
that the DNA content of the constructs cultured in perfusion was on average 2.75 ± 0.27 
fold increased in comparison with the static control. To get a better understanding of 
the time-dependent influence on hPDC proliferation of a constant volumetric flow rate 
in combination with a morphological changing matrix, which resulted in a time 
dependent increase in SS, the 0.04 ml/min and 4 ml/min flow rate conditions were 
selected and compared to the static culture for 14, 21 and 28 days. For all time-points 
the perfused conditions showed a significant increased DNA content in comparison to 
the static control. However, the static control as well as the perfused conditions did not 
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show any significant time dependent changes from 14 up to 28 days (Figure 6.2.B), 
although an increasing trend was still observed for the perfused constructs.  
Based on our in-house 2D hPDC expansion database an average cell expansion of 2.9 
± 0.65 was determined in comparison to the initial cell density for a 7 day expansion 
period or 8.4 ± 2.6 in 14 day when cells are replated according to standardized cell 
expansion protocols (n=20).  
6.4.3. Live/Dead staining 
Cell distribution at the periphery of the constructs was visualized using the Live-Dead 
viability/cytotoxicity kit (Figure 6.3). For both the statically cultured and the 0.04 
ml/min perfused samples the construct was fully covered with cells after 21 days of 
culture. For the high flow rate (4 ml/min) the cell coverage of the outer surfaces did not 
seem to increase over time for the imaged time points. A clearly less dense coverage of 
the surface was observed in comparison with the two previously described conditions. 
There were no significant amounts of dead cells observed in any of the examined 
conditions.  
6.4.4. 3D matrix image analysis by CE-nanoCT 
CE-nanoCT using Hexabrix® as contrast agents was used to visualize and quantify in 
3D the neo-tissue formed in the constructs. Figure 6.4 shows axial 2D cross-sections 
representative for the entire construct for 0.04 and 4 ml/min as well as the static control 
for different time points. In the raw images (left 3 columns) the white zones represent 
the scaffold structure, while the delineated grey features represent the neo-tissue in the 
constructs. The binarised images (right) show the quantified neo-tissue fraction in 
white. In correspondence with the Live/Dead staining shown in Figure 6.3, the outer 
Figure 6.2: DNA content for constructs cultured at different flow rates 
(A) DNA content of the constructs relative to the static control after 3 weeks of dynamic 
culture (n=4 to 6), (B) DNA content of the constructs after 14, 21 or 28 days of culture 
in a static or perfused (0.04 ml/min and 4 ml/min) system (n=4, ***p<0.001, black bars 
show standard deviations of the mean). 
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surface of the statically cultured constructs was nearly completely covered with cell-
matrix after 14 days, which is visible as a thin line with a lighter shade of grey on the 
images in Figure 6.4 as indicated with the arrows. Increasing the static culture duration 
did not result in a significant increase in cell-matrix volume for these constructs. The 
perfusion cultured constructs showed that the morphology of the cell-matrix formed 
was influenced by the culture condition. Instead of forming a cell sheet on the outer 
edges of the construct as was the case for the static control, cell-matrix was formed 
throughout the entire scaffold resulting in a much denser and more filled construct as 
was also observed by DNA analysis (Figure 6.2.B). In both the 0.04 ml/min and 4 
ml/min perfused culture the Hexabrix® based images showed that the cell-matrix was 
gradually filling up the available space in the construct. 
As reported earlier, the amount of cell-matrix present in the statically cultured 
constructs was too low to be quantified (Papantoniou et al. 2014b). As shown in Figure 
6.4 the neo-tissue developed in these constructs was fibrous in appearance and was only 
located in thin strands (average diameter of about 5 µm as determined with DataViewer, 
Bruker MicroCT) at the outer edges of the constructs. Although most of these structures 
can be visually discriminated in the CE-nanoCT images, the limited contrast difference 
between the stained neo-tissue and the background did not allow to accurately segment 
both from each other, resulting in an erroneous quantification of the neo-tissue volume. 
Therefore, quantitative analysis of the cell-matrix volume was performed only on the 
Figure 6.3: Live/dead stainings for constructs cultured at different flow rates 
Live/Dead staining of constructs for different culture regimes and durations. The green 
fluorescent dye shows all the living cells while the red dye visualises the nuclei of the 
dead cells. Scale bar is 1mm 
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perfused constructs. In Figure 6.5, the relative filling volume, determined using 
Hexabrix® as a contrast agent, was normalized to DNA content. For the high flow rate, 
a stronger increase after 21 days of culture was observed compared to the low flow rate 
where this increase was only observed after 28 days indicating a difference in matrix 
deposition kinetics. At the final time-point however, no differences in deposited matrix 
per cell was present. 
6.4.5. Gene expression analysis 
Finally gene expression analysis was performed to assess the influence of the different 
culture conditions on cell differentiation (Figure 6.6). For the statically cultured 
constructs a significant down regulation of the Col1 expression was observed in 
function of time. The 14 and 21 day expression of Col1 in the perfused conditions was 
Figure 6.4: 2D CE-nanoCT based slices of constructs cultured under different 
conditions 
Representative 2D CE-nanoCT cross-sectional images stained with Hexabrix® of the 
constructs cultured at different conditions and their corresponding processed images 
for 3 weeks of perfusion culturing. White arrows indicate cell-matrix in the static 
conditions. Scale bar is 1mm. 
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also down-regulated in comparison to the static constructs but this difference was no 
longer present at the 28 day time point. For RunX2 the expression remained stable in 
function of time for the static constructs and no differences were observed between the  
static and perfused conditions. For the low flow rate a significant increase was observed 
between day 14 and 28. For the high flow rate this increase was observed at the 21 day 
time point, although it was no longer present at the final day 28 time point. In the case 
of OCN no significant differences were observed between the static controls and both 
perfused conditions. At day 14 a higher expression was observed for the low flow rate 
in comparison to the high flow rate but this difference was no longer observed at later 
time points. Except for the low flow rate at day 14 no differences were observed in 
OPN expression between the static control and the perfused conditions. Although a time 
dependent increase was observed for the low flow rate, OPN expression was 
significantly higher for the high flow rate in comparison to the low flow rate. BSP 
showed a time-dependent increase in both perfused conditions resulting in a 
significantly higher expression in comparison to the static control at day 28. No 
significant differences between the perfused conditions were observed. Sox9 
expression decreased significantly over time in the static control. In both perfused 
conditions Sox9 expression was significantly lower at day 14 and 21 but this difference 
was no longer observed at day 28. OSX expression showed a time dependent decrease 
in the static control. Except at day 14 no differences were present between the static 
control and the low flow rate condition. The high flow rate showed a significantly 
higher expression in comparison to the low flow rate (all time points) and to the static 
control (after 21 and 28 days).  
 
Figure 6.5: CE-nanoCT based filling of the constructs. 
Relative filling of the scaffold determined with Hexabrix® normalized to cell content, 
$ indicates a significant difference between the two flow rates (p<0.05), *: 
0.05>p>0.01, **: 0.01>p>0.001 
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Figure 6.6: Gene expression profile for constructs cultured at different conditions. 
Gene expression of the cultured constructs by means of RT PCR for Col1, RunX2, 
OPN, OCN, BSP, Sox9 and OSX relative to HPRT. & indicates a significant difference 
with the corresponding time point of the static control (p<0.05, *; 0.05>p>0.01, **;
0.01>p>0.001, ***) (n=4). 
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6.5. Discussion 
Perfusion bioreactor systems show great promise as a  tool for automated 3D cell 
expansion and their use will be essential for the clinical implementation of current 
tissue engineering and regenerative medicine strategies (Martin et al. 2010, Fisher et 
al. 2011, Salter et al. 2012a). Therefore, it is imperative to understand the influence of 
the process environment on the behavior and properties of the cell populations 
expanded in these systems and define suitable operating conditions which support cell 
expansion while maintaining a progenitor cell phenotype. The present study used 
hPDCs seeded on a Ti6Al4V scaffold in a perfusion bioreactor system to determine its 
potential for cell expansion by evaluating the influence of flow-induced SS on the 
proliferation, differentiation and extracellular cell-matrix deposition in the absence of 
additional differentiation-inducing stimuli such as osteogenic inductive medium. 
3D perfusion bioreactor culture has been extensively used for the production of bone 
TE constructs and has shown to significantly increase proliferation, differentiation and 
mineralised matrix deposition in comparison to static controls (McCoy et al. 2010, 
Fisher et al. 2011). Additionaly, SS dependent increases in proliferation and 
mineralisation have been reported for MSCs in combination with osteogenic medium 
(Bancroft et al. 2002, Cartmell et al. 2003, Sikavitsas et al. 2003, McCoy et al. 2010). 
Additionally, the use of intermittent SS exerted on the a construct developing in normal 
growth medium resulted in the significant induction of an osteogenic phenotype in 
comparison to the continuous shear conditions, although no comparison with a static 
control was made here (Liu et al. 2012). In correspondence with this literature data, our 
work showed that perfusion significantly increased the cell number on the Ti6Al4V 
scaffolds in comparison to the static control (Figure 6.2.A), as both dynamic conditions 
resulted in a significant increase in DNA content in comparison to the static control for 
all time points. The enhanced mass transport present in a perfusion setup in comparison 
to the static setup will provide an optimal nutrient supply to the entire construct, thereby 
enabling all the cells in the construct to proliferate under more optimal conditions. This 
was confirmed with the CE-nanoCT which shows that the developed neo-tissue is only 
present at the outer edges of the statically cultured constructs while in both perfused 
conditions the neo-tissue is deposited uniformly throughout the entire construct. As the 
use of a higher flow rate did not significantly improve the nutrient supply to the 
developing constructs, the absence of correlated changes in proliferation could be 
explained, as also reported earlier for similar systems using osteogenic medium 
supplements (Sikavitsas et al. 2003, Dai et al. 2009, Grayson et al. 2011).  
An average cell density increase of 3.6 ± 0.6 times, with respect to the static constructs 
or an 8.4 ± 1.7 fold increase in relation to the initial cell density were observed after 28 
days (Figure 6.2.B). These expansion rates were not significantly different from those 
observed in the standard 2D culture at the 14 day time point for the high flow rate (8.4 
± 2.6 for 2D  vs 7 ± 1.2 in the perfusion system), without the need for replating. For 
later time points the proliferation rate, based on the DNA measurement, in the 3D 
perfusion bioreactor setup decreased, due to the gradual filling and closing of the open 
spaces in the construct as shown in Figure 6.4 In 2D culture systems a decrease in 
proliferation is also observed when cells are not replated prior to confluence, but for 
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2D static culture systems this phenomenon already occurs after 8 to 10 days resulting 
in an average cell expansion of 4 to 5 times. This shows that the perfusion bioreactor 
system performs at least as efficient as a standard 2D sub-culture system with regard to 
cell expansion, but not requiring manual intermediate trypsinisation and replating steps.  
Besides conventional, manual, 2D cell expansion, the use of micro carriers is often 
mentioned to be a promising technique for automated cell expansion despite the 
absence of a real 3D environment (dos Santos et al. 2011b, Hewitt et al. 2011, Goh et 
al. 2013). In these systems 7 to 20 fold increases in cell number have been reported 
after already 7 days of cell expansion resulting in significantly higher expansion rates 
in comparison to the 3D perfusion bioreactor system used for this work. However, the 
maximal cell density that could be obtained in micro-carrier based expansion systems 
is on average between 2*105 and 8*105 cells/cm³  (dos Santos et al. 2011b, Hewitt et 
al. 2011, Goh et al. 2013) while, based on the DNA content and assuming an average 
of 8.9 pg DNA/cell as reported earlier (Zhou et al. 2013), the 3D perfusion system used 
in this work reached a cell density of 5 to 6*106 cells/cm³. This demonstrates that a 
higher cell number per volume unit can be obtained, thereby indicating their high cell 
expansion potential per volumetric unit. Additionally, current protocols for the 3D 
perfusion bioreactor system have not been optimised yet for cell expansion. Reducing 
the initial cell seeding density in the system from 7*105 cells/cm³ or 17 100 cells/cm² 
to the densities which are currently used for micro carrier expansion (10 to 20 fold 
lower (Hewitt et al. 2011)) could further increase the yield of the 3D perfusion 
bioreactor culture. 
Live/dead staining of the constructs showed that the flow rate had no significant 
influence on the cell viability in the outer layers of the formed neo-tissue (Figure 6.3). 
The differences in DNA content between static and dynamically cultured constructs 
could not be visually confirmed. However, microscope-based live/dead staining is a 
line-of-sight visualization technique, allowing only observation of the peripheral part 
of the scaffold, hence a novel imaging technique, CE-nanoCT was used in order to 
monitor cell growth and provide quantitative volumetric information regarding cell and 
extracellular matrix distribution throughout the entire volume of the scaffold (Figure 
5.4)(Papantoniou et al. 2014b). CE-nanoCT images showed a time dependent 3D filling 
of the scaffold void volume. For the static constructs cell-matrix was only situated on 
the outer edges of the construct as reported by other groups using destructive 2D based 
techniques such as histology (Ishaug et al. 1997, Bancroft et al. 2002, Sikavitsas et al. 
2003). In function of time not only was more cell-matrix deposited but also the amount 
of cell-matrix deposited per cell, as calculated based on the CE-nanoCT based images 
and the measured DNA content, increased for both flow rates as observed by the 
Hexabrix® based images (Figure 6.4, Figure 6.5). As higher SS has been reported to 
result in increased matrix deposition (Jaasma et al. 2008, Grayson et al. 2011), the 
increase in SS present in the developing constructs due to the filling of the available 
volume could explain the observed increase in matrix deposition per cell. Despite the 
difference in matrix deposition kinetics no differences in matrix deposition were 
observed for the different flow rates at the final time-point.  
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In this work initial SS values exerted on the developing constructs, as determined by 
CFD, ranged between 5.59*10-4 and 8.38*10-2 Pa. Although  in this range, enhanced 
osteogenic differentiation and collagen production has been previously reported for 
MSCs in combination with osteogenic medium (McCoy et al. 2010) its influence in 
normal growth medium is not known. The SS values determined using CFD were based 
on the empty Ti6Al4V scaffold geometry. However, as observed by the experimental 
data, cell and matrix growth gradually filled up the internal volume of the Ti6Al4V 
scaffold, thereby significantly altering the flow environment. The increase in cell-
matrix volume will reduce the volume available for the fluid to flow through, thereby 
increasing the flow rate of the medium and the correlated SS. Calculated SS values will 
therefore more closely represent those SS values that hPDCs will experience during the 
initial period of the bioreactor culture and serve mainly as a reference for comparison 
with  literature data in which a similar approach was used (Bancroft et al. 2002, 
Sikavitsas et al. 2003, Kim et al. 2012, Liu et al. 2012). In future work the neo-tissue 
filling determined via CE-nanoCT as function of culture duration may be used as input 
for CFD modeling to obtain dynamic SS information to which the cells are actually 
exposed during the expansion process. 
To further assess the influence of flow rate on the hPDCs the expression of a range of 
genes was analyzed to determine cell commitment towards a specific lineage (Figure 
6.6). Results showed that Sox9 was significantly down-regulated for both perfusion 
conditions at day 14 and 21 in comparison to the static control, but that this was no 
longer the case at day 28 due to the gradual decrease observed in the static control. 
Sox9 expression was already shown to be increased in a perfusion system in 
chondrogenic medium (Tigli et al. 2011) but, in correspondence with our findings, there 
were no reports of increased chondrogenic differentiation in the absence of biochemical 
inducers in a perfusion system. Therefore no additional chondrogenic markers were 
evaluated in this work. Different osteogenic markers, such as Col1, RunX2, OPN and 
OCN, showed limited time-dependent changes in expression. In accordance to 
previously reported data (Bjerre et al. 2008, Kim et al. 2012), certain flow-rate-
dependent changes in expression were observed, but perfusion as such did not have a 
significant influence on the expression of these key osteogenic markers as no 
differences between the static control and the perfused conditions were present (Figure 
6.6). Additionally, the limited observed time dependent changes in expression of these 
markers are negligible in comparison to what was reported earlier for induced 
osteogenic differentiation for this cell type (Chai et al. 2011). Despite that no significant 
changes were observed in the expression of ECM related genes such as Col1 and OCN 
significant differences in the ECM deposition per cell were observed between the 
different conditions. The culture of cells under SS has earlier been shown to potentially 
induce changes in posttranscriptional regulation of certain ECM proteins (Bjerre et al. 
2008) and differences in the incorporation of secreted matrix proteins (Grayson et al. 
2011). This indicates that SS can significantly influence the composition of the 
deposited neo-tissue in a 3D culture system without influencing gene expression, thus 
potentially explaining the differences in neo-tissue volume deposited in static versus 
the perfused conditions. 
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BSP on the other hand showed, compared to the static control, an 8-fold time-dependent 
increase in expression in both perfused conditions. However, as shown by Grayson et 
al, 2011  the combination of perfusion and osteogenic medium can result in a 100-fold 
increase in BSP expression after one week and even a 1 000-fold increase after 5 weeks 
of perfusion culture using MSCs (Grayson et al. 2011), indicating that the increase 
observed in our study is limited for both perfused conditions. For OSX, an important 
early osteogenic transcription factor (Kim et al. 2012), a flow rate dependent increase 
in expression was observed. In the normal osteogenic differentiation cascade of events 
this increase would be preceded by an increase in RunX2, of which OCN is a 
downstream target, and followed by an increased expression of BSP and OCN (Lian et 
al. 2006, Franceschi et al. 2007, Kim et al. 2012). This cascade of events was, however, 
not observed in the studied system. Although the expected initial increase of RunX2 in 
osteogenic differentiation could have occurred at an earlier time point and a subsequent 
increase in BSP expression was present no differences in OCN expression were 
detected. In the absence of the OCN increase, the increased OSX expression could be 
explained by cell lineage commitment rather than to full osteogenic differentiation. 
This was confirmed by comparing the expression of Sox9, OCN, OPN and OSX for 
constructs cultured for 21 days using normal growth medium and bio-instructive 
mineralization medium (Figure 6.7.A). Although a significant lower Sox9 expression 
was detected in the normal constructs after 21 days, a 100-fold stronger decrease in 
expression was present in the induced constructs. For the OCN, OPN and OSX 
expression respectively a 12-, 90- and 6-fold increase in expression was detected for 
the induced constructs in comparison with the growth medium cultured. Alizarin red 
Figure 6.7: Comparison bioreactor cultured constructs in normal and osteogenic 
medium. 
(A) Gene expression of perfusion bioreactor cultured constructs with normal growth 
medium (Black) and mineralization medium (Grey) for 21 days relative to HPRT and 
to the static control (ΔΔCT) by means of RT PCR for Sox9, OCN, OPN and OSX. $ 
shows relative to the static control. P<0.05, n=3 (B and C) Alizarin red staining of 
respectively normal growth medium and mineralization medium cultured constructs 
after 21 days of culture. Scale bars are 1 mm 
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staining visually confirmed the presence of a mineralized matrix in the induced 
constructs (Figure 6.7.C), while this was not detected in the growth medium constructs 
(Figure 6.7.B). This further confirmed that expansion of the MSC like hPDC cell 
population in a perfusion bioreactor system does not result in significant osteogenic 
differentiation nor in an associated mineralized matrix deposition although there are 
indications of osteogenic lineage commitment as shown by the increased OSX and BSP 
expression. In conclusion, we can state that, for our experimental set-up, perfusion 
bioreactor culture resulted in expansion rates similar to those obtained in different 
validated cell expansion systems. Additionally, the system did not induce significant 
changes in the expression pattern of the osteogenic and chondrogenic markers analyzed. 
Although small differences in the expression of certain markers were observed between 
different flow rates, these were limited in comparison to the reported increases in 
expression when using osteo- or chondro-inductive media in both static and perfused 
conditions as well as to changes in gene expression in the constructs cultured with bio-
instructive mineralization medium. Perfusion did, however, significantly increase cell 
proliferation and resulted in flow rate-dependent changes in matrix deposition kinetics. 
These results indicate the potential of perfusion bioreactor facilitated stem cell 
expansion. 
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7.1. Abstract 
The use of a 3D perfusion culture environment for stem cell expansion has been shown 
to be beneficial for maintenance of the original cell functionality but due to several 
system inherent characteristics such as the presence of extracellular matrix, the 
continued development and implementation of 3D perfusion bioreactor technologies is 
hampered. Therefore, this study developed a methodology for harvesting a progenitor 
cell population from a 3D open porous culture surface after expansion in a perfusion 
bioreactor and performed a functional characterization of the expanded cells. An initial 
screening showed collagenase to be the most interesting reagent to release the cells 
from the 3D culture surface as it resulted in high yields without compromising cell 
viability. Subsequently a Design of Experiment approach was used to obtain optimized 
3D harvest conditions by assessing the interplay of flow rate, collagenase concentration 
and incubation time on the harvest efficiency, viability and single cell fraction. Cells 
that were recovered with the optimized harvest protocol, by perfusing a 880 U/ml 
collagenase solution for 7 hours at a flow rate of 4 ml/min, were thereafter functionally 
analyzed for their characteristics as expanded progenitor cell population. As both the 
in vitro tri-lineage differentiation capacity and the in vivo bone forming potential were 
maintained after 3D perfusion bioreactor expansion we concluded that the developed 
seeding, culture and harvest processes did not significantly compromise the viability 
and potency of the cells and can contribute to the future development of integrated 
bioprocesses for stem cell expansion.  
7.2. Introduction 
As the field of tissue engineering evolves towards clinical applications, the 
development of well characterized bioprocesses to provide consistent production of 
tissue engineered (TE) advanced therapy medicinal products (ATMPs) becomes 
imperative. However, at current, the production of such ATMPs consists of a series of 
discrete manual unit operations ranging from progenitor cell isolation from donor 
biopsies, to cell expansion and differentiation to achieve those numbers needed for 
therapy and functional TE construct development. Although preliminary studies using 
these manual methodologies have demonstrated the potential of TE ATMPs for in vivo 
tissue regeneration (Roberts et al. 2011, Chai et al. 2012b), closed and integrated 
bioprocesses should be developed to reduce the dependence on operator expertise and 
minimizing risk of contamination. The use of bioreactors is considered to be essential 
for the successful clinical introduction of novel ATMPs in these aspects (Schneider et 
al. 2010, Salter et al. 2012b). Next to contributing to the development of automated, 
controlled and monitored processes, bioreactors also enable the use of 3D cell culture 
substrates which were hypothesized to have beneficial effects on the characteristics of 
the expanding cell population such as enhanced maintenance of the original cell 
phenotype (Banfi et al. 2000, Martin et al. 2004, Scadden 2006, Wagner et al. 2008, 
Haycock 2011).  
The use of perfusion bioreactors, incorporating 3D open porous inert and rigid scaffolds 
as 3D culture substrate for cell expansion, has been associated with significant 
advantages concerning the identity and potency of the resulting cell population 
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(Papadimitropoulos et al. 2014a). In previous studies the ability of cells to grow into 
the third dimension leading to 3D culture surface with filled pores, has been 
demonstrated (Sonnaert et al. 2014a). During 3D growth, cells secrete extracellular 
matrix (ECM) depending, amongst others, on the flow rate employed for cell culture 
(Papantoniou et al. 2014b, Sonnaert et al. 2014a). Even though the presence of a 
supportive ECM has been shown to possess significant advantages concerning 
maintenance of the potency of the expanded cells (Chen et al. 2007, He et al. 2009, Li 
et al. 2011, Pei et al. 2011), cell recovery is significantly impaired, requiring dedicated 
process development and optimization.  
Detachment or dissociation of cells from the culture surface with subsequent retention 
of cell quality is therefore equally important as cell attachment and proliferation, given 
that the product of interest in cell therapy applications is the cell itself (Abbasalizadeh 
et al. 2013, dos Santos et al. 2013).  Despite reports of adverse effects on cell 
characteristics (Wersinger et al. 2004, Mitalipova et al. 2005, Brown et al. 2007), 
trypsin is one of the most widely used reagents for cell recovery and was already used 
for the recovery of cells from microcarrier based expansion systems (dos Santos et al. 
2011b, Rafiq et al. 2013, Nienow et al. 2014) as well as for the digest of primary tissues, 
although often in combination with other enzymes which specifically target the 
collagen containing fraction of the ECM (Jakob et al. 2003, Papadimitropoulos et al. 
2014a). Additionally, various optimization studies for collagenase-based digestion of 
primary tissues such as cartilage are available indicating the feasibility of a trypsin free 
approach although no detailed reports are available regarding the recovery of cells from 
3D culture surfaces (Oseni et al. 2013, Centola et al. 2014, Lau et al. 2014).  
Functional characterization of the expanded and recovered cell population is imperative 
to assess the relevance of the developed processes. Current approaches focus mainly on 
the in vitro characterization which enables the potential classification of the expanded 
population as being an adult mesenchymal stromal stem cell population (Eibes et al. 
2010, Bianco et al. 2013, Rafiq et al. 2013, Zhou et al. 2013a, Nienow et al. 2014, 
Papadimitropoulos et al. 2014a, Sonnaert et al. 2014a). However, the final goal of these 
expansion processes is to obtain a progenitor cell population which can contribute to 
the development of an in vivo functional tissue. Therefore not only the post expansion 
characterization but also the functional in vivo assessment of the expanded cell 
population is critical (Bianco et al. 2013). 
In this work we expanded human periosteum derived cells (hPDCs) in a 3D flow-
through perfusion bioreactor (Sonnaert et al. 2014a) and monitored their growth non-
destructively using the Presto Blue metabolic assay (Sonnaert et al. 2014b). Upon 
confluence, as was confirmed by contrast enhanced X-ray nano-computed tomography 
(CE-nanoCT), a range of cell recovery reagents was assessed. Subsequently the most 
efficient harvest reagent was selected and for the harvest protocol was further optimized 
for the reagent concentration, flow rate used for detachment and harvest time leading 
to maximal cell viability and harvested single cell yield based on a Design of 
Experiment (DoE) approach. Finally, the functionality of the expanded progenitor cell 
population was defined using a combination of in vitro and in vivo proliferation, 
differentiation and bone forming assays. 
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7.3. Materials and Methods 
7.3.1. Human periosteum-derived cells 
hPDCs were isolated from periosteal biopsies obtained from 4 different donors (age 11, 
13, 14 and 17, equal distribution of gender) as described previously and pooled for 
further use (Eyckmans et al. 2006a). This procedure was approved by the ethics 
committee for Human Medical Research KU Leuven (ML7861). Patient informed 
written consent was provided by the legal guardian. hPDCs were expanded in 
Dulbecco’s modified Eagle’s medium with high-glucose (Life Technologies) 
containing 10% fetal bovine serum (FBS, Gibco), 1% sodium pyruvate (Life 
Technologies) and 1% antibiotic–antimycotic (100 units/mL penicillin, 100 mg/mL 
streptomycin, and 0.25 mg/mL amphotericin B; Life Technologies), further mentioned 
as culture medium (CM). The cells were seeded at 5,700 cells/cm² and passaged at 
80%–90% confluency. Cell expansion was performed in standard cell culture 
conditions (relative humidity: 95%, 5% CO2, 37°C). 
7.3.2. Ti6Al4V scaffolds 
For 3D perfusion bioreactor cell expansion, additive manufactured Ti6Al4V scaffolds 
(Ø = 6 mm, h = 6 mm) (Van Bael et al. 2011, Pyka et al. 2012) were used as described 
before (Papantoniou et al. 2014a, Papantoniou et al. 2014b, Sonnaert et al. 2014a, 
Sonnaert et al. 2014b). The total volume of the scaffolds was 166 ± 3 mm³, the available 
volume 130 ± 5 mm³ and the available surface 7.5 ± 0.6 mm² as determined with µCT 
(Kerckhofs et al. 2013a). Scaffolds were cleaned and prepared for experiments as 
described before (Papantoniou et al. 2014a, Papantoniou et al. 2014b, Sonnaert et al. 
2014a, Sonnaert et al. 2014b).  
7.3.3. Scaffold seeding and culture 
Prior to the 3D culture experiments cells were harvested at passage 6 using Triple 
Express (Life Technologies) and drop-seeded onto the scaffolds at a final density of 
120,000 cells per scaffold (Papantoniou et al. 2014a, Papantoniou et al. 2014b, Sonnaert 
et al. 2014a, Sonnaert et al. 2014b). Scaffold-cell constructs were incubated overnight 
in standard culture conditions resulting in an initial cell density of 17,100 cells/cm² or 
700,000 cells/cm³. 
For cell expansion, seeded constructs were inserted in an in-house developed perfusion 
bioreactor system consisting of an interconnected bioreactor chamber and a medium 
reservoir (Papantoniou et al. 2014a, Papantoniou et al. 2014b, Sonnaert et al. 2014a, 
Sonnaert et al. 2014b). A total volume of 10 ml CM was perfused at a constant flow 
rate of 1 ml/min. CM was refreshed every two days by attaching a new medium 
reservoir containing 10 ml fresh CM. 
7.3.4. Presto Blue measurement 
To monitor cell growth, a Presto Blue (PB, Life Technologies) measurement was 
performed every second day on quadruplicate samples as described earlier for a period 
of 17 days (Sonnaert et al. 2014b).  5 ml of a 9% solution was perfused for 2 hours at 
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1 ml/min after which three 100 µl samples were taken from each unit and the 
fluorescent signal was measured with a Synergy HT Multi-Mode Microplate Reader 
(Biotek) using an excitation wavelength of 544 nm and an emission wavelength of 590 
nm (Sonnaert et al. 2014b). The measured fluorescent signal was expressed as arbitrary 
fluorescent units (FU).  
7.3.5. Calcein Acetoxymethyl staining 
A Calcein acetoxymethyl (AM) staining was used to qualitatively visualize the 
distribution of live cells by optical fluorescent microscopy. At day 3, 8 and 15, 
representative cell loaded scaffolds (based on PB measurements) were imaged. 
Constructs were rinsed with 1 ml phosphate buffered saline (PBS) after which they 
were incubated in the staining solution (0.5 µl of a 4 mM Calcein AM in anhydrous 
dimethylsulfoxide solution, Life technologies) for 20 min in normal cell culture 
conditions. The constructs were imaged using a Leica M165 FC microscope. 
7.3.6. Contrast enhanced nano computed X-ray 
tomography of cell expansion constructs 
Cell - ECM structure developed during the expansion (further mentioned as neo-tissue) 
was visualized using contrast enhanced CE-nanoCT (Kerckhofs et al. 2013b, 
Papantoniou et al. 2014b, Sonnaert et al. 2014a). Prior to staining constructs were fixed 
in a 4% paraformaldehyde solution (Sigma) for 2 hours. To enable visualization of the 
neo-tissue, constructs were stained with a 60% Hexabrix® 320 solution (Guerbet) for 
20 min (Papantoniou et al. 2014b, Sonnaert et al. 2014a). A Phoenix NanoTom S (GE 
Measurement and Control Solutions) with a 180 kV/15 W high-performance nanofocus 
X-ray tube was used with a tungsten target, which was operated at a voltage of 90 kV 
and a current of 170 µA. An aluminum and copper filter, both 1 mm thick, were used 
to reduce beam hardening and metal artefacts. The exposure time was 500 ms, a frame 
averaging of 1 and image skip of 0 were applied, resulting in a scanning time of 20 min. 
The obtained radiographic images were reconstructed using Phoenix Datos|X (GE 
Measurement and Control Solutions). The reconstructed images had an isotropic voxel 
size of 3.75 µm (Papantoniou et al. 2014b, Sonnaert et al. 2014a). 
7.3.7. Cell harvest 
For the use of the StemPro® Accutase® Cell Dissociation Reagent (Life Technologies) 
or 0.05% Trypsin – ethylenediaminetetraacetic acid (EDTA) solution (Life 
Technologies) the bioreactor circuits were first rinsed with Phosphate buffered saline 
(PBS, Life Technologies) to remove all FBS remnants. Cell harvest using the Accutase® 
solution was performed at a flow rate of 1ml/min up to one hour at 37°C or up to 6 
hours at room temperature (incubation times and temperatures according to the 
manufacturer’s instructions for cell recovery and tissue dissociation). The trypsin 
solution was applied up to 40 min at 37°C at 1ml/min. For the collagenase IV solution 
(Life Technologies) a 440U/ml solution in CM was perfused at 1ml/min up to 13 hours 
at 37°C as was also performed for the initial digest of the periosteum (Eyckmans et al. 
2006b). Harvest efficiency was determined based on DNA measurements on the 
scaffolds after harvest and on the resulting cell suspension as described further. 
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Scaffolds that did not receive any harvest treatment were used as a control. All 
conditions were performed in triplicate on constructs expanded for 13 days.   
A DoE approach was used to further optimize the cell harvest procedure using the 
Collagenase IV solution. In order to determine the influence of incubation time, 
concentration and flow rate on the cell yield and the viability of the harvested cell 
population a 3-level, 3-parameter fractional factorial design was used resulting in 9 
combinations of the aforementioned parameters as shown in Table 7.1. The assessed 
range of flow rates was selected based upon pervious work where we showed that no 
significant influence of the fluid flow could be observed on cell proliferation between 
0.04ml/min and 4ml/min (Sonnaert et al. 2014a). As the preliminary screening 
experiment for Collagenase IV showed no significant increase in cell yield after 7 hours 
this was selected as the maximal incubation time. Additionally, no negative influence 
of the used setup was observed on cell viability. Therefore, the assessed preliminary 
concentration was selected as the low value for the DoE to achieve potential higher 
yields using shorter incubation times using higher concentrations. Harvest efficiency 
was determined both based on DNA measurements and by using a hemocytometer in 
combination with trypan blue staining, thereby enabling to determine the viability of 
the resulting cell suspension. Each measurement was performed on triplicate samples 
obtained from 13 day cultured constructs.  
For the functional characterization of the expanded cell population the optimal harvest 
condition as determined by the DoE was used. A total of 20 expansion constructs was 
cultured for 13 days and resulting cell suspensions were pooled for functional 
characterization of the harvested cells. 
7.3.8. DNA measurement 
The DNA content of samples was determined using a highly quantitative and selective 
DNA assay (Quant-iTTM dsDNA HS kit, Life Technologies). The constructs were 
Table 7.1: Experimental conditions used for optimization of Collagenase IV harvest of 
the expanded cells according to a 3-parameter, 3-level fractional factorial design. 
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rinsed with PBS and lysed in 350 µl RLT lysis buffer (Qiagen) supplemented with 3.5 
µl β-mercaptoethanol after which the lysed samples were vortexed for 60 s and stored 
at -80°C. Prior to analysis, the samples were thawed at room temperature and spun 
down for 1 min at 13,000 rpm. 10 µl of the sample was diluted in 90 µl milliQ water 
after which the DNA content was quantified with a Qubit® Fluorometer (Life 
Technologies) (Chen et al. 2012). For measurement of DNA content of the cell 
suspensions resulting from the harvest procedure the cells were rinsed with PBS and 
re-suspended in 350 µl RLT lysis buffer supplemented with 3.5 µl β-mercaptoethanol. 
Further processing for the DNA measurements was identical as described for the 
constructs.  
7.3.9. Proliferation assay 
In order to determine the proliferative capacity of cells expanded in the 3D perfusion 
bioreactor cells were seeded at a density of 10,000 cells/well in a standard 24-well cell 
culture plate (Nunc) and cultured for 6 days in CM (n=4). Proliferation was monitored 
daily using the Presto Blue metabolic assay by replacing the growth medium with 0.5ml 
of a 9% Presto Blue solution and incubating for 2 hours. The resulting fluorescent signal 
was subsequently measured as described before. 2D expanded cells were used as 
control.  
7.3.10. Osteogenic differentiation assay 
Both 2D and 3D expanded cells were seeded at 4,500 cells/cm² in quadruplicate wells 
and were allowed to proliferate for 2 days prior to adding osteogenic inductive medium 
(CM supplemented with 100 nM Dexamethasone, 50 µg/ml ascorbic acid and 10 mM 
β-glycerolphosphate (All from Sigma)) which was subsequently refreshed every two 
days for 21 days (Roberts et al. 2014). Cultures were subsequently rinsed with PBS, 
fixed with 4% formaldehyde and rinsed with distilled water prior to staining with 
alizarin red solution (pH 4.2) for 60 min. Non-specific staining was removed by 
extensive rinsing with distilled water after which the calcium deposits were quantified 
by dissolving the bound dye with 10% cetylpyridinium chloride (in distilled water) for 
60 min and measuring the absorbance of the resulting solution at 570 nm.  
7.3.11. Chondrogenic differentiation assay 
The chondrogenic differentiation capacity of the 3D and 2D expanded hPDCs was 
determined based on a micromass assay as described earlier (Roberts et al. 2014). 
Briefly, quadruplicate 10 µl micro-masses containing 200,000 cells each were made in 
24-well plates for both 2D and 3D expanded cells and incubated overnight in CM. 
Subsequently the medium was replaced by chondrogenic inductive medium based on 
DMEM-F12 (Life Technologies) supplemented with 2% FBS, 1% antibiotic–
antimycotic, 1X insulin, transferrin, selenous acid (ITS+) Premix universal Culture 
Supplement (Corning), 100 nM Dexamethasone, 10 µM Y27632 (Axonmedchem), 50 
µg/ml Ascorbic Acid, 40 µg/ml Proline (Sigma) and 10 ng/ml transforming growth 
factor beta 1 (TGFβ1) (Peprotech) (Roberts et al. 2014).  Chondrogenic medium was 
refreshed every 2 days for 7 days after which the micro-masses were rinsed with PBS 
and fixed with ice cold methanol for 1 hour at 4°C. Subsequent rinsing steps with PBS 
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and MiliQ water were followed by staining for 1 hour with a 0.1% Alcian Blue solution 
(in 0.1 M HCl). Non-specific dye was thereafter removed and a 6M guanidine 
hydrochloride solution was added overnight to dissolve the dye bound to the 
glycosaminoglycans present and quantification was performed by measuring the 
resulting absorbance at 620nm.  
7.3.12. Adipogenic differentiation assay 
2D and 3D expanded cells were seeded at a density of 10,000 cells/cm² in 24-well plates 
in quadruplicate and incubated overnight in CM. Subsequently medium was replaced 
by adipogenic inductive medium based on αMEM (Life technologies) supplemented 
with 10% FBS, 1% antibiotic–antimycotic, 1µ M Dexamethasone, 10 µg/ml human 
insulin, 100 µM indomethacin and 25 µM 3-Isobutyl-1-methylcanthine (all from 
Sigma) (Roberts et al. 2014). Medium was refreshed every 2 days for a total duration 
of 14 days after which the cultures were rinsed with PBS and fixed with a 10% 
formaldehyde solution for 30 min. Plates were subsequently rinsed twice with PBS and 
dried at room temperature prior to adding the Oil red O staining solution (0.2% Oil Red 
O in a 60% Isopropanol solution). Samples were stained for 1 hour after which the 
staining solution was removed, rinsed with PBS to remove non-specific staining and 
destained for quantification at 492 nm with pure isopropanol.  
7.3.13. In vivo ectopic implantation 
In vivo bone forming capacity was evaluated using an ectopic implantation model 
(Roberts et al. 2011). NuOssTM, a porous bone mineral matrix material (ACE surgical 
Sypply CO), and Bio-Oss®, a bone substitute for regenerative dentistry (Geistlich), 
were used as a scaffold material. Cylindrical scaffolds with a diameter and height of 3 
mm were punched out of the raw material and drop seeded with 1,000,000 2D or 3D 
expanded cells in a volume of 25 µl (n=3 or 4 respectively for the Bio-Oss® and 
NuOssTM scaffolds). Scaffolds were incubated overnight at 37°C in 3 ml of CM to allow 
cell attachment after which they were implanted ectopically in the back at the cervical 
region and the lower back of female NMRI-nu/nu mice as described previously [2]. 
Empty scaffolds were implanted as negative control. The total of 21 scaffolds were 
randomly distributed between the 6 experimental animals and grouped per scaffold 
type. The implants were collected after 8 weeks of implantation and fixed in 4% 
paraformaldehyde. The animals were sacrificed using cervical dislocation. The volume 
of mineralized tissue in the explants was quantified using nanoCT as described further 
on, after which they were decalcified in EDTA/PBS (pH 7.5) for 14 days, embedded in 
paraffin and processed for haematoxylin and eosin (H&E) as well as Masson’s 
Trichrome staining. All procedures on animal experiments were approved by the local 
ethical committee for Animal Research, KU Leuven (P171-2011). The animals were 
housed according to the guidelines of the Animalium Leuven (KU Leuven). 
7.3.14. nanoCT based quantification of mineralized tissue 
volume 
For visualization and quantification of the mineralized tissue volume the same system 
was used as for the neo-tissue visualization in the perfusion bioreactor expanded 
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constructs but the tungsten target was operated at a voltage of 60 kV and a current of 
210 µA. A 1 mm thick aluminum filter was used to reduce beam hardening and the 
isentropic voxel size was 3µm.   
The resulting transaxial images were analyzed by CTAn (Skyscan NV). Images were 
segmented into three distinct phases (background, mineralized tissue and scaffold 
grains) using a 2-Level, 3D multilevel Otsu algorithm generating grayscale images with 
distinct grayscale values for each fraction. A global threshold was applied to select the 
scaffold fraction upon which a closing of 1 voxel was applied in combination with a 
despeckling operation of 200 voxels (black and white) to remove image noise prior to 
analysis of the scaffold volume. In order to prevent edge effects and the correlated 
partial volume effect from influencing quantification of the bone volume the selected 
scaffold fraction was subsequently dilatated with 1 voxel and subsequently subtracted 
from the original grayscale images. The grayscales corresponding with the newly 
formed bone were selected and image noise was removed as performed for the scaffold 
fraction prior to volumetric analysis. 
7.3.15. Statistical analysis 
Student t-test was performed to analyse significant differences between individual 
conditions for data not analysed in the DoE using Statistica 7 (Statsoft). A p-value < 
0.05 was considered significant. 
7.4. Results 
7.4.1. Perfusion bioreactor facilitated cell expansion 
The Presto Blue metabolic assay was used to monitor hPDC population proliferation 
during bioreactor expansion in correspondence with earlier published work (Sonnaert 
et al. 2014b). A strong increase in metabolic activity was observed during the first 10 
days of culture which thereafter levelled off at day 13 to subsequently decreased 
towards day 17 as shown in Figure 7.1. Both Calcein AM staining and CE-nanoCT 
showed that 3D cell growth and ECM deposition gradually filled the voids on the 3D 
culture substrate, resulting in filled pores towards day 15. Based on the Presto Blue, a 
10 fold expansion of the initial cell population was obtained at day 13 with an average 
cell density of 9,200 cells/mm³ or 1,200,000 cells/construct.  
7.4.2. Reagent screening for cell harvest  
DNA measurements on the scaffolds after harvest showed a significant decrease of cells 
attached to the 3D culture substrate in function of time for all 3 harvest reagents (Figure 
7.2). Despite the significant, time dependent, decrease in cells remaining on the 
scaffolds, DNA measurement on the harvested cell suspension did not showed a 
significant recovery of cells using trypsin (Figure 7.2.A). Accutase® enabled the 
recovery of approximately 23% of cells after 15 minutes of incubation but no time-
dependent increase in yield was observed at 37°C. Subsequent testing for longer 
incubation times at room temperature resulted in significant cell loss (Figure 7.2.B). 
Using collagenase IV a significant increase in cell recovery up to 76% was observed 
up to 7 hours of incubation. Prolonged incubation did not result in further significant 
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increases of cell yield and no cell loss was either observed (Figure 7.2.C). Therefore 
collagenase IV was chosen as reagent for harvest optimization.  
Figure 7.1: Perfusion bioreactor facilitated expansion. 
(A) Presto Blue based metabolic activity of perfusion bioreactor expanded constructs 
(n=4). (B) Contrast Enhanced nano-Computed X-ray Tomography images of constructs 
at day 3, 8 and 15. Scale bar is 1 mm (C) Calcein AM staining of perfusion bioreactor 
expanded constructs at day 3, 8 and 15. Scale bar is 1mm. 
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Figure 7.2: Harvest efficiency for different treatment protocols. 
Harvest efficiency for different treatment protocols as determined by DNA 
measurements and shown relative in comparison to non-treated constructs (DNA 
control). Grey bars depict fraction of the cells remaining on the scaffold, black bars the 
recovered cell fraction. (A) 0.05% Trypsin  - EDTA treatment (B) Accutase treatment 
at 37°C or room temperature (RT) (C) 440 U/ml Collagenase IV treatment. Significant 
differences in DNA content of the constructs after treatment in comparison to the DNA 
control are depicted with *(0.05>p>0.01), ** (0.01>p>0.001) and ***(0.001>p). 
Significant differences in DNA content of the recovered cell fraction in comparison to 
what was obtained at the first time point for each treatment are depicted with $. n=4 for 
all measurements. 
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Figure 7.3: DoE analysis of harvest optimisation study using collagenase IV. 
(A-D) Pareto chart of standardised effects and (E-H) 3D surface plots for respectively 
(left to right) Cell viability, Harvest yield as determined with DNA measurements, 
Single cell yield determined by hemocytometer, Single cell content of the recovered 
cell suspension. 
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7.4.3. Dynamic harvest optimization 
A 3-level, 3-parameter fractional factorial design (Table 7.1) was employed to study 
the (i) influence of incubation time, (ii) flow rate and (iii) concentration of collagenase 
IV on 3D dynamic harvest efficiency. The incubation time did not influence the 
viability of the harvested cells (Figure 7.3.A and E). Additionally, neither collagenase 
concentration, nor shear stress due to fluid flow were shown to have an influence on 
the viability of the harvested cell population which was on average 96 ± 2 %. Both 
incubation time and collagenase concentration significantly increased cell recovery as 
determined by DNA measurements (Figure 7.3.B and F). Flow rate was not shown to 
influence the overall harvest efficiency within the examined range. Incubation time, 
flow rate and concentration (ranked in order of importance) did however have a 
significantly positive effect on the single cell yield as determined by manual cell 
counting (using a hemocytometer) (Figure 7.3.C and G). As for certain conditions the 
presence of cell aggregates was observed in the recovered cell fraction the single cell 
fraction was also quantified and shown to be positively influenced by an increase in 
incubation time and flow rate (Figure 7.3.D and H).  
7.4.4. In vitro functional assessment of the harvested 
hPDC population 
Harvested cells were seeded in well plates to investigate their proliferative potential. 
The Presto Blue assay was used to monitor cell growth over time showing a 
significantly lower metabolic activity in the proliferation assay for the 3D expanded 
cells (Figure 7.4). The profile of the growth curves was however similar for the duration 
of the proliferation assay. 
Post-harvest tri-lineage differentiation assays showed that the dynamically 3D 
expanded and harvested cells maintained their in vitro differentiation capacity as shown 
in Figure 7.5. For the osteogenic differentiation assay a significantly higher amount of  
Figure 7.4: in vitro proliferation assay  
Metabolic activity during 2D proliferation assay of 2D and 3D expanded cells as 
measured with the Presto Blue®. n=4 
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Figure 7.5: In vitro functional assessment of the harvested cells 
(A) Quantification of the calcium depositions in the osteogenic differentiation assay using 
Alizarin red absorbance at 570nm. (B-D) Alizarin red staining of osteogenic induced hPDCs 
subsequent to (B) 2D expansion or (C) 3D expansion and (D) non-induced control from 2D 
expanded cells. (E) Quantification of the glycosaminoglycan deposition in the micromass 
based chondrogenic differentiation assay using Alcian blue absorbance at 620nm. (F-H) 
Alcian Blue staining of chondrogenic induced hPDC micromass systems subsequent to (F) 
2D expansion or (G) 3D expansion and (H) non induced control from 2D expanded cells. (I) 
Quantification of the lipid globules formed in the adipogenic differentiation assay using Oil 
Red O absorbance at 492nm. (J-L) Oil Red-O staining of adipogenic induced hPDCs 
subsequent to (J) 2D expansion or (K) 3D expansion and (L) non induced control from 2D 
expanded cells. 3D expanded cells were recovered using a 880U/ml collagenase IV solution 
for 7 hours at a flow rate of 4ml/min.  n=4 for all samples. Scale bar is 100µm. 
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mineral deposits was observed in comparison to the 2D expanded cells as well as to the 
negative control as shown after quantification of the alizarin red staining (Figure 7.5.A). 
Gycosaminoglycan accumulation induced by chondrogenic differentiation in the 
micromass system was lower than what was observed for the 2D expanded cells though 
still significantly higher than for the negative control (Figure 7.5.E). Both 2D and 3D 
expanded cells also showed a significant capacity for adipogenic differentiation as 
shown by the lipid globule deposition visualized by Oil Red-O staining and no 
significant differences were observed between both culture conditions (Figure 7.5.I).  
7.4.5.  In vivo functional assessment  
The in vivo bone forming functionality of the expanded hPDC population was evaluated 
in an established ectopic bone formation model using calcium phosphate – collagen 
based scaffolds (Roberts et al. 2011). Both in Bio-Oss® and NuOssTM significant bone 
formation was observed as determined with H&E and Masson’s Trichrome staining 
(Figure 7.6). Quantification of the bone volume was performed based on nanoCT 
analysis (Figure 7.7.A and B) and showed no significant differences between 2D and 
3D expanded cells for both scaffold types. Respectively 4.25% and 12.1 % of the 
available volume were filled with bone in the Bio-Oss® and NuOssTM scaffolds (Figure 
7.7.C). No significant bone formation could be observed in the non-cell seeded controls 
for both materials as can be observed in the histological sections (Figure 7.6). CT-based 
quantification of the mineralized tissue could therefore also not be performed on these 
samples.   
7.5. Discussion 
Despite the need for the development of methods for cell recovery from 3D cell culture 
substrates this still remains a largely unexplored field (Abbasalizadeh et al. 2013, dos 
Santos et al. 2013). Although recently the use of microcarrier based expansion systems 
has started to receive more attention, differences between these and other culture setups 
hamper the translation of existing harvest techniques across setups (Abbasalizadeh et 
al. 2013). We therefore developed and optimized a dynamic methodology that enabled 
the recovery of cells from a 3D culture substrate after which the functional 
characteristics of the expanded cell population was assessed and compared to 
established 2D cultured cells. 
Using metabolic activity measurements, which are directly correlated with the total cell 
number (Sonnaert et al. 2014b),  the time-point for cell recovery was set at 13 days to 
ensure maximum cell expansion and prevent over-confluence (Figure 7.1). Both the 
Calcein AM staining and the CE-nanoCT showed that the 3D culture environment was 
gradually being filled by cells and ECM resulting in 3D confluency by day 15 where 
no further hPDC expansion was expected (Papantoniou et al. 2014b, Sonnaert et al. 
2014a). The decrease of metabolic activity measurements at subsequent time points 
further indicated that cell growth ceased at this time point. 
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Figure 7.6: Histological analysis of explants obtained after the in vivo functional assessment 
of harvested cells. 
Histological sections (H&E, H&E autofluorescence and Masson’s Trichrome) from Bio-Oss 
and NuOss constructs seeded with 2D and perfusion bioreactor expanded hPDCs respectively 
as well as the non-cell seeded controls after 8 weeks of in vivo. Asterisks indicate remaining 
Calcium Phosphate grains, arrow heads indicate newly formed bone with embedded 
osteocytes. Scale bar is 100 µm.  
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In order to choose the most suitable harvest reagent for cell recovery the use of 
Trypsin/EDTA, Accutase® and collagenase IV was evaluated (Figure 7.2). Trypsin and 
Accutase® are commonly used reagents for cell recovery from 2D cell culture substrates 
on which cells grow predominantly in a monolayer such as standard 2D cell expansion 
Figure 7.7: Bone volume analysis using µCT. 
(A and B) sagittal, transaxial and coronal 2D µCT based section of respectively Bio-
Oss (A) and NuOss (B) explant showing CaP grains of the scaffold material (light grey) 
and newly formed bone (dark grey, indicated with white arrow) combined with 3D 
visualization of the processed images showing the newly formed bone (right top). Scale 
bar is 500µm. (C) µCT based quantification of bone formed in the explants after the 
respective implantation periods normalized to the available volume in the scaffold. 3D 
expanded cells were recovered using a 880 U/ml collagenase IV solution for 7 hours at 
a flow rate of 4 ml/min. Scale bar is 100 µm.   n=3 for Bio-Oss constructs, n=4 for 
NuOss constructs. * p<0,05 
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systems or microcarriers (Frauenschuh et al. 2007, Eibes et al. 2010, dos Santos et al. 
2011a, Hewitt et al. 2011, Rafiq et al. 2013). The loss of cells observed using trypsin 
and Accutase® (respectively up to 35% and 57%) could be explained by the mechanism 
by which they act. Both agents are known to specifically cleave peptide chains at the 
carboxyl site of lysine or arginine. They will therefore cleave extracellular proteins as 
well as trans-membrane associated structures leading to the time dependent increase in 
cell loss observed for both solutions. Most setups (always 2D) therefore use a maximal 
incubation time of 10 to 15 minutes (Wersinger et al. 2004, Mitalipova et al. 2005, 
Brown et al. 2007). Additionally, trypsin it is known to be unable to cleave the helical 
structures of the collagen fibers, hence limiting its capacity to degrade the in vitro 
deposited collagen. As this is a major constituent of the ECM its application for cell 
recovery from a 3D cell culture environment within which abundant ECM is present is 
therefore suboptimal. Prolonging the incubation with trypsin in our system did 
consequently not result in an increased release of the cells from the deposited ECM but, 
as shown in Figure 7.2, only resulted in progressive damage to the expanded cell 
population. The use of a pure collagenolytic solution was expected to prevent this 
proteolytic related cell degradation as these enzymes specifically target the peptide 
bounds in collagen. As this is a major constituent of the ECM but is not present in the 
cell membranes it was successfully used previously for the recovery of primary cells 
from various tissues (De Bari et al. 2001, van Gastel et al. 2012b, Oseni et al. 2013) 
and application in our system resulted in a successful recovery with an overall cell 
recovery efficiency of up to 92% (Figure 7.2.C).  
Expanding further on the successful application of the collagenase IV solution for the 
recovery of single cells from the 3D culture substrate a DoE approach was employed 
to optimize its use. Prolonged exposure to collagenase (between 10 and 24 hrs) was 
previously shown to affect cell viability for the digest of primary tissues (Yonenaga et 
al. 2010, Oseni et al. 2013), and as the strongest increase in yield was observed during 
the first 7 hours in the screening experiments (Figure 7.2.C), this was chosen as the 
maximal incubation time for the DoE study. None of the studied parameters showed a 
linear influence on the viability of the recovered cell population within the examined 
operating window which was on average 96% (Figure 7.3.A and E). Concentration and 
incubation time were shown to have a significant effect on both overall harvest 
efficiency and single cell yield while flow rate only had a significant positive effect on 
the single cell yield (Figure 7.3.B, C, F and G).  The single cell fraction was positively 
influenced by a high incubation time and flow rate resulting in a continued dissociation 
of the aggregates into a single cell suspension as was shown earlier for different stem 
cell aggregate systems (Figure 7.3.D and H)(Papantoniou et al. 2011). No adverse 
effects related to shear stress on cell viability were observed in accordance with 
previous studies for comparable flow regimes as the maximal shear stress experienced 
by the cells in the tubing was approximately 2 mPa (Zoro et al. 2009, Mulhall et al. 
2011). This was evidenced by unaffected single cell viability while the cumulative 
DNA content of the cells remaining on the 3D culture substrate and in the harvested 
suspension was equal to that of the post expansion, pre-harvest culture environment (as 
also shown in Figure 7.2.C).  
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Despite the fact that no adverse effects of the applied procedure on the cell viability 
were detected the metabolic activity of the hPDCs was significantly decreased after 
replating in comparison to standard 2D expanded cells (Figure 7.4.). Adverse effects of 
prolonged use of a collagenase solution between 10 and 24 hours were reported for the 
digest of primary tissues which could result in a decrease of the metabolic activity of 
the harvested cell population (Yonenaga et al. 2010, Oseni et al. 2013). Recent work 
also showed cells to possess a “mechanical memory” which can influence their 
behavior depending on the previous physical environments used for culture (Yang et 
al. 2014a). The switch from the complex, ECM containing 3D culture environment in 
the perfusion bioreactor system to the standard tissue culture plastic might therefore 
also influence the metabolic activity of the recovered hPDC cell population and might 
result in an initial lower metabolic activity.  
Maintenance of the in vitro differentiation potential of a progenitor cell population 
expanded in bioreactor systems has been reported for several MSC cell sources and was 
also observed in our system (Figure 7.5)(Rafiq et al. 2013, Dos Santos et al. 2014, 
Papadimitropoulos et al. 2014a). The observed increase in calcium depositions and 
decrease in GAG accumulation suggest an osteogenic priming of the expanded cell 
population (Figure 7.5). In previously published work we already hypothesized that the 
shear stress exerted on the cells during expansion might result in osteogenic priming of 
the expanded cell population based on the up regulation of certain gene markers 
associated with osteogenic differentiation which is further substantiated by this data 
(Sonnaert et al. 2014a). Although the 3D perfusion bioreactor expansion of primary 
MSCs was previously shown to result in enhanced in vitro osteo-, chondro- and 
adipogenic differentiation potential as well as an enhanced clonogenicity of freshly 
isolated primary MSCs (Papadimitropoulos et al. 2014a), we only observed an increase 
in osteogenic differentiation (Figure 7.5.A). The cells used for this study were however 
pre-expanded for multiple passages using standard cell culture methodologies, 
including the use of plasma treated polystyrene. This has been correlated with the 
progressive loss of the progenitor cell phenotype and commitment to the osteogenic 
lineage indicating that the differences in post expansion differentiation potential for 
primary cells might originate from an enhanced maintenance of the progenitor cell 
phenotype (Banfi et al. 2000, Scadden 2006, Wagner et al. 2008). The initial 2D 
expansion of the hPDC population used for this work could therefore explain the 
absence of a significant difference in differentiation potential between 2D and 3D 
expanded cells in this culture setup. 
Post expansion cell characterization is currently focused on cell identity as established 
by in vitro assays (Rafiq et al. 2013, Dos Santos et al. 2014, Papadimitropoulos et al. 
2014a) while their functionality as evidenced by their performance in both in vitro and 
in vivo models is largely subsided. Furthermore the lack of such data hinders the 
development of correlations that will eventually allow to link in vitro and in vivo cell 
behavior (Bianco et al. 2013). To the best of our knowledge no reports exist assessing 
the in vivo potency of a progenitor cell population after expansion and recovery in a 
3D bioreactor system despite the need for adequate in vivo controls for the validation 
of these processes (Bianco et al. 2013). We therefore assessed the in vivo bone forming 
capacity of the 3D expanded and recovered cells in a standard ectopic bone formation 
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assay (Roberts et al. 2011). Histological staining showed the clear presence of bone 
spicules in all cell seeded conditions (Figure 7.6). In addition, the presence of bone 
marrow lacunae and blood vessels was unimpaired in comparison to their 2D control 
indicating the unaffected in vivo differentiation capacity of the 3D expanded cells. This 
was further confirmed and quantified by nanoCT analysis where no differences 
between 2D and 3D expanded cells were apparent (Figure 7.7.C) and observed volumes 
of newly formed bone were comparable to what was shown earlier (Roberts et al. 2011).  
In conclusion, we optimized a closed bioprocess enabling the expansion and recovery 
of a viable cell population. The produced cell population showed minor differences in 
its in vitro differentiation potential as compared to the 2D standard while it showed an 
uncompromised bone forming potential upon ectopic implantation. The development 
of this multi-unit integrated bioprocess shows the potential for integrated bioprocess 
development and sets the scene for the continued integrated optimization of current 
manual tissue engineering strategies to a clinical relevant setting. 
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General discussion and future 
perspectives 
8.1. Summary 
The development of cost-effective, scalable and robust processes for stem cell 
expansion will be imperative for the successful translation of current lab-scale TE 
approaches to clinical applications. Integrated bioprocess development, combining 
multiple unit operations in a continuous, closed and controlled culturing strategy, 
thereby negating the need for manual, labor intensive methodologies and circumventing 
various process bottlenecks, is considered to be essential for this clinical translation. 
Within this context bioreactor systems are a powerful enabling technology as these 
permit a high degree of scalability, control and automation. As discussed in the 
introduction of this dissertation a variety of bioreactor systems, each demonstrating 
specific advantages and shortfalls both on the technological and biological aspects of 
the process, are currently under investigation. Although technological advances will be 
essential for successful industrialization, the influence of the in vitro micro-
environment within which the cells reside on their functional characteristics and 
identity will determine the final applicability of the different systems. In order to assess 
the potential use of a 3D perfusion bioreactor system for the expansion of a progenitor 
cell population the primary objective of this dissertation was therefore to elucidate the 
influence of this culture system on the proliferation, differentiation, matrix deposition 
and post-harvest functionality of the expanded cell population. In order to facilitate 
these observations two additional objectives were defined; (i) to enable the quantitative 
monitoring of the cell proliferation within the bioreactor system and (ii) to visualize 
and quantify the neo-tissue formation within the 3D culture environment. A schematic 
representation of the different aspects addressed in this dissertation is shown in Figure 
8.1 and the main findings discussed in the different chapters are concisely summarized 
in the next sections.
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In order to characterize the influence of a range of culture parameters on cell 
proliferation in bioreactor systems the development of quantitative methods for 
monitoring cell number is essential. As non-destructive, direct measurements of cell 
number during the expansion process are largely limited to 2D culture systems, indirect 
methods need to be developed. In this context the use of metabolic assays has been 
suggested as an interesting candidate, although contradicting reports exist regarding its 
quantitative application. Therefore, a quantitative validation of the PB metabolic assay 
was performed showing that indeed a correlation existed between the metabolic 
conversion of the resazurin and the number of cells present in the culture system 
(chapter 3). Depending on the cell culture but also on the measurement setup different 
conversion rates were obtained. Further validation showed these to be correlated to 
differences in the measurement setup rather than to the changes in the in vitro culture 
environment as measurement of samples cultured under different conditions using the 
same measurement setup yielded similar conversion rates. This indicated that changes 
in culture setup (2D to 3D culture and static vs perfusion culture) did not induce 
significant changes in the metabolic activity of the cell population and therefore also 
did not significantly influence cell behavior. This hypothesis was further supported by 
the absence of significant changes in gene expression comparing the 3D static and 
perfusion culture system (chapter 6) as well as the post expansion functionality of cells 
expanded in both culture systems (chapter 7). The established correlations subsequently 
enabled estimating the cell number during the exponential growth phase of the cells 
based on the metabolic measurements within the linear operating window of the system.  
Visualization and quantitative analysis of neo-tissue formation (the combination of 
cells and the deposited ECM) in Ti6Al4V alloy scaffolds was enabled through the 
development of CE-nanoCT. A first proof of concept study (chapter 4) showed the 
potential of visualizing the neo-tissue using two different contrast agents, Hexabrix® 
Figure 8.1: Schematic overview of the various aspects of the 3D perfusion bioreactor 
expansion process addressed in this dissertation.  
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and PTA. Using Hexabrix® a linear correlation between neo-tissue volume and net dry 
weight of the neo-tissue was established suggesting that it enables visualization and 
quantification the full neo-tissue in the scaffold. This was visually confirmed 
comparing the obtained images with established optical techniques such as life/dead 
and picrosirius red staining. Using PTA the comparison between stained neo-tissue 
volume and dry weight suggested that only a fraction of the neo-tissue was visualized 
using this contrast agent. In addition, distinct differences in PTA stained neo-tissue for 
the different experimental conditions hinted that this staining enabled the visualization 
of a specific sub-fraction of the neo-tissue. As intensive manual image processing was 
required for quantitative analysis of the datasets in this proof of concept study a follow 
up study was conducted aimed at the optimization of the staining procedure as well as 
a further validation of both staining agents (chapter 5). Using a DoE approach the 
influence of staining parameters (i.e. incubation time, concentration of the staining 
agent and neo-tissue volume) on image contrast and dataset quality (i.e. the mismatch 
between raw and processed images) was determined. Both for Hexabrix® as well as for 
PTA an increase in concentration of the staining agent resulted in a positive influence 
on the image contrast and consequently also on the image dataset quality. In addition, 
for PTA an increase in neo-tissue volume was also shown to result in an increased 
dataset quality. Using a different scaffold material, Hexabrix® was confirmed to stain 
the entire neo-tissue present in the scaffolds. PTA staining on the other hand was shown 
to result in a concentration dependent degradation of the neo-tissue rather than being a 
staining with a higher specificity as hypothesized based upon the results obtained in the 
proof of concept study discussed in chapter 4. Although the DoE showed high 
concentrations resulted in higher image contrast and dataset quality, PTA should be 
used at low concentrations to prevent significant tissue shrinkage and enable 
quantitative interpretation of the data. No such restrictions are present when using 
Hexabrix® for visualizing the full neo-tissue and based upon the DoE optimal staining 
conditions for quantitative data analysis could be determined. 
In order to determine the influence of the micro-environment created in the 3D 
perfusion bioreactor system a first study elucidating its effects on the proliferation, 
differentiation and ECM formation was conducted (chapter 6). Proliferation was shown 
not to be influenced within the examined range of flow rates but was significantly 
increased in comparison to the 3D static controls. Live/dead staining showed a similar 
neo-tissue distribution at the outside of the scaffolds for both perfused and static culture 
conditions. However, CE-nanoCT enabled the visualization and quantitative analysis 
of the complete neo-tissue and showed that while static cultured constructs mainly 
contained neo-tissue at the outer layers of the scaffolds the perfused conditions resulted 
in densely filled scaffolds which was potentially caused by the enhanced nutrient 
transport in the perfused conditions. Total neo-tissue volume after 4 weeks of culture 
was shown not to be influenced by the flow rate although the neo-tissue deposition 
kinetics were different. Gene expression analysis showed minor differences in the 
expression profile of several osteogenic and chondrogenic marker genes. Comparison 
with the gene expression profile obtained from chemically induced osteogenic 
differentiation in the same bioreactor setups showed that the observed changes in the 
gene expression profile were significantly lower (between 2 and 100 fold) than for the 
124                                                               General discussion and future perspectives 
 
  
chemically induced conditions indicating that the perfusion bioreactor culture does not 
induce full osteogenic differentiation though it might result in an osteogenic priming of 
the cell population.  
To further characterize the influence of the perfusion bioreactor expansion on the cell 
characteristics, post expansion functionality of the progenitor cell population was 
evaluated (chapter 7). Therefore, a method for cell recovery from 3D scaffold based 
cultures was developed and optimized using a DoE approach. An initial screening of 
different reagents showed collagenase to be the most efficient in the recovery of a viable 
cell population which was then used for the optimization study using DoE. This showed 
that the high levels off all three process parameters (i.e. flow rate, concentration and 
incubation time) were beneficial for cell recovery as well as the single cell fraction in 
the recovered cell suspension. In order to determine the time point at which maximal 
expansion was obtained the previously validated PB assay was used to monitor cell 
proliferation while CE-nanoCT was employed to assess the degree of filling and 
provide an estimate on volumetric ‘confluence’. Subsequent functional assessment of 
the recovered cells showed that both the in vitro tri-lineage differentiation potential as 
well as the in vivo bone forming capacity of the cells was maintained post expansion 
and harvest confirming the potential of this system to be used as a tool for cell 
expansion. This was the first systematic investigation of 3D cell harvest from scaffold 
based cultures. Moreover it builds further on the recently expanding field of integrated 
bioprocessing for regenerative medicine, adopting a whole bioprocessing approach 
from ‘vial to patient’. 
8.2. Critical reflections on perfusion bioreactor 
development for tissue engineering 
The results discussed in this dissertation and summarized in the previous section present 
a proof of concept for the use of a 3D perfusion bioreactor system as a tool for the 
expansion of a progenitor cell population. The next section provides some critical 
reflections upon the presented results towards the continued progression of the field to 
clinical relevant processes.
8.2.1. Development of methods for bioprocess monitoring 
and characterization 
The use of metabolic assays for monitoring cell proliferation has already been 
suggested as an interesting approach for monitoring cell proliferation in bioreactor 
systems but contradicting results prevented their quantitative use to date. We 
hypothesized that one of the constraints in earlier published studies was the presence of 
mass transport limitations induced by the high cell densities used (up to 750.000 
cells/cm²) resulting in the reported non-linear behavior (Ng et al. 2005, Quent et al. 
2010). Our results confirmed that indeed diffusion limitations can influence the 
performance of the assay as depending on the mass transport characteristics of the 
measurement setup, changes in the conversion efficiency of the assay were detected. A 
quantitative correlation between assay conversion and cell number could, however, be 
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established given that the measurement setup ensured adequate and homogenous supply 
of the assay to the entire construct.  
Another important aspect to enable the quantitative use of the methodology is the 
homogeneity of the cell population with respect to phenotypic state, both in function of 
time as well as on a given time point. Proliferation of a MSC like population is 
associated with glucose consumption through the glycolytic pathways supporting a 
high degree of nutrient incorporation into the biomass and resulting in high lactate 
production rates. Upon differentiation these cells will switch their metabolism towards 
oxidative phosphorylation requiring higher levels of oxygen but resulting in higher 
energy yields for each processed glucose molecule (Sart et al. 2014a). Detailed 
assessment of cell energy metabolism showed that mitochondrial ATP production 
through oxidative phosphorylation only contributed up to 30% in the total ATP 
generation during cell proliferation while this fraction increased up to 48% during 
osteogenic differentiation and only contributed 13% during chondrogenesis (Pattappa 
et al. 2011). Although the exact mechanism of action for the metabolic conversion of 
the resazurin is not yet clear most authors concur that the reduction to the fluorescent 
resorufin is facilitated by the mitochondrial activity (Nociari et al. 1998, O'Brien et al. 
2000, Quent et al. 2010). As changes in the cellular metabolism impact upon 
mitochondrial activity, this will therefore influence the conversion of the metabolic 
assay. This could also be observed in our results as a decrease in proliferation, and 
therefore a decrease in cellular activity, resulted in a decreased conversion of the assay. 
This prevents a broader application of the developed methodology towards for example 
the monitoring of the maturation of an in vitro developing neo-tissue but, as shown, 
does not impair its use for monitoring cellular proliferation in systems such as the ones 
used in this work which enable the expansion of a cell population without significantly 
influencing its phenotype.  
This thesis presents a significant contribution to the field as no validated methods for 
online monitoring of proliferation in systems with a similar setup were available. In 
addition, it provides a valuable tool for in vitro models and assays for e.g. drug 
compound screening.  As at current, however, no clinical approved version of the assay 
is available its potential for application in clinically relevant systems is limited. The 
implementation of methods used for monitoring large scale fermenters such as oxygen, 
glucose and lactate measurements provide an interesting alternative. Until recently 
however, limited sensitivity of the sensors, required for monitoring the relative low 
number of cells present in systems such as used in this study, considerably restricted 
their application. Advances in sensor technology combined with the development of 
novel monitoring strategies, however, started to address these limitations. This was 
shown for example in a proof of concept study correlating changes in oxygen 
concentration with cell number and PB signal (Lambrechts et al. 2014). Indisputably, 
these methods have the advantage of being in- or on-line and present significant 
advances towards the development of clinically relevant systems. However, they often 
require a significant investment both in equipment as in the implementation in the 
bioreactor systems which on a research scale might be a significant limitation in 
comparison to the use of the PB assay. Moreover, monitoring the concentration of a 
single metabolite focuses on one specific aspect of the energy metabolism of the cells 
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and is associated with the same limitations as the PB metabolic assay concerning 
monitoring of a cell population throughout different stages of proliferation and 
differentiation. Due to the complexity of the pathways involved in the energy 
metabolism no single metabolite can be defined that would enable to monitor cell 
number through various in vitro stages of neo-tissue development. Simultaneous 
monitoring of a number of key metabolites and nutrients such as lactate, glucose, 
glutamate, ammonia, oxygen and carbon dioxide could enable to obtain significant 
insight in the energy metabolism of the cell population and correlate this with cell 
number and differentiation stage. Detailed understanding of the influence of the various 
processes involved in cellular differentiation could enable to use this information to 
define cell state but quantitative definition thereof would require compiling a more 
elaborate metabolic profile of the cell population including not only components 
involved in the energy metabolism but also several key metabolites or molecular 
markers associated with cellular differentiation (Kell et al. 2005, McNamara et al. 
2012). The information obtained from these advanced techniques could significantly 
improve the understanding of the various processes taking place in the bioreactor 
system and their integration in clinical relevant systems might be required in order to 
ensure process compliance with the operating window approved by the regulatory 
agencies. However, large scale implementation of these techniques in research scale 
bioreactors might not be feasible due to economic considerations. 
As discussed, the PB metabolic assay is an interesting candidate as it can provide 
quantitative information on the proliferation of the expanding cell population. During 
this expansion in the 3D system cells will start secreting a supportive ECM. The 
composition of this in vitro developed neo-tissue as well as the kinetics of the matrix 
deposition can provide valuable additional information on the cell population in the 
bioreactor system.  
As mentioned in the introduction of this dissertation different techniques which enable 
3D visualization of the neo-tissue such as confocal tomography, micro-magnetic 
resonance imaging and optical coherence tomography are available (Appel et al. 2013, 
Nam et al. 2014). Restriction on spatial resolution and penetration depth as well as 
limited throughput, however, put significant restraints on the application of these 
techniques as a tool for online monitoring (Georgakoudi et al. 2008, Appel et al. 2013, 
Nam et al. 2014). In this respect the development of the CE-nanoCT provides a 
significant addition to the field of non-destructive 3D imaging as the combined high 
penetration depth and resolution enable quantitative analysis on the in vitro developed 
neo-tissue. In addition to volumetric analysis, the use of contrast agents with 
composition dependent staining specificity could also enable their use for 
compositional analysis towards the development of non-destructive 3D histology 
(Pauwels et al. 2013, Gignac et al. 2014, Kerckhofs et al. 2014). As the tissue specific 
binding mechanism of several of these contrast agents is, however, still unknown, 
extensive experimental validation of these techniques is still required. In addition, the 
influence of the staining procedure and contrast agent on the neo-tissue integrity needs 
to be assessed in detail as we for example showed that PTA, a contrast agent frequently 
reported in literature in the context of the staining of embryos (Pauwels et al. 2013), 
can significantly influence the integrity of the stained neo-tissue. 
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The use of this technique for the characterization of the in vitro developed neo-tissue 
will enable to obtain a better understanding of the cellular processes progressing during 
3D in vitro cell expansion and construct development. At the same time it also addresses 
a significant need in the regenerative medicine field for non-destructive tools for quality 
control of engineered tissues. Regulatory requirements for clinical applications will 
entail to show process and product consistency within a clearly defined operating 
window in order to meet the final release criteria for the product. The availablility of 
non-destructive, quantitative methods for 3D characterization of these products such as 
CE-nanoCT will therefore be imperative. In this respect, enabling online monitoring of 
neo-tissue formation and construct development could even further improve the 
applicability of the methodology as it would enable early fault detection. In addition, it 
could enhance the understanding of the cellular processes during expansion in the 
bioreactor and create new opportunities for further optimization of the methodology. 
Depending on the contrast agents used this could not only provide information on the 
kinetics of the neo-tissue formation but potentially also on tissue composition which 
could, in combination with results obtained from the PB metabolic assay, be used as an 
indication of tissue maturation and cell differentiation. Although X-ray toxicity due to 
prolonged or repeated exposure is a significant concern for the in- and on-line 
application of this methodology, various studies on in vivo and in vitro monitoring of 
mineralization confirm the feasibility (Porter et al. 2007, van Lenthe et al. 2007, 
Hagenmuller et al. 2010, Laperre et al. 2011, Beck et al. 2013, Appel et al. 2015) 
8.2.2. Engineering a supportive in vitro micro-
environment for progenitor cell expansion 
The above mentioned novel techniques were, in combination with a range of 
established methods, subsequently used to characterize the influence of the perfusion 
bioreactor facilitated cell expansion on cell behavior and potency. Our results indicated 
that within the used operating window the in vitro micro-environment to which the cells 
were exposed did not significantly influence the functionality of the expanding cell 
population. Despite the hypothesized advantages of a 3D culture system on the 
maintenance of progenitor cell potency only limited differences were observed in 
comparison to standard 2D cell expansion. The cells used for this work were, however, 
already pre-expanded for multiple passages using standard cell culture methodologies 
which probably already resulted in the progressive loss of progenitor cell phenotype 
and potency as discussed earlier in this dissertation (Banfi et al. 2000, Scadden 2006, 
Wagner et al. 2008).
Secondly, the rationale behind the use of a 3D environment for progenitor cell 
expansion was to create a micro-environment which more closely resembles the native 
cell niche and therefore better supports the maintenance of cell phenotype. Although 
the use of a Ti6Al4V based 3D scaffold enabled us to study the influence of the fluid 
flow induced SS on the cell behavior during and after expansion the relevance of this 
scaffold system in respect to the native cell niche is limited. Additionally, the use of 
artificial substrates for cell culture has been shown to influence cell identity and 
functionality potentially resulting in spontaneous (de)differentiation, replication 
senescence,… (Banfi et al. 2000, Scadden 2006, Wagner et al. 2008). In an attempt to 
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prevent or limit these in vitro culture induced artefacts different strategies for 
engineering an in vitro cell niche in which the combination of different active 
components such as fibronectin and collagen could result in a more supportive cell 
culture environment have been assessed (Chen et al. 2007, Abraham et al. 2010, Sadr 
et al. 2012). Due to the complex nature of the native environment of the cells successes 
using these approaches have been limited. Rather than isolating a defined set of active 
components, a decellularized version of the native ECM in which the cells reside is 
hypothesized to be another interesting candidate to enable maintenance of the original 
cell characteristics (Scadden 2006). As these materials are, however, difficult to obtain, 
engineering strategies in which a cell deposited ECM was used as cell culture substrate 
are being evaluated (He et al. 2009, Seib et al. 2009, Lai et al. 2010, Thibault et al. 
2010, Pei et al. 2011, Prewitz et al. 2013). Different successes reporting enhanced 
proliferation (Chen et al. 2007, He et al. 2009, Li et al. 2011, Pei et al. 2011, Pattabhi 
et al. 2014), differentiation (Chen et al. 2007, He et al. 2009, Lai et al. 2010, Li et al. 
2011, Pei et al. 2011) and construct development (Pham et al. 2008, Thibault et al. 
2010, Sadr et al. 2012) show the potential of this strategy. Further exploration of this 
approach for the development of functional constructs is ongoing (Papadimitropoulos 
et al. 2014b) but the use of these decellularized, ECM based materials for cell expansion 
is less explored and could result in significant changes in cell behavior. 
Next to cell culture surface a range of other parameters associated with standard cell 
expansion methodologies result in a micro-environment which is significantly different 
from the native niche. The ambient air currently used for cell culture is for example 
significantly different from the oxygen concentrations present in the MSC niche which 
ranges between 2 and 8% (Mohyeldin et al. 2010). Hypoxic culturing conditions 
(oxygen concentrations under 2%) have been shown to result in significant decreases 
in proliferation and differentiation of MSCs while normoxic culture (oxygen 
concentrations between 2 and 8%) was shown to enhance proliferation and maintenance 
of stemness as well as influence the differentiation towards the different MSC lineages 
(Mohyeldin et al. 2010, Sheehy et al. 2012). Next to the oxygen concentration used 
during cell culture another important aspect of the extracellular micro-environment 
during in vitro culture is the medium composition. At current irradiated fetal bovine 
serum is a standard supplement for the culture of human derived cells. Although its use 
is still accepted by the European medicine agency, the large inter-batch variability can 
result in significant changes in cellular behavior and, combined with the associated risk 
for zoonosis, limits its applicability in clinically relevant processes (Heathman et al. 
2015). Recent advances have shown human platelet lysate to be a valuable alternative 
to the use of animal derived products although also here the inter-batch variability 
remains a limiting factor (Schallmoser et al. 2007, Bieback et al. 2009, Hofbauer et al. 
2014). The development of standardized, chemically defined media is therefore still a 
priority (Mannello et al. 2007, Jung et al. 2012a, Bieback 2013). 
8.2.3. Integrated bioprocess development 
Although the optimization of the expansion micro-environment, and thereby the 
expansion process, is essential for the performance of this process step, its 
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implementation within ‘whole’ bioprocess schemes will be imperative for its future 
industrial applicability.  
To date, most methods for large scale cell expansion are based upon systems with a 
high surface to volume ratio such as hollow fiber bioreactor systems or micro-carrier 
based setups. Due to the predominant 2D cell growth in these systems, enzymatic 
methods for cell recovery subsequent to the expansion are closely related to the 
procedures used in the standard 2D expansion setups and require only limited 
optimization. The added complexity in 3D culture systems within which significant 
amounts of ECM is secreted during the expansion requires significant alterations to the 
procedure such as for example the reagents used for cell recovery. Although our work 
showed that this could be achieved without impairment to the cell functionality, 
additional optimization will still be needed as for example long holding times can 
significantly influence cell characteristics (Delahaye et al. 2015). Further optimization 
of this procedure towards economic feasibility in terms of cost of goods and time will 
be a significant contributor to the potential industrial implementation of this expansion 
methodology (Heathman et al. 2015). 
In addition to cell recovery, a number of other challenges for post-processing in the 
bioreactor field remain to enable successful implementation of automated expansion 
methodologies. The enzymatic harvest procedures result in large volumes of cell 
suspensions which require considerable volume reduction and washing steps. Current 
lab scale processes use dead end centrifugation as standard tool for cell concentration 
and several clinical scale expansion systems such as the Quantum cell expansion system 
(Terumo BTC) and the Xpansion multiplate bioreactor system (Pall) still rely on this 
manual procedure in the absence of other acceptable alternatives. While this method 
cannot be translated to a fully automated and closed unit operation, it provides a 
standard operational procedure applicable over a wide range of systems (Delahaye et 
al. 2015). The potential for scale-up or scale-out and full automation and integration of 
this batch process is, however, limited. Various other systems for automated, on-line 
cell separation already exist within the biopharmaceutical world with the production of 
vaccines as an example. The main goal of these processes is, however, to remove the 
cells from the solution as they are merely a byproduct rather than retaining them for 
future applications. Recent advances showed, however, that optimization of these 
methods, such as tangential flow filtration, do enable the successful retention of a 
significant fraction of the cells without altering their viability or potency indicating the 
potential of these techniques (Cunha et al. 2015a, Cunha et al. 2015b). 
8.3. Future perspectives for perfusion bioreactors in 
tissue engineering 
Substantial progress in the development of automated cell expansion has been made 
using various systems which each have considerable operational advantages over the 
3D culture system. Despite often mentioned, the hypothesis that a biomimetic 3D 
environment would be beneficial for stem cell maintenance during expansion in 
comparison to other, predominantly 2D based setups, has not been confirmed yet 
(Prewitz et al. 2013, Gattazzo et al. 2014, Papadimitropoulos et al. 2014b). The absence 
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of suitable methodologies for cell expansion, recovery and online monitoring of the 
proliferation and neo-tissue formation have been important restrictions in this respect 
which we attempted to address within the framework of this dissertation. Within the 
next section we will discuss some future perspectives required for the continued 
development of perfusion bioreactor systems in the field of TE based upon the general 
discussion formulated in the previous section.  
8.3.1. Micro environment 
The rationale behind the use of a 3D perfusion bioreactor system is the hypothesized 
relevance of the 3D culture environment in respect to the development of a supportive 
in vitro micro-environment resembling the in vivo stem cell niche (Tan et al. 2013). In 
order to assess this hypothesis and thereby harness the full potential of 3D perfusion 
bioreactor systems the development of suitable scaffolds should be a priority. As 
detailed above, the use of decellularized ECM based materials provides interesting 
perspectives in this context and should be pursued further. Firstly, the influence of 
various types of this ECM on cell behavior should be elucidated. Although a 
biomimetic approach, attempting to recreate the native in vivo environment of the 
hPDCs, could be interesting as this in vivo niche is supportive for the maintenance of 
the progenitor cell phenotype, its potential to support substantial proliferation is 
unknown. An in vivo environment which is supportive of periosteal cell proliferation is 
the fracture callus within which the first steps of endochondral ossification take place 
being mesenchymal cell proliferation and condensation. As recapitulating the different 
aspects of the in vivo stem cell niche in an in vitro engineered environment will be a 
considerable challenge requiring new insights on the in vivo micro-environment and its 
interaction with the cells, this will be a time consuming approach without a guarantee 
of success. Based upon the same principles the use of different types of ECM deposited 
by the same cell type that will subsequently be expanded on the decellularized ECM 
could be evaluated. Proof of concept of this methodology is already present for some 
time but these principles have mainly been applied for the development of 
decellularized constructs as implants rather than as in vitro scaffold system (He et al. 
2009, Seib et al. 2009, Lai et al. 2010, Thibault et al. 2010, Pei et al. 2011, Prewitz et 
al. 2013, Bourgine et al. 2014b, Papadimitropoulos et al. 2014b). 
Independent from the applied strategy, the development of a scaffold based upon 
decellularized ECM will entail the availability of a stable cell line needed to guarantee 
consistent production. Various cell lines are already available and of special interest in 
this context is an immortalized MSC line with an integrated inducible apoptotic 
mechanism (Bourgine et al. 2014a, Bourgine et al. 2014b). Although the tri-lineage 
differentiation potential of these cells after genetic engineering was maintained the 
reported use of the cell line is at current limited to the development of a cartilaginous 
ECM indicating that further work is required. Induced pluripotent stem cells are a 
different promising cell source in this context. The pluripotent differentiation potential 
of these cells, combined with their unlimited capacity for self-renewal make them an 
interesting candidate for cell therapy products and various reports of their use for 
skeletal applications illustrate the potential of this novel cell source for tissue 
engineering strategies (Park et al. 2014). The availability of such a cell line which could 
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be cultured under different conditions resulting in either a neutral, osteogenic or 
chondrogenic induced ECM could result in a wide range of off the shelf available 
scaffolds which could be used either as a substrate for cell expansion but also as a 
template for further construct development and tissue regeneration. 
8.3.2. Integrated bioprocess development 
A number of systems for automated cell expansion are already available on the market 
and efforts are being made towards the development of fully automated processes 
integrating up- and down-stream process steps. Due to cost of goods, equipment and 
process time, cell expansion, however, remains an expensive process step, thereby 
significantly influencing the price of ATMPs for which these cells are needed. Limiting 
the required cell expansion by optimizing process performance but also post expansion 
cell potency should therefore be a priority. Multi-passage in vitro expansion of a cell 
population has been shown to result in reduced proliferative and differentiation 
potential (Banfi et al. 2000, Scadden 2006, Wagner et al. 2008). The use of a supportive 
in vitro micro-environment, potentially based upon an ECM derived culture substrate 
but also including optimized media compositions and oxygen concentrations, could 
allow the cells to better maintain their original potency. 
Also in construct development further tailoring of for example the supportive matrix or 
added growth factors as well as optimizing the delivery methods ensuring optimal 
implant survival could further decrease the need for an extensive cell expansion phase. 
Within skeletal TE the application of the developmental engineering paradigm aims for 
the in vitro development of a cartilaginous template to facilitate the in vivo bone 
formation (Lenas et al. 2011). As this process is initiated by MSC proliferation and 
condensation the final cell expansion step can be integrated with the initiation of the 
construct development circumventing the need for cell recovery, rinsing, volume 
reduction and seeding between these steps. Overall elimination of these particular 
down-stream process steps by using a one-step expansion and construct development 
process would be ideal to advance towards a streamlined, lean bioprocess. Due to the 
limited availability of autologous cells a number of expansion steps preceding the 
construct development will, however, be inevitable for most approaches. The use of a 
potent cell population which is readily available in larger numbers, such as MSCs 
isolated from the bone marrow or adipose tissue, could, however, significantly reduce 
the number of passages required form 6-8 for hPDCs to 2-3 for bone marrow derived 
MSCs (Robey et al. 2015) and potentially even less for adipose derived MSCs (Baer et 
al. 2012).  
Finally, as mentioned before, the development of closed, automated processes will be 
imperative for the successful industrial implementation of current TE and regenerative 
medicine concepts in a clinically relevant setting. Rather than transferring the often 
manual lab scale processes to such an automated environment the intended production 
process should be considered from the conceptual phase onwards. Ideally, containment 
of the different optimized process steps within one system, such as the Cocoon 
bioreactor developed by Octane, should be aimed for (Martin et al. 2009). This 
modular, GMP compliant bioreactor is, to the best of our knowledge, the first system 
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combining the three main steps of the TE process (biopsy digest, cell expansion and 
construct development) in one integrated system. Despite the availability of this 
regulatory compliant system its application for the development of novel strategies is 
limited due to the associated costs. A better integration between research and product 
development through industrial collaborations, evolving towards research for 
development, will therefore be required to bring current TE concepts to the market. 
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